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Abstract 
The utility of a model organism for studying biological processes is closely tied to its 
amenability to genome manipulation.  Although tools for targeted genome engineering in 
mice have been available since 1987, most organisms including zebrafish have lacked 
efficient reverse genetic tools, which has stymied their broad implementation as a model 
system to study biological processes.  The development of zinc finger nucleases (ZFNs) 
that can create double-strand breaks at desired sites in a genome has provided a universal 
platform for targeted genome modification.  ZFNs are artificial restriction endonucleases 
that comprise of an array of 3- to 6- C2H2-zinc finger DNA-binding domains fused with 
the dimeric cleavage domain of the type IIs endonuclease FokI.  C2H2-zinc fingers are the 
most common, naturally occurring DNA-binding domain, and their specificity can be 
engineered to recognize a variety of DNA sequences providing a strategy for targeting 
the appended nuclease domain to desired sites in a genome. The utility of ZFNs for gene 
editing relies on their activity and precision in vivo both of which depend on the 
generation of ZFPs that bind desired target sites high specificity and affinity. 
Although various methods are available that allow construction of ZFPs with novel 
specificities, ZFNs assembled using existing approaches often display negligible in vivo 
activity, presumably resulting from ZFPs with either low affinity or suboptimal 
specificity.  A root cause of this deficiency is the presence of interfering interactions at 
the finger-finger interface upon assembly of multiple fingers.  In this study we have 
employed bacterial-one-hybrid (B1H)-based selections to identify two-finger zinc finger 
units (2F-modules) containing optimized interface residues that can be combined with 
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published finger archives to rapidly yield ZFNs that can target more than 95% of the 
zebrafish and human protein-coding genes while maintaining a success rate higher than 
that of ZFNs constructed using available methods.  In addition to genome engineering in 
model organisms, this advancement in ZFN design will aid in the development of ZFN-
based therapeutics.  
In the process of creating this archive, we have undertaken a broader study of zinc finger 
specificity to better understand fundamental aspects of DNA recognition.  In the process 
we have created the largest protein-DNA interaction dataset for zinc fingers to be 
described that will facilitate the development of better predictive models of recognition. 
Ultimately, these predictive models would enable the rational design of synthetic zinc 
finger proteins for targeted gene regulation or genomic modification, and the prediction 
of genomic binding sites for naturally occurring zinc finger proteins for the construction 
of more accurate gene regulatory networks. 
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 CHAPTER I 
INTRODUCTION 
 
1
General 
Complex metazoans such as humans can possess more than two hundred different cell 
types.  Although these cell types originate from a common cell (the zygote), each one has 
its own gene expression profile, which helps to define its identity thus creating unique 
characteristics for each cell type.  Each unique expression profile is the result of 
differential gene expression, which is controlled in large part by transcription factors 
(TFs).  Regulation of gene expression by TFs plays pivotal roles in all cellular processes 
throughout development and when perturbed, can be detrimental to organismal fitness. 
 
Transcription Factors 
Transcription factors are trans-acting proteins that bind to cis-regulatory DNA elements 
either directly or indirectly through protein partners to influence the transcription of a 
gene.  There are two broad categories of TFs: general transcription factors and gene-
specific transcription factors. General transcription factors are components of the RNA 
polymerase machinery that are required for basal transcription of almost all genes and 
therefore are essential for an organism to survive1,2.  Gene-specific transcription factors 
are required for transcription of certain genes and can act either as activators or repressors 
of transcription.  These factors are central for differential gene expression and therefore 
are major determinants of phenotypic diversity and evolution of species3. 
Sequencing the human genome provided insights into total number of genes in each 
family of transcription factors4.  The human genome consists of ~20,000 genes5,6 which 
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seems low considering much simpler organisms, like drosophila and C. elegans have 
~14,0007,8 and ~20,000 genes9 respectively.  In contrast, the TFs represent ~10% of the 
total genes in the human genome10, whereas they represent only ~5% in the drosophila 
and C. elegans genomes8,11 suggesting an expansion of TF genes in more complex 
organisms.  This increase in the TF numbers along with the increase in the non-coding 
genome, which includes binding sites for these TFs, may result in more entangled gene-
regulatory networks imparting greater complexity to higher order organisms12,13. 
 
DNA binding domains 
Majority of TFs consist of one or more DNA binding domains (DBDs) that provide 
sequence specificity or selectivity to the TFs allowing them to recognize their genomic 
targets.  DNA binding domains have been categorized into different families based on 
their sequence homology.  DBDs within a family also share basic mechanism of DNA 
recognition.  Although TFs in the human genome can be divided into more than 20 
groups based on their DBD, over 80% fall into three groups of DBDs namely, C2H2-Zinc 
finger domain (ZFD), Homeodomains (HD) and basic helix-loop-Helix domain 
(bHLH)14. 
Basic Helix-loop-helix proteins 
Basic Helix-loop-helix proteins are the third most common type of TFs14. These proteins 
function as dimers where each monomer consists of two α-helices connected by a small 
3
loop15,16.  The basic region is an extension of the first helix and binds the major groove of 
DNA making base specific contacts.  BHLH TFs typically bind to a consensus sequence 
CANNTG,which is known as the E-Box and play important roles in cell proliferation and 
differentiation17.  
Homeodomains 
Homeodomains, first discovered in drosophila as homeotic genes18, are the second most 
abundant DBDs in TFs14.  These are ~60 amino acid long DBDs that fold into three α-
helices preceded by a flexible N-terminal arm.  Each homeodomain recognizes 3 to 8 bp 
of DNA where the third α-helix docks into the major groove of DNA making base 
specific contacts to the 3’ end of the target sequence. The N-terminal arm may dock in 
the minor groove of DNA and contacts the 5´ bases.  Recently, Noyes et al. determined 
the DNA binding specificity of 84 homeodomains from the drosophila genome and 
classified them into 11 different groups based on their specificities19.  Homeodomains 
can bind DNA as both monomers and dimers, where the dimerization is mediated by the 
YPWM motif on the N-terminal arm of the homeodomain20.  Dimerization of 
homeodomains allows them to bind to longer binding sites providing them additional 
specificity and finer control of gene expression.  Homeodomain containing genes are 
involved in regulating developmental processes such as body axis formation, appendage 
formation, organogenesis and therefore it is not surprising that they are highly conserved 
from insects to mammals.  
 
4
C2H2-Zinc finger domain 
The C2H2-Zinc finger domain (ZFD) is the most frequently used DNA binding domain 
with more than 50% of TFs in the human genome incorporating this domain14.  The 
C2H2-Zinc finger family has expanded considerably in mammals through gene 
duplications followed by functional divergence, where there is evidence of strong 
positive-selection pressure at the specificity determinants in paralogs generating novel 
recognition preference12,21,22.  The expansion of zinc fingers has resulted in more than 
700 multi-zinc finger genes in humans with ~8.5 zinc fingers per TF4,12,22.  Since, each 
zinc finger in the canonical mode of DNA recognition (see below) binds to 3 basepairs of 
DNA, multifinger-TFs may recognize longer DNA sequences with higher affinities.  
However, all ZFDs in a multifinger TF may not be involved in DNA recognition.  For 
example, TFIIIA contains 9 ZFDs, but only 6 of them bind DNA where only 4 make 
majority of the DNA contacts23.  Similarly, CTCF contains 11 ZFDs but only fingers 4 
through 8 are required for binding site recognition24.  In fact, CTCF may employ different 
combination of fingers to bind different DNA sequences in the genome25.  Moreover, in 
addition to binding DNA, C2H2-Zinc finger domains can bind to proteins and RNA26-28.  
For example, TFIIIA protein binds to both the DNA and the 5S rRNA29.  Ikaros, a six 
finger zinc finger protein (ZFP), uses its four N-terminal fingers to bind DNA and the 
two C-terminal fingers for homodimerization26. 
Most zinc-finger containing TFs in the human genome are associated with either a SCAN 
(SRE-ZBP, CTfin51, AW-1 and Number 18 cDNA), KRAB (kruppel associated box) or 
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BTB (Broad complex, Tramtrack, Bric-a-Brac) effector domains or a combination of 
SCAN and KRAB domains.  SCAN is small, leucine-rich domain that is found only in 
the vertebrates.  It allows homo- and hetero-dimerization with other SCAN containing 
domains and is not associated with transcriptional regulating properties30.  BTB domain 
is an evolutionary conserved domain that is found in all eukaryotic organisms.  It is 
estimated that 5-10% of zinc finger containing TFs in the human genome incorporate the 
BTB domain22.  The BTB domain allows homo- or hetero-dimerization of these TFs.  
Interactions of the BTB domain with corepressors Sin3A, SMRT, and N-CoR recruit 
histone deacetylase to the target genes which are then repressed30.  KRAB domain is a 
tetrapod specific transcriptional repressive domain that is associated with almost 40% of 
zinc finger proteins22.  The KRAB domain binds with its co-repressor, KAP1 (KRAB-
associated protein 1) and similar to the BTB domain, recruits histone deacetylases and 
represses target genes through changes in chromatin architecture31.  
Although most zinc finger proteins associated with the KRAB and BTB act as 
transcriptional repressors, there are instances of zinc finger proteins such as Sp132 and 
Zelda33 that act as transcriptional activators.  Sp1, is a three finger ZFP that was 
identified from HeLa cell extracts as an activator of transcription of SV40 promoters34.  
Through biochemical experiments it was shown to bind to GC rich DNA elements35,36.  
Currently, it is known that Sp1 and its paralogs can regulate expression of more than 
1,000 genes both TATA-containing and TATA-less genes37 involved in many vital 
cellular functions through its interaction with transcriptional co-activators hTAFII130 and 
hTAFII250 or with other TFs27,32.  Moreover, association of Sp1 with chromatin-
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modifying factors such as p300 and histone deacetylases (HDACs) has been linked to its 
role in chromatin remodeling37. 
ZFD-containing TFs are involved in a wide variety of biological processes.  TFIIIA is a 
gene specific transcription factor required for transcription initiation of the 5S rRNA 
gene, nuclear export and cytoplasmic storage of the 5S rRNA27.  Egr1 (also known as 
Zif268), which contains a well-studied three finger ZFP is involved in differentiation, 
mitogenesis, and tumor progression38.  CTCF (CCCTC binding factor) is a highly 
conserved TF in metazoans that is involved in chromatin remodeling, enhancer blocking, 
and transcriptional regulation39.  A recent study showed that syntenic and constitutively 
bound CTCF sites overlap with cohesin-associated loci and may function as insulator 
elements40.  Moreover, these CTCF sites preferentially flank disease-associated genes40.  
Prdm9 is a 12-finger zinc finger protein (ZFP) that is involved in specification of meiotic 
recombination hotspots41,42.  Although, the DNA sequence for chimpanzee is highly 
similar to that of humans, the hotspot locations have changed between these species that 
has been linked to corresponding changes in the DNA recognition properties of Prdm9, 
implicating its importance in the evolution of species41. 
History of C2H2 zinc finger research 
Zinc finger proteins (ZFPs) were first discovered in Xenopus through biochemical studies 
on TFIIIA which itself was the first transcription factor to be identified29.  TFIIIA is a 
part of the transcription initiation complex that was known to bind RNA as well as DNA.  
Hanas et al. first reported zinc binding for TFIIIA but later Klug and colleagues reported 
a more correct stoichiometry for zinc binding29,43.  Through biochemical experiments 
7
Klug and colleagues showed that binding of zinc, and not other ions stabilizes the 
TFIIIA-RNA complex.  They also found that each molecule of TFIIIA binds to 
approximately 7 molecules of zinc ions.  Proteolytic digestion of TFIIIA resulted in 
intermediate products that differed in size by ~3KDa before finally breaking down into 
~3KDa products implying that TFIIIA is composed of repeating structures.  Alignment of 
the amino acid sequence of TFIIIA, published by Ginsberg et al.44, revealed a repeating 
~30 amino acid long motif that corresponded to a size of ~3KDa29.  This motif was 
termed as ‘zinc-finger’ since it bound zinc and also gripped DNA.  Since, there were 9 
repeating motifs, each one binding to one zinc ion, the estimate of approximately 7 
molecules of zinc per molecule of TFIIIA was almost right on target.  The Klug lab also 
proposed a model for zinc finger binding to DNA that had some agreement with the 
structure of Zif268 published a few years later29,45.  Soon after the zinc finger motif was 
reported in TFIIIA, two other proteins were reported to contain a zinc finger motif: the 
Serendipity gene and Kruppel, both from drosophila46,47. As additional zinc finger 
sequences became available, the following consensus sequence for zinc fingers was 
revealed48:  
(F/Y)-X-C-X2−5-C-X3-(F/Y)-X-X-X-X-X-Ψ-X-X-H-X3−5-H 
where ‘X’ represents any amino acid and ‘Ψ‘ is a hydrophobic residue.  The positions 
indicated in bold represent potential DNA-interacting amino acids on the recognition 
helix that were defined later through biochemical and structural analyses. 
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DNA recognition by zinc finger proteins 
The NMR structures described by the Wright group revealed that zinc fingers fold into a 
ββα-fold stabilized by tetrahedral coordination of a zinc ion by two cysteines and two 
histidines49.     However, significant understanding of DNA recognition by zinc finger 
came from the X-ray crystal structure of the DNA-bound Zif268 protein described by the 
Pabo lab45,50.  Zif268, or Egr1, is a three-finger protein that has served as the framework 
for understanding DNA recognition and creation of zinc fingers with novel DNA binding 
specificity.  Zif268 was crystallized with its preferred binding site (GCGTGGGCG) as 
determined from prior biochemical analysis51 (Figure 1-1a).  The zinc finger folding, 
docking, and DNA recognition of Zif268 is considered as a benchmark for evaluating 
other zinc fingers and therefore are considered ‘canonical’ (for review refer to Wolfe et 
al.48).  
The crystal structure revealed that zinc fingers fold into a ββα-fold stabilized by 
tetrahedral coordination of a zinc ion by two cysteines and two histidines45 (Figure 1-
1b).  The α-helix docks into the major groove of DNA, making base specific contacts 
through residues on the ‘recognition helix’.  The amino acids on the recognition helix are 
numbered indicting their position relative to the start of the α-helix.  The three fingers of 
Zif268 bind similarly to the DNA and make majority of the base specific contacts to one 
strand of the DNA called the ‘primary strand’ (Figure 1-1c).  The fingers run anti-
parallel to DNA that is, the N-terminus of the zinc finger is facing the 3´ end of the 
binding site and vice versa (Figures 1-1c and 1-2).  In the canonical mode of binding,  
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Figure 1-1 
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 Figure 1-1: Structure of Zif268. (a) X-ray crystal structure of Zif268 bound to its 
binding site45. (b) Close-up of finger-1 of Zif268 bound to the ‘GCG’ subsite45.  Amino 
acids that contact the ‘GCG’ triplet are highlighted and numbered referring to their 
positions relative to the start of the recognition helix.  Hydrogen bonds from the arginines 
to guanines are shown in red and from Asp at +2 to Arg at -1 are shown in grey.  Glu at 
+3 makes van der Waals contacts (green) to cytosine. (c) Schematic showing base 
contacts for Zif26845,52.  Arrows represent the hydrogen bonds and black dots indicate 
van der Waals contacts.  Red bar indicates inter-finger interactions. 
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Figure 2-2: Canonical model of DNA recognition by zinc fingers and context 
dependent effects. (a) In the canonical mode of DNA recognition, each zinc finger binds 
to 3 basepairs of DNA (represented by 5,M and 3) in the anti-parallel orientation.  The 
amino acids on the recognition helix are numbered relative to the start of the helix.  
Residues at positions 6, 3, and -1 bind to three basepairs 5, M and 3 respectively. Amino 
acid at position 2 contacts the base (pink) outside the 3 bp core site on the complementary 
strand of DNA.  (b) In a multi-finger protein, zinc fingers bind adjacent 3bp sites.  The 
red-boxed basepairs form the 2 bp junction that is specified by the amino acids at the 
interface of the two neighboring fingers.  The pink base contacted by the amino acid at 
position 2 of the C-terminal finger is shared by the amino acid at position 6 of the 
neighboring N-terminal finger.  (c) An example of context dependent alteration of 
specificity. The ‘TTG’ finger (red) in different contexts in two 3-finger proteins shows 
different specificities (red triplets)53. 
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 each finger binds to a core 3bp element of DNA (represented by NNN) with amino acids 
at positions -1, 3, and 6 making base specific contacts to the 3´ base, middle base and the 
5´ base respectively in the 3bp core element (Figures 1-1 and 1-2). The contacts made by 
the finger-1 of Zif268 to the ‘GCG’ core DNA sequence are shown in figure 1-1b.  The 
amino acid at position 2 makes a contact to the base complementary to the base just 
outside (3’) the 3bp core element (Figures 1-1c and 1-2).  Since neighboring fingers in a 
ZFP bind to adjacent DNA triplets, the base outside the core triplet is shared by the 
amino acid at position of 6 of the neighboring N-terminal finger (Figures 1-1c and 1-2) 
and therefore, the sequence preference of a finger can be influenced by the sequence of 
the neighboring finger. 
Many of the neighboring zinc fingers in ZFPs are linked by an evolutionary conserved 5-
amino acid linker (TG(E/Q)KP)22.  This linker is flexible in solution but takes a more 
rigid conformation upon binding to DNA based on NMR analysis of the free and DNA-
bound protein49.  In addition to the phosphate contact made by lysine, threonine, and glycine 
cap the C-terminus of the neighboring N-terminal finger’s helix48.  Mutating residues T, G, 
K, and P in the TGEKP linker of TFIIIA resulted in atleast 6-fold reduction in its affinity 
to DNA showing that the linker sequence is important for binding of zinc fingers to DNA 
with high affinity54,55.  Moreover, phosphorylation of Thr/Ser residue of the 
(T/S)G(E/Q)KP linker can modulate binding of the ZFP to DNA and might be used by 
nature to control activity of ZFPs during mitosis56,57.  Also, the sequence and the length 
of the linker dictates the spacing between the subsites for neighboring fingers.  Adjacent 
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fingers linked by the conserved five amino acid linker, bind adjacent DNA subsites 
(Figures 1-1c and 1-2).  One of the potential problems with polydactyl proteins with 
more than 3 or 4 fingers is that they might get out of phase of the DNA helical pitch48,58.  
Studies have shown that using a modified non-canonical linker, with an extra residue 
inserted between the canonical TG(E/Q)KP linker, to connect every 2N and 2N+1 finger 
in a 5 or 6 finger ZFP can help build high affinity polydactyl ZFPs that may show 
improved discrimination for their cognate vs mutant sites59,60. Moreover, using longer 
linkers or inserting extra spacer finger can help build ZFPs that bind neighboring subsites 
separated by 1 or more base pairs59-65. 
The Zif268-like canonical mode of binding is followed by many zinc fingers from other 
proteins such as finger 2 of tramtrack66, finger 3 of YY167, and finger 2-4 of WT168.  
However, DNA recognition by many zinc fingers deviates from this canonical mode of 
binding.  For example, F1 of tramtrack66, fingers 4 and 5 of Gli69, fingers 1, 2 and 4 of 
YY167, fingers from the engineered zinc finger protein-TATAZF52 make DNA contacts in 
a pattern different than the Zif268-like fingers and thus follow a non-canonical mode of 
DNA binding even though in some cases (e.g. TATAZF) they dock with the DNA in a 
Zif268-like manner52. 
Using zinc fingers to create artificial DNA binding domains 
Initial site-directed mutagenesis experiments demonstrated that the specificity of zinc 
fingers can be altered to bind desired sequences70-72.  The finger swapping experiments 
revealed the modular nature of zinc fingers71.  Moreover, first Choo et al. and later Liu et 
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al. demonstrated that artificial zinc finger proteins can be constructed and used to recruit 
an effector domain to desired locations in the genome to modulate gene expression in a 
directed manner73,74.  These characteristics of zinc fingers present the opportunity to 
engineer zinc finger proteins (ZFPs) to bind a desired DNA sequences where these 
proteins could then be used to regulate gene expression at will. Understanding the 
protein-DNA interactions that define sequence preference on a broad scale for zinc 
fingers would allow the development of recognition models that would enable not only 
rational design of sequence specific ZFPs but also prediction of specificities for naturally 
occurring zinc finger containing TFs.  In this direction, zinc finger libraries based on the 
backbone of Zif268 or its variant with randomized DNA-contacting amino acid residues 
have been utilized to isolate novel zinc fingers with desired DNA-binding specificity via 
selection based methods. 
 
Selections of Zinc finger proteins with novel DNA-binding specificity 
The following selection techniques have been successfully utilized to isolate active zinc 
finger members from a randomized library. 
Phage Display 
In the past, phage display based selections, where each member of zinc finger library is 
expressed on the surface of a M13 bacteriophage, have been successfully employed to 
obtain zinc fingers that bind to desired DNA sequences with high affinity75-86. Pabo, 
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Barbas, and Klug labs have utilized phage display to select a large number of zinc fingers 
with novel specificities (discussed below).  Most of the zinc finger modules that are 
currently being used by Sangamo BioSciences were selected using phage display.  
Although, this method allows the use of large unbiased zinc finger libraries with up to 
1010 members, the selection of zinc fingers is performed in vitro through multiple rounds 
of enrichment, which sometimes drives the selections in favor of high affinity instead of 
specificity. 
Yeast based selection method 
In comparison to the phage display, the yeast based selection method allows selection of 
zinc finger proteins in vivo but owing to the low transformation efficiency of yeast, only 
medium complexity libraries with ~107 members can be searched restricting the use of 
this method to explore complex libraries87.  A yeast-based reporter system has also been 
used to screen for zinc fingers from the human genome to isolate zinc fingers that could 
be employed to build artificial ZFPs88. 
Bacterial selection methods 
There are two bacterial selection methods available: the bacterial-1-hybrid (B1H) and the 
bacterial-2-hybrid (B2H).  The B1H method, a modified version of the original bacterial 
system described by Dove et al., uses the yeast HIS3 and URA3 genes as reporter genes 
downstream of the zinc finger binding site (Note: the URA3 gene also serves a counter- 
selectable marker for eliminating self-activating or false positive sequences from the 
library).  The zinc finger library is fused directly to either the α-subunit of the RNA 
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polymerase89,90 or in the more recent version, to the ω-subunit of the RNA polymerase19.  
A member of the zinc finger library and the binding site reporter plasmid are 
compartmentalized in a bacterial cell lacking the hisB (bacterial homolog of HIS3), pyrF 
(bacterial homolog of URA3) and rpoZ (gene encoding the ω-subunit -only for the recent 
ω-subunit version) genes.  Binding of the ZFP to its binding site recruits the RNA 
polymerase (via the fused α- or ω-subunit) on the promoter controlling the reporter genes 
inducing their expression and ultimately allowing the bacterial cell containing the active 
zinc finger protein to grow on the selective media.  Originally described for determining 
the binding site specificity of transcription factors19,89-93, the B1H system can also be used 
to select for ZFPs that bind to desired target sites94.   
The B2H system, working on a similar principle as B1H, employs a reporter construct 
containing the reporter genes HIS3 and aadA downstream of the zinc finger binding sites.  
When the zinc finger member fused to the Gal11p domain binds to the desired target site, 
dimerization of the Gal4-fused α-subunit of the RNA polymerase is induced allowing 
expression of the reporter genes and survival of bacterial cells on selective media95-100.  In 
comparison to the B2H system, the ω-based B1H selections can be performed in a ω-
deficient strain (ΔrpoZ) providing higher sensitivity to the system that allows weaker 
DNA-protein interactions to be characterized92. 
The B1H and B2H selection methods combine the advantages of phage display and 
yeast-based selection system.  They are performed in vivo where the bacterial genomic 
DNA acts as a sink for non-specific binding of zinc finger proteins thus selecting ZFPs 
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for both specificity and affinity89,91,94,95.  Moreover, bacterial based selection methods 
allow survey of large libraries with ~109 zinc finger members in a single round of 
selection as compared to multiple rounds of enrichment required in phage display thus 
making the selection process easy and rapid. 
Selection Strategies 
Starting from the single finger selections, the selection strategies to identify ZFPs with 
desired specificities were refined as the field matured.  The following is a summary of the 
different selection strategies that have been employed, their advantages and 
disadvantages. 
Single finger selections ignoring complications of context-dependence 
The foremost selection studies involved creating libraries of zinc fingers based on three 
finger proteins, Zif268 or a variant of this sequence83,101, where the base specifying 
contacts for one of the zinc fingers were randomized and the other two fingers were kept 
constant due to the limitations of the library size that can be screened by the utilized 
selection systems.  This library was then used for selections via one of the selection 
methods described above to identify ZFPs that bind different 3bp subsites in a 9bp 
binding site75-80,82,83,95.  The Barbas lab used this strategy to identify individual zinc fingers 
that bind almost all 3bp sequences75,82,83.  These individual zinc finger modules could be 
combined to rapidly create multi-finger zinc finger proteins in a process termed modular 
assembly.  Although, modularly assembled ZFPs have been shown to bind their desired 
targets in vitro, only 20% of the analyzed ZFPs contained a ‘non-GNN’ recognizing finger102.  
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Modularly assembled ZFPs showed low activity when tested using the B2H-based reporter 
assay where their success rate was again dependent on the number of GNN recognizing 
fingers incorporated into the ZFP100,103.  The low success rate of these modularly assembled 
ZFPs was attributed to their low affinity for the target sites104 which presumably results from 
context dependent effects82,83,100,103. 
Problem of context dependence 
One of the problems with the ‘single finger selection, no context dependence’ strategy is 
that it assumes a modular nature of zinc fingers ignoring two types of inter-finger 
interactions: 
a) The amino acid at position 2 (and sometimes at position 1 52) interacts with the 
base outside the 3bp-core triplet on the strand complementary to the primary 
strand (Figures 1-1c and 1-2a)45,105.  In the context of a multifinger ZFP, this base 
outside the core-3bp element is also shared by the N-terminal neighboring finger 
(Figure 1-2b).  Therefore, when selections were performed in the context of the 
three-finger protein, the outcome was influenced by the neighboring fingers that 
were kept constant in the library of zinc fingers.  Moreover, when individually 
selected zinc fingers are combined to create novel combinations of ZFPs the 
contact from the amino acid residue at position 2 to the 5’ base of the subsite of 
the neighboring C-terminal finger can alter the DNA-binding specificity of the 
neighboring fingers altering53 (Meng et al. unpublished data). These problems can 
be exacerbated if zinc fingers bind in a non-canonical mode making non-standard 
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contacts that can influence the specificity of the selected fingers or the 
neighboring fingers in an engineered protein52. 
b) Since the neighboring zinc fingers bind adjacent DNA subsites that are 
approximately 3.4 Å away, amino acids at the finger-finger interface, especially 
residue at position 6 of the N-terminal finger and residue at position -1 of the C 
terminal finger, can interact with each other45,52,105.  These protein-protein 
interactions at the finger-finger interface can again influence the outcome of the 
selections and influence specificity of fingers in an engineered zinc finger protein. 
Single finger selection factoring in context dependence 
New strategies were developed to address the problems of context dependence.  The Pabo 
lab developed a protocol for sequential selection of three-finger zinc fingers, where one 
finger is selected at a time while moving through the 9bp binding site81,86.  This protocol 
although highly effective, is a labor-intensive process.  Another strategy, termed OPEN 
(Oligomerized Pool ENgineering) involves constructing three different libraries, one for 
each of 3 fingers in the context of two constant anchor fingers and then searching them 
individually in parallel using the B2H system to select for a few active clones that bind 
constituent subsites of the desired 9bp site97,99.  These active clones for each finger are then 
fused to yield a smaller library of three-finger proteins that is now reselected to identify for 
three finger ZFPs that bind the desired 9bp target site96-99,106.  Although these selections yield 
highly active ZFPs, they are labor-intensive to perform and therefore they are not feasible for 
rapid generation of engineered zinc-finger proteins.  Moreover, during the individual library 
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selections the finger-finger interactions still exist and can affect the outcome of the 
selections. 
Selecting for interface residues 
One of the ways to minimize effects of context dependence in multi-finger assemblies is 
by selecting for zinc-finger units with optimal interface-residues that are kept constant 
during the assembly.  Isalan et al. created a library of three finger ZFPs where the 
residues at the finger-finger interface were randomized and then searched this library to 
identify groups of interface-residues that are optimal for binding to all 2-bp DNA 
junctions84.  However, this study was not detailed enough to understand properties of 
interface recognition in different contexts and was never followed up to demonstrate its 
utility to build multi-finger proteins.  The same group devised a ‘bipartite’ strategy where 
they created two overlapping three finger libraries of limited diversity each with 
randomized DNA contacting residues of 1.5 fingers85.  This library was used to identify 
1.5 fingers that bind overlapping half sites of the desired 9-bp sequence.  The selected 
proteins were then combined to create active three-finger ZFPs.  This strategy was further 
utilized to create an archive of two-finger (2F) units that could be combined to create 
multi-finger ZFPs.  This archive, however, is proprietary to Sangamo Biosciences and 
thus is not available for general use.  Recently, the Joung lab utilized their OPEN 
(Oligomerized Pool ENgineering) pools98 to identify overlapping 2F-units that could be 
combined to create active ZFPs via context-dependent assembly (CoDA) method100.  
However, their archive mainly consists of modules that recognize ‘GNN’ triplets or ‘N-
G’ junctions.  Moreover, the artificial ZFPs and ZFNs assayed, were almost entirely 
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constructed from 2F-modules that recognize ‘GNN-GNN’ 6bp sites with ‘N-G’ type 
junctions that are not the limiting factor for advancing ZFN design100. 
 
Binding site selections  
The artificial zinc-finger proteins selected from randomized libraries can bind to or even 
prefer other DNA sequences to the desired target site82,83,86.  Therefore, determining the 
binding-site specificity is a useful way to validate the selected ZFPs.  Moreover, 
identification of binding site preferences of transcription factors (TFs) would allow for 
the prediction of TF sites and cis-regulatory modules in the genome providing a better 
understanding of gene-regulation networks.  The following is a summary of available 
methods for determining binding site specificities (reviewed by Stormo et al.107). 
Initially, phage display and ELISA-based methods were used to determine the specificity 
of selected ZFPs75,82,83,108.  However, these methods could determine specificity of only 
one finger at a time and were labor intensive.  SELEX (Systematic Evolution of Ligands 
by EXponential enrichment) involves the extraction of binding-sites from an unbiased 
pool of oligonucleotides through multiple rounds of enrichment of sites bound to the 
protein109-112.  It has been utilized to assess binding site specificities for selected ZFPs but 
since it involves multiple rounds of enrichment, energetic differences between different 
binding sites cannot be estimated62,63,113-116.  A modified version of SELEX, HT-SELEX 
requires only one round of enrichment and couples this with high-throughput sequencing 
to develop energetic models that fit better than the regular SELEX117.  However, like 
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SELEX this method is in vitro and requires protein purification or in vitro protein 
expression.  Another in vitro method for identifying binding-site preferences for naturally 
occurring TFs or engineered ZFPs is using protein-binding microarrays (PBMs) wherein 
a library of binding sites is spotted onto a microarray chip.  This chip contains ~40,000 
spots of 60-mer oligos in which all possible 8-base sequences are represented in 32 
different contexts118.  The TF, either purified or in vitro expressed, is added to the chip 
and the TF-bound DNA oligos are identified using fluorophore-conjugated antibody that 
binds to the TF.  The binding specificity of a TF can then be estimated using motif-
finding algorithms.  Although PBM is a medium throughput method to estimate binding 
specificities and affinities of DNA-binding proteins, it is limited by the number of sequences that can be interrogated on a chip thereby restricting its utility to TFs with 
short (~10mer) binding sites107,118,119. 
In comparison to in vitro methods, Chromatin Immunoprecipitation (ChIP) coupled with 
microarray (ChIP-chip) or high-throughput sequencing (ChIP-Seq) followed by 
computational analysis of over-represented sequence motifs provides a powerful way to 
determine in vivo binding sites for a TF in a genome120-122.  However, this method is low 
throughput and dependent on the availability of antibodies specific to the protein of 
interest and on the condition of the in vivo sample.  A more recent method, bacterial-one-
hybrid (B1H) based selection method involves identifying ZFP binding sites from a 
randomized library through reporter activation19,89-94,123.  This method has several 
advantages over in vitro methods and ChIP.  This is a medium-throughput in vivo method 
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that does not require protein purification and involves only single round of selection thus 
making it easy to perform. 
 
Recognition Codes   
A recognition code is a set of rules describing the interactions of an amino acid with a 
nucleotide at a given position such that for any residue (amino acid or nucleotide) its 
interacting partner(s) can be accurately predicted.  Although, the differences in docking 
mechanisms and non-independent interactions limit the possibility of an accurate 
universal code for all DNA-binding domains, there can be recognition codes that describe 
DNA-protein interactions within families and subfamilies of DNA-binding domains124.  
If such a code is available for zinc-finger proteins, it can be used to rationally design 
artificial ZFPs with desired specificity and also predict specificity of artificial as well as 
naturally occurring ZFPs.  Qualitative models have been described for zinc finger-DNA 
recognition that provide information on the amino acids that can be used for recognizing 
desired nucleotides48,108,125.  However, these models being qualitative, do not provide any 
information on the energetics of DNA recognition and also ignore context-dependent 
interactions.  Benos et al. created quantitative models that used frequencies of contacts 
observed in SELEX and phage display data 126.  However, their predictive capabilities are 
limited mainly due to the paucity of high quality zinc finger-DNA interaction data that 
took into account the context-dependent effects and assumption of independence of 
protein-DNA interactions.  Also, the DNA-protein data was biased toward proteins that 
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recognized ‘GNN’ subsites and, therefore, availability of extensive unbiased DNA-
protein interaction data for zinc-finger proteins would be necessary to build accurate 
predictive models. 
 
Applications of artificial zinc finger proteins 
Owing to their semi-modular nature and ability to recognize a wide variety of DNA 
sequences, zinc-finger proteins proved advantageous for creating artificial DNA-binding 
domains that could recruit any given effector domain to a desired address in the 
genome127.  Most common applications of ZFPs include their use as artificial 
transcription factors and as zinc-finger nucleases. 
Artificial Transcription Factors 
The first application for artificial ZFPs was to use them to mimic their natural function of 
gene regulation by fusing them with either an activation domain, such as the VP16 128 or 
p65 129 domain or a repression domain such as the KRAB domain130.  Choo et al. first 
demonstrated artificial ZFPs selected using phage display could be used to repress as well 
as activate transcription73. Although the activation was mediated by the VP16 domain, 
repression was not induced by any effector domain but was caused by interfering with the 
interaction of RNA polymerase with its promoter73.  Liu et al. in comparison employed 
the KRAB domain for repression of reporter genes in transiently transfected cells74.  The 
Barbas lab showed for the first time that the individual fingers selected using phage 
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display could be combined to create artificial TFs that could specifically regulate 
expression of desired endogenous genes82.  Since then a number of applications have 
been reported employing ZFPs as artificial TFs including the repression of HIV-1 5´ LTR 
promoter131, the repression of herpes simplex viral (HSV) genes132, the repression of 
pparγ-1 and pparγ-2 genes in 3T3 cells133, activation of human erythropoietin gene 
(EPO)134, the activation of VEGFA gene to induce angiogenesis135 and the activation of 
glial cell line-derived neurotrophic factor gene136.  Moreover, it has been demonstrated 
that the activity of these artificial TFs can be influenced by the chromatin structure at and 
around the target site and conversely, these artificial TFs can remodel the chromatin 
around the target site82,134,137,138.  In another strategy to regulate gene expression, artificial 
ZFPs were fused to a chromatin modifying enzyme, v-ErbA, that repressed the targeted 
gene expression139,140.  Some of these applications have potential for use as therapeutics.  
VEGFA activator (VEGFA-TF) is a chimeric protein with a p65 activator domain fused 
to the three-finger ZFP that binds a 9bp sequence GGGGGTGAC135.  This activator 
upregulates expression of all isoforms of VEGFA, thus inducing angiogenesis resulting in 
the formation of new functional blood vessels141.  Later, VEGFA-TF injection in the rat 
model of diabetes was shown to alleviate some symptoms of peripheral diabetic 
neuropathy, which causes damage to microvasculature in extremities encouraging the use 
of VEGFA-TF as a therapeutic142.  Although the results of clinical trials showed that the 
therapy is safe but there was no clear statistically significant difference in alleviation of 
symptoms between patients who received the therapy versus those who got a placebo 
resulting in the recent cessation of the clinical trial143.  Another artificial TF (GDNF-TF) 
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being evaluated in clinical trials is a six-finger ZFP fused to the p65 domain that activates 
the expression of the endogenous glial cell line-derived neurotrophic factor (GDNF) 
gene136.  Microarray results showed that GDNF was the highest upregulated gene by 
GDNF-TF with only a few off-target genes being activated at lower levels.  AAV2 
mediated striatal delivery of GDNF-TF in rat model of Parkinsons disease resulted in 
improvements of certain symptoms of the disease.  Pre-cinical trials are underway for this 
potential therapeutic. 
 
Zinc finger Nucleases 
Zinc finger nucleases are synthetic restriction endonucleases comprising of artificial zinc 
finger proteins fused to the cleavage domain of the FokI type IIs endonuclease.  ZFNs 
can create a double strand break in DNA at targeted loci thus allowing targeted genome 
manipulation.  The current architecture of ZFNs includes either a homodimeric or 
obligate heterodimeric versions of the FokI cleavage domain fused by a linker to a 3- to 
6-finger ZFP that binds to 9- to 18 basepairs of DNA.  Since the FokI endonuclease 
domain requires dimerization for activity, two monomers of ZFNs are designed each 
binding up to 18bp long DNA half-site where the two monomeric sites separated by a 5- 
or 6-bp spacer (Figure 1-3). 
FokI, isolated from Flavobacterium okeanokoites, is a type IIs restriction enzyme that 
binds to 5´GGATC3´ sequence and non-specifically cleaves DNA 9/13-bp away leaving a 
4bp 5´ overhang144.  Through biochemical assays and later confirmed by structural  
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Figure 1-3 
                            
 
 
Figure 1-3: Zinc finger nucleases. A schematic drawing showing the ZFNs bound to the 
target site.  The FokI nuclease domain is fused at the C-terminal of the zinc finger 
protein.  The two ZFN monomers (ZFNL and ZFNR) bind respectively to the 9 bp 5′ and 
3′ half sites through the associated ZFPs (fingers indicated by numbered ovals), which 
position the heterodimeric nuclease domain over the 6 bp spacer between the two ZFP 
half sites. 
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studies, FokI was shown to consist of two modular domains: the N-terminal DNA 
recognition domain and the C-terminal cleavage domain145,146. The modular nature of 
FokI allowed replacement of its DNA-binding domain with other naturally occurring 
DNA binding domains147-150.  Further studies, again both biochemical and structural, 
demonstrated that dimerization of FokI cleavage domain is essential for its activity151,152, 
however, at very high concentrations, only one monomer needs to bind DNA for 
activity151.  As a result, dimerization interface mutants of FokI (D483A and R487A) that 
were found to be inactive in a cleavage assay151.  Interestingly, these same residues were 
engineered to create some of the obligate heterodimeric pairs (D483R in the ‘RR’ 
monomer and R487D in the complementary ‘DD’ monomer) of the FokI nuclease 
domain153.  These and other dimerization mutants force the ZFNs to heterodimerize and 
therefore, reduce undesired off-target activity of ZFNs153-155.  However, these mutants of 
the dimerization interface show reduced on-target activity as compared to the wild type 
nuclease domain presumably due to the lowered dimerization potential 153-155.  To 
enhance the activity of these dimerization mutants, other mutations both at the 
dimerization interface155 and the cleavage domain156 of the FokI were recently described. 
Recently, ZFNickases were described where the cleavage domain of one of the nuclease 
domain was rendered inactive resulting in creating nick at the target site instead of a 
DSB157,158.  These ZFNickases, although less active than ZFNs, allow DNA repair 
through HR and suppress NHEJ mediated repair and thus, would suppress unwanted 
lesions at off-target sites in the genome.  These results show that the choice of the FokI 
nuclease domain can effect on- as well as off-target activity of ZFNs. 
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The sequence specificity to ZFNs is provided by a tandem array of 3 to 6 zinc finger 
domains termed as zinc finger protein (ZFP) or zinc finger array (ZFA).  Highly specific 
ZFPs are required both to increase the on-target activity of ZFNs and decrease their off-
target activity159,160.  ZFPs that bind desired binding site can be selected from randomized 
libraries as described above81,94,99 but these selections are time consuming and require 
expertise.  A rapid way to generate ZFPs is using modular assembly wherein pre-
characterized zinc finger modules are combined to create tandem arrays of zinc fingers.  
Although zinc finger modules are available for most of 64 DNA triplets75,82,83, but when 
combined with each other, they (especially the ‘non-GNN’ recognizing modules) often 
show context-dependent specificities (Meng et al., unpublished data) which may result in 
low success rates of modularly assembled ZFAs as ZFNs53,100,103.  Although archives of 
improved single zinc finger modules (1F-modules) exist, ZFNs assembled from them still 
show low success rate (~25%)53,161.  One of the ways to minimize these context 
dependent interfaces is to identify two-finger modules (2F-modules) that contain optimal 
residues at the interface and combine them in a modular assembly fashion such that the 
interface residues are preserved.  Using phage display and the bipartite strategy, 2F-
modules have been selected and subsequently employed by Sangamo BioSciences to 
create active ZFNs84,85,162.  However, these modules are a proprietary of Sangamo 
BioSciences limiting their use to ZFNs purchased through Sigma-Aldrich at a cost that is 
prohibitive for many laboratories.  A recent study from the Joung lab used their OPEN 
selection strategy to identify 2F-modules that could be assembled using CoDA assembly 
method wherein the 2F-modules, F1-F2 and F2-F3 with a common F2, are assembled to 
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create three-finger ZFAs.  ZFNs created using this assembly showed high activity in 
zebrafish100.  However, their archive mainly contains 2F-modules that bind to ‘GNN-
GNN’ 6bp sites with ‘N-G’ type junctions that are not the limiting factor for advancing 
ZFN design.  In chapter IV, we describe a publicly available archive of 2F-modules that 
bind even ‘non-N-G’ type of junctions with high specificity and allow highly efficient 
ZFN-mediated gene targeting. 
The linker joining the FokI nuclease domain to the ZFP can also influence the activity 
and the specificity of ZFNs.  Conventionally, a 4 amino acid linker (TGGS or LRGS) is 
used which allows for a 5- or 6- bp spacing between the two half-sites of a ZFN.  
Changing the length and composition of this linker can impact the spacing between the 
half-sites64 and therefore can influence specific and non-specific activity of ZFNs. 
Mechanism of Action of ZFNs 
ZFNs upon binding to their half-sites in proper orientation create a double-strand break 
(DSB) at the spacer between the two half-sites which stimulates DNA repair pathways 
namely non-homologous end joining (NHEJ) and homologous repair (HR).   
NHEJ primarily involves simple religation of the DNA ends created by the DSB but 
occasionally the ends are modified through insertion or deletion (InDel) of a few base 
pairs before ligation.  These insertions or deletions can result in a frameshift of the open 
reading frame that might cause gene disruption.  Since, ZFN cleavage predominantly 
leaves 4bp overhangs, majority of InDels are 4bp insertions that result from simple 
blunting of the overhangs followed by ligation163,164. 
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HR is a more complex but precise DNA-repair pathway where a second copy of DNA 
that has homology to the region flanking the target site is required for repair.  This copy 
can either be the second allele in the genome or an exogenously supplied double-stranded 
DNA or a single stranded oligonucleotide165.  Unlike NHEJ, HR can use an exogenously- 
supplied DNA that allows precise genomic modifications including site-specific gene 
insertions, gene deletions, and gene correction.  Although low frequency spontaneous HR 
has been used in ES cells of mice for genomic editing, HR in most other organisms is not 
feasible.  However, DSB creation stimulates the rates of HR by ~5,000 fold166.  ZFNs 
thus, have allowed high frequency genome modification through HR in organisms such 
as flies167, mice65 and rats65. 
Applications of ZFNs  
The first use of ZFNs was reported by Chandrasegaran lab wherein they fused the FokI 
cleavage domain to engineered zinc finger proteins147.  Since then, ZFNs have been used 
for targeted gene editing in a variety of cell lines62,63,113,115,168-171 and model organisms 
such as Drosophila167, zebrafish94,114,172, C. elegans173, rats174, mice65,175, pigs116,176, 
Arabidopsis177, maize178 and tobacco179,180 (reviewed by Urnov et al.162).  Although 
NHEJ mediated gene editing is reported in all these studies, HR mediated gene repair has 
been limited to only cell lines162 and a few organisms such as flies167,181, mice65, and 
rats65,174.  Orlando et al. demonstrated that NHEJ-mediated repair pathway following 
ZFN-induced DSB can be employed to insert double stranded DNA containing 
compatible overhangs at the target site164.  Moreover, employing two pairs of ZFNs can 
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result in targeted large chromosomal deletions182.  Since ZFNs allow targeted gene 
editing, they show tremendous potential for use as therapeutics and are being evaluated in 
clinical trials.  Sangamo Biosciences demonstrated that ZFN mediated disruption of the 
CCR5 gene (the receptor required for HIV entry) in human CD4+ T cells and CD34+ 
hematopoietic stem cells allows HIV-1 control113,183.  These ZFNs are currently 
undergoing the Phase II clinical trials (Sb-728).  In another study they demonstrated that 
ZFN-induced DSB creation and homology mediated or homology independent repair 
allows for replacement or insertion of the blood coagulation factor IX gene in a 
hemophilia mouse model63.  These ZFNs are currently undergoing pre-clinical trials. 
Off-target effects of ZFNs 
Similar to any other technology or drug, ZFNs also can have side effects.  Like on-target 
activity, the off-target activity of ZFNs is influenced mainly by the specificity of the 
incorporated ZFPs, the choice of the nuclease domain and the sequence and composition 
of the linker as described above and will be described in detail in chapter 2.  In majority 
of studies, the off-target activity of ZFNs is assessed by in silico identification of a few 
potential off-target sites (<20 heterodimer sites) followed by InDel detection either by 
deep sequencing or Cel1 nuclease assay62,94,113,114.  Some of these studies detected 
infrequent off-target events in their cursory analysis.  In the chapter 2 of this thesis we 
describe a more in-depth analysis of in vivo off-target activity for kdrl ZFNs and its 
dependence on the dose of ZFNs, specificity of the incorporated ZFPs and the choice of 
the FokI nuclease domain160.  Recent studies report a more genome-wide analysis of off-
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target activity and are discussed in Chapter 2 184,185.  A recently published study showed 
that the ZFN activity can also be affected by the chromatin structure around the target site 
which might also impact the off-target activity of ZFNs186. 
 Gene targeting in zebrafish 
Zebrafish, Danio rerio, is a tropical freshwater fish that has become an attractive model 
to study vertebrate development.  Some of the attractive features of zebrafish that have 
facilitated research are its large clutch size (>100 embryos) and rapid development, 
which makes large forward-genetic screens and drug screens feasible.  Moreover, since 
the zebrafish embryos develop ex utero, they can be viewed and manipulated at all stages 
of development. Most importantly, zebrafish embryos remain transparent through much 
of their early embryonic stages, allowing detailed microscopic observations. Although 
forward genetic approaches for manipulating the zebrafish genome have existed since 
early 1980s, development of reverse genetic approaches has been challenging.  Reverse 
genetic approaches for gene manipulation prior to the use of ZFNs includes include 
Targeting Induced Local Lesions in Genomes (TILLING) or retroviral or transposon 
mediated insertional mutagenesis172.  Since both of these approaches are random 
mutagenesis methods, a significant effort is required to carry out these screens.  
Morpholino mediated gene knockdown provides another pseudo-reverse genetics tool for 
studying gene function in zebrafish.  Although it is gene-targeted approach, the 
knockdown is only transient lasting up to 72 hours post fertilization, thus limiting its 
applicability to genes that are expressed early in the development.  Recently, ZFNs have 
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been employed in zebrafish for gene disruption. Since their first use by Meng et al.94 and 
Doyon et al.114, they have become a popular tool for gene inactivation in 
zebrafish53,96,100,187-189.  ZFNs create a DSB at the desired target site in the genome that 
gets repaired by the NHEJ pathway resulting in small insertions or deletions at the target 
site where a subset of these lesions can result in gene disruption.  The primary limitation 
on the use of ZFNs is the absence of a method to efficiently and reliably create highly 
specific ZFPs for use in ZFNs (see chapter IV).  
Other Chimeric Nucleases 
In addition to ZFNs, meganucleases190 and the recently introduced Transcription 
Activator-Like Effector Nucleases (TALENs) allow targeted gene editing173,191-193.  The 
utility of meganucleases is limited due to their inability to recognize a wide range of 
sequences.  TALENs on the other hand have minimum limitations in terms of range of 
sequences that can be targeted and thus have a tremendous potential for gene editing194,195 
Summary 
Zinc fingers are naturally occurring DNA binding domains that can be engineered to 
recognize a variety of DNA sequences.  Engineered zinc fingers can be utilized to create 
zinc finger nucleases that have demonstrated tremendous potential for targeted gene 
editing in cell lines and model organisms. The activity and precision in vivo of ZFNs is 
dependent on the specificity and affinity of the incorporated zinc fingers. We 
characterized the off-target effects of ZFNs in zebrafish and demonstrate their 
dependence on the specificity of the incorporated zinc fingers.  We also employed 
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bacterial-one-hybrid based selections to identify and characterize zinc finger modules 
with optimal inter-finger interactions that allow efficient ZFN-mediated gene targeting in 
vivo and increased the targeting range of ZFNs by ~5-fold over existing modules.  Our 
results not only advance ZFN-mediated gene targeting but also provide crucial 
understanding of zinc finger-DNA recognition that will in future facilitate development 
of predictive models of recognition that would allow the prediction of genomic binding 
sites for naturally occurring zinc finger proteins for the construction of more accurate 
gene regulatory networks. 
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CHAPTER II 
ZINC FINGER PROTEIN-DEPENDENT AND -INDEPENDENT 
CONTRIBUTIONS TO THE IN VIVO OFF-TARGET ACTIVITY OF ZINC 
FINGER NUCLEASES 
 
 
 
 
 
Contents of Chapter II have been published previously as: 
Ankit Gupta, Xiangdong Meng, Lihua J. Zhu, Nathan D. Lawson, and Scot A. Wolfe 
(2011) Zinc finger protein-dependent and -independent contributions to the in vivo off-
target activity of zinc finger nucleases. Nucleic acids research 39, 381-392 
 
Xiangdong Meng selected the old and new kdrl ZFPs.  Lihua J. Zhu performed the 
computational analysis of the data. Nathan Lawson injected the ZFNs in fish and isolated 
the genomic DNA.  He also prepared the sequencing sample for the first Illumina run.
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INTRODUCTION 
Zinc Finger Nucleases (ZFNs) are artificial restriction enzymes that hold tremendous 
potential for the manipulation of genomes in a wide variety of plants and animals162,196.  
These enzymes generate a site-specific Double Stranded Break (DSB) that can abrogate 
gene function through imprecise repair (via generation of a frameshift) or can introduce 
tailor-made changes by stimulating homology directed repair from an exogenously 
supplied DNA template.  The utility of ZFNs for gene inactivation and genome editing 
has been demonstrated in a wide variety of cell lines170,171, including human ES cells and 
iPS cells62,169, as well as in the germline of plants179,197-199 178,180and 
animals94,96,114,167,174,200.  Due to their demonstrated utility, ZFN-based therapies are being 
evaluated in clinical trials113,201.  
ZFNs are composed of two modular domains: a tandem array of Cys2His2 zinc fingers 
(ZFP) tethered to the cleavage domain of FokI endonuclease (Fig 1-3)147.  The 
incorporated ZFPs can be engineered to recognize a specific DNA sequence94,98,100,104,202, 
thereby targeting the attached nuclease domain to a desired location within the genome.  
Dimerization of the cleavage domain is required for enzymatic activity151.  As a 
consequence, a pair of ZFNs must bind with the proper orientation and spacing to 
generate a DSB64,203.  ZFN-mediated gene inactivation/modification is sufficiently robust 
to generate cell lines with multiple biallelic knockouts204 and, when applied directly in 
vivo, founder animals that transmit mutant alleles to their offspring with high 
frequency94,96,114,174,200.  However, in many instances cytotoxicity is observed as a side 
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effect of ZFN treatment, which presumably results from ZFN-generated DSBs at off-
target sites within the genome94,159,168,205. 
Efforts to improve the in vivo precision of ZFNs have focused primarily on properties 
influencing DNA recognition.  For each ZFN, the number of binding sites within a 
genome is primarily dictated by the number and quality of the incorporated zinc fingers.  
Consequently, utilizing ZFPs with higher specificity can reduce the cytotoxicity of 
ZFNs159.  The type of nuclease domain dictates the active ZFN configurations.  ZFNs 
bearing engineered nuclease variants that preferentially heterodimerize display reduced 
toxicity in vivo by disfavoring homodimeric DNA recognition153,154.  The number of 
functional target sites is also defined by the composition and length of the linker joining 
the ZFP and nuclease domain, which determines the required spacing between ZFN half-
sites for activity64,203.  Finally, restricting the in vivo half-life of ZFNs can also attenuate 
their cytotoxicity206. 
Although the in vivo precision of ZFNs has been analyzed via the characterization of off-
target lesion events, an in depth analysis of ZFN properties that influence these effects 
has not been performed.  Potential off-target sites are typically defined by using the 
DNA-binding specificity of the incorporated ZFPs to scan the genome for sites most 
similar to these recognition sequences with the appropriate spacing for nuclease activity 
62,94,113,114.  In the majority of these studies, ZFN-induced lesions are identified at these 
off-target loci by Cel1 endonuclease or Restriction Fragment Length Polymorphism 
(RFLP) assays62,114,174.  Most of these studies did not detect lesions at their predicted off-
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target sites, however they typically examined only a small number of off-target sites 
(<10).  Moreover, these assays are not sensitive enough to detect lesion frequencies at ≤ 
1%113.  In two studies94,113, massively parallel sequencing technology has been used to 
characterize ZFN-induced off-target lesions with greater sensitivity.  Both of these 
studies revealed that, although infrequent, lesions were present at a subset of the analyzed 
sites.  However, only a small number of off-target sites were analyzed between these two 
studies: 7 heterodimeric sites for the CCR5 ZFNs and 17 for the kdrl ZFNs.  Moreover, 
the influence of ZFN properties on in vivo precision was not examined in either of these 
studies.  
The kdrl ZFNs, which display a low but measurable frequency of off-target events94, 
provide an excellent system for exploring the parameters that affect ZFN precision in 
vivo.  In our present study, we performed an in-depth analysis of ZFN precision by 
assaying lesion frequencies at 141 potential off-target sites in the zebrafish genome.  The 
kdrl ZFNs generate lesions at a small subset of these sites and demonstrate greater 
promiscuity with increasing dose.  Unexpectedly, we found that both the ZFP specificity 
and dimerization interface of the nuclease domain can influence the precision and activity 
of ZFNs.  These results provide a broader picture of factors that influence the precision of 
ZFNs with implications for the best compositions to employ for genome manipulations in 
both model organisms and clinical gene therapy. 
RESULTS 
Off-Target analysis of Meng et al. kdrl ZFNs  
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In our previous study we demonstrated the efficacy of ZFNs targeting the kdrl gene in 
zebrafish, which incorporated ZFPs optimized through bacterial one-hybrid (B1H) 
selections and the “DD/RR” engineered heterodimeric nuclease domain94.  As an initial 
assessment of the off-target lesions produced by these nucleases, we assayed the presence 
of lesions at 41 off-target sites (17 heterodimeric and 24 homodimeric), which revealed 
four heterodimeric off-target sites that accumulated lesions at a low frequency (~1%).  
However, the small number of off-target sites examined and the small number of 
sequences analyzed per site (~250) provided only a limited overview of the off-target 
activity in the genome.  
In order to assess ZFN off-target activity in greater depth, we determined lesion 
frequencies generated by the kdrl ZFNs at the target site and off-target sites.  The off-
target sites were chosen based on the DNA-binding specificities of the ZFPs (ZFPL & 
ZFPR), which we previously determined using the B1H system94.  To provide greater 
complexity to these motifs, we repeated B1H selections and sequenced the binding sites 
from the pool of surviving colonies by Illumina sequencing, where more than 1000 
unique sequences were used to generate the binding site logo for each ZFP (Figure 2-1).  
Based on these more informative motifs, we found that position 3 in the ZFPL motif and 
positions 1 and 2 in the ZFPR motif provide limited discrimination in DNA recognition.  
Consequently these positions were not considered when identifying the most favorable 
potential off-target sites within the genome based on matches to the target sequence.  
Based on the ZFPL and ZFPR binding specificity, we chose to characterize 141 putative 
off-target sites in the zebrafish genome that contained from one to five mismatches   
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Figure 2-1 
 
 
 
 
 
Figure 2-1: DNA binding specificities of kdrl ZFPs94. The DNA-binding specificities of 
the kdrl ZFPs determined at high stringency (5 mM 3-AT) using the B1H system 
displayed as a Sequence logo 207,208. The expected binding site is provided at the bottom 
of the logo. 
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relative to the target site (Figure 2-2 and Online Tablea).  Twenty-eight of these sites 
represent potential recognition sequences for homodimeric ZFNs to examine the 
exclusivity of the engineered DD/RR nuclease domains.  Among the remaining 113 
heterodimeric sites, 59 contained the conventional 5 or 6 bp spacer between the two ZFN 
half-sites.  The remaining 54 heterodimeric off-target sites contain a 14, 15 or 16bp 
spacer, as previous studies have indicated linker-dependent ZFN activity at sites with 
longer gaps between the half-sites64,203. 
To assess activity of ZFNs at these sites, zebrafish embryos were injected with two 
different doses of mRNAs (10 or 20 pg) encoding the kdrl ZFNs.  These embryos were 
scored for viability and morphology at 24 hours post fertilization (hpf) to provide an 
overt assessment of toxicity (Figure 2-3).  At the 10 pg dose, ~50% of the surviving 
embryos were morphologically normal whereas the remainder displayed developmental 
abnormalities (‘deformed’ henceforth).  Separate pools of ~25 injected embryos were 
prepared from morphologically normal and deformed embryos for lesion analysis.  At the 
20 pg dose, the majority of embryos were deformed or dead.  Consequently, only 
deformed embryos were characterized at this dose. Restriction Fragment Length 
Polymorphism (RFLP) analysis confirmed the activity of kdrl ZFNs at the target site 
(Figure 2-4). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a Online Table available at: http://nar.oxfordjournals.org/content/39/1/381/suppl/DC1 	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Figure 2-2 
          
 
 
 
Figure 2-2: Overview of the off-target analysis for the original kdrl ZFNs. The 
number of active (grey) and inactive (black) off-target sites is depicted in the graph.  The 
sites are subdivided according to the type of site (homodimeric or heterodimeric), where 
heterodimeric sites were divided into 5 different groups based on the spacing between the 
two half-sites.  A total of 8 active off-target sites (see text for criteria) were found in 
normal embryos from 10 pg ZFN dose (Table1), and 11 additional off-target sites were 
active either only in deformed embryos from 10 pg or 20 pg ZFN dose or in one of the 
two biological replicates, as described in the text.  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Figure 2-3           
  
 
Figure 2-3: Proportion of ZFN-treated embryos with different morphology at 24 
hpf. The number in parentheses represents the total number of embryos used for analysis. 
The activity of ZFNs containing two different sets of ZFPs were compared: the original 
ZFNs (oZFNs)94 and new ZFNs (nZFNs) generated in this study. 
Uninjected (117)
oZFNs DD/RR 10pg Replicate 1 (58)
oZFNs DD/RR 20pg Replicate 1 (55)
nZFNs DD/RR 10pg (51)
nZFNs DD/RR 20pg (50)
oZFNs DD/RR 10pg Replicate 2 (30)
oZFNs DD/RR 20pg Replicate 2 (38)
oZFNs EL/KK 50pg (51)
oZFNs EL/KK 100pg (39)
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Figure 2-4 
 
 
Figure 2-4: The RFLP analysis performed for ZFN-treated embryos. Genomic DNA 
from untreated or ZFN-treated embryos was pooled. The DNA flanking the kdrl target 
site was PCR-amplified94 and digested with NspI enzyme which cleaves the unaltered 
spacer region within the ZFN target site resulting in two bands each ~110 bp in size.  
Indels within the spacer region at the target site result in the loss of NspI site, which is 
detected as the presence of undigested band of 220 bp in size. 
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Figure 2-5 
      
Figure 2-5: High correlation between the replicates. Pearson correlation analysis of the 
lesion log odds ratio for 41 identical sites between three identical treatment groups from 
different biological replicates. After excluding sites where the odds ratio was 0, there are 
total of 71 dots in the plot with each dot representing a pair of log odds ratios from 
replicate 1 and replicate 2 that have the same ZFN dose at the same site. The three 
treatment groups are Original ZFNs DD/RR 10pg Monsters, Original ZFNs DD/RR 10pg 
Normals and Original ZFNs DD/RR 20pg Monsters. A significant correlation exists 
between the replicates (r = 0.78, p-value= 8.9e-16) where the red dots indicate sites with 
a significant increase in lesion frequency in either replicate 1 or replicate 2 (BH adjusted 
p-value <0.05) as compared to the uninjected control.  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The presence and frequency of lesions at each site was determined by Illumina-based 
sequencing of PCR amplicons spanning each genomic locus.  On average approximately 
8,000 reads per site were obtained, which allowed confident assessment of combined 
insertion and deletion (indel) frequencies ≥ 0.1%.  Owing to the short read length of 
Illumina sequencing (~36bp), our analysis was limited to the detection of small insertions 
or deletions.  Only indels that were >1bp in length were counted to avoid the bulk of the 
sequencing artifacts.  To ascertain the consistency of the data, lesions at a subset of off-
target sites were analyzed from a second independent biological replicate of the ZFN 
injections. Analysis of the site-specific lesion frequency between the biological replicates 
shows that they are significantly correlated (Figure 2-5). The presence of indels at each 
site was considered significant only if the following criteria were fulfilled: a) indels 
occurred at a significantly higher frequency (Benjamini-Hochberg (BH) adjusted p-value 
< 0.05) in the injected sample relative to the uninjected control to account for noise in the 
sequencing data at some sites, which leads to a small fraction of sequences that appear to 
contain lesions even in the uninjected control209; b) indels constituted ≥ 0.1% of the 
sequence reads (in the average of the two replicates where available); and c) more than 
one different indel sequence was observed (to avoid potential jackpot effects).  We 
believe these criteria constitute a conservative assessment of activity, and may assign 
sites as inactive that actually incur indels at a low frequency.  Consistent with the RFLP 
analysis of the kdrl ZFNs, the lesion frequency at the target site was ~7% in normal 
embryos at the 10pg dose, which increased to ~15% at the 20pg dose (Table 2-1). 
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CACACCTTCAGCATGTTGGTGGGA 18 6 7.3 11.7 15.8 7.4 9.4 8.5 
OT1 TCCCACCcgAGTCCTGcAGGTGTG 15 6 1.6 4.5 3.4  0.3* ND ND 
OT2 CACACCaTCCTACCTTTGGTGGGt 16 6 1.3 2.5 2.7 0.1 ND ND 
OT3 CACACCTTCACAGACgTGGgGGGA 16 6 0.8 1.5 2.6  1.4* 0^ 0.3 
OT4 cCCgACCAgATTGTGAAGGTGTG 15 5 0.4 0.4 1  0.2* 0.1* 0.2* 
OT6 aCCCACCgAGATACGcgGGTGTG 14 5 0.3 0.5 0.7 0 0.0 0.2* 
OT7 CcCACCcTCGTGATGTTGGaGGGA 15 6 0.3 0.4 0.7 0 0.2* 0.0 
OT8 CACACCggCAGACTgcGGcGGGA 13 5 0.2 0.3 0.4 0 0.2* 0.1* 
OT9 CACACCcaCAAAAGaTGGTGGGt 14 5 0.2 0.4 0.8 0.1 0^ 0.0 
OT5 TCCCACCcAGGAAGTGAtGGTGaG 15 6 0.2 0.4 0.8 0 0.1 0.1 
OT11 TCCCACCggAGCGGTGAtGGTGaa 13 6 0.2 0.2 0.6 0 0.0 0.1 
OT12 TCCCgCCAACAAATGAcGGaGTG 15 5 0.1 0.5 0.8 0 0.1 0.1 
OT13 CgCACCgcCAGACATaTGGTGGGA 14 6 0.1 0.1 0.6 0 0.1 0.0 
OT10 TCCCcCCtgCCATGAGgAGGTGTG 14 6 0.2 0.7 0.4 0.2 0.4* 0.8* 
OT14 aCCCACCcACTACTGAgGGTGaG 14 5 0.1 0 0.3 0 0.1 0.1* 
OT15 CACACCTcCAATTAgaGGcGGGA 14 5 0.1 0.3 0.1 0.1 0.1 0.1 
OT16 TCCCtCCctAAGGGTGAtGGgGTG 13 6 0 0.2 0.3 0 0.1 0.0 
OT18 CACACCagCTGCATTTTGGTGGGt 15 6 0 0 0.1 0 0.0 0.0 
OT20 TtCCACCAAGTATCAGAAGGTGTa 16 6 0 0 0.1 0 0.0 0.1 
OT22 TCCCACCAgGATATCCGGGTTAC GcAGGTGTG 16 14 0 0 0.3 0 0.0 0.0 
50
Table 2-1: Sequences and lesion frequencies for each ZFN pair and dose at the 
target and 19 active off-target sites. Off-target sites show significant lesion frequencies 
either for normal embryos (green) or only in deformed embryos (yellow) injected with 
original ZFNsDDRR (oZFNsDDRR).  Off-target sites in orange displayed significant activity 
in only one of the biological replicates. The red off-target site has a 14 bp spacer 
separating the ZFP recognition sequences.  Asterisks in the final three column indicate 
off-target sites that meet our significance criteria.  Only one off-target site showed 
increased lesion frequency in nZFNs as compared to oZFNs-DD/RR (OT3 in Blue). “0^” 
in the 50 pg oZFNELKK column indicates two off-target sites which had insufficient 
sequencing reads to determine the lesion frequency. 
 
 
51
Overall, only 19 off-target sites were “active” (i.e., displayed indels at a significant 
frequency based on the criteria above) even at the higher ZFN dose (Figure 2-2).  All of 
the examined homodimeric sites were inactive, which is consistent with previous studies 
indicating that the DD/RR nuclease domain suppresses activity at homodimeric sites94,153.  
In ZFN-treated embryos with normal morphology, only 8 of the 113 heterodimeric sites 
were active (across both biological replicates where available, Figure 2-6 and Table 2-
1).  Notably, all of these sites contain a 5 or 6 bp spacer between the two half-sites.  At 
the higher ZFN dose an additional 4 off-target sites were actively cleaved.  Moreover, 7 
other off-target sites were found to be active in one of the two biological replicates. Since 
these 7 sites contained hallmarks of ZFN induced lesions (multiple types of lesions in the 
spacer region between the two ZFN half-sites), we included them in our analysis of active 
sites. One of these sites (OT22 in Table 2-1) contains a longer spacer (14 bp) between 
the ZFN binding sites. Among the examined off-target sites, those containing a 6 bp 
spacer were the most likely to be active, both based on the fraction of active sites (38%) 
and the indel rates at active sequences (Figure 2-2 and Table 2-1).  Off-target sites 
containing a 5 bp spacer were the only other group where multiple sites (23%) were 
actively cleaved.  These results are consistent with a previous study indicating that ZFNs 
with a ‘TGGS’ linker connecting the ZFP and the nuclease domain are most active on 
target sites separated by a 6 bp spacing followed by sites with a 5 bp spacing, whereas 
sites with longer spacers are inefficiently cleaved64.  With regards to the types of 
observed lesions 4 bp insertions, which represent a simple fill-in and religation of the 5ʹ′ 
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Figure 2-6 
         
 
Figure 2-6: Dose dependent effects of kdrl-ZFNs on its in vivo activity and precision. 
The lesion frequency was plotted for the on-target (blue) and 8 off-target sites active in 
the morphologically normal embryos at the 10 pg dose.  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overhangs generated by the FokI nuclease domain, are the most common events (Figure 
2-7). 
Concomitant with greater on-target lesion frequency, increasing the ZFN dose increased 
the degree of off-target cleavage within the genome (Figure 2-6).  However, preferential 
activity at the target site was maintained at both ZFN doses, as the on-target lesion 
frequency exceeded that of any off-target site by at least 4-fold.  Notably, animals treated 
with the higher ZFN dose were more likely to be deformed suggesting that increased 
collateral damage within the genome may contribute to their abnormal development.  
Consistent with this hypothesis, normal embryos at the 10 pg dose displayed fewer active 
off-target sites than the deformed embryos at the 20pg dose (8 vs. 12 considering active 
sites in both the replicates or 12 vs. 18 considering activity in one replicate).  Moreover, 
these normal embryos also exhibited significantly lower frequencies of off-target lesions 
at the 8 common active off-target sites with the median lesion frequency increasing from 
0.6% in normal embryos to 1.5% in deformed embryos at the 20pg dose (p-value < 
0.0001).  Thus, increased off-target lesion frequency is associated with the presence of 
developmental abnormalities. 
Common features of active off-target sites 
We next sought to identify common characteristics of active off-target sites that 
distinguish them from inactive sites.  Since active sites could simply share greater 
homology to the kdrl target sequence, we compared the total number of matches to the 
target site for active versus inactive off-target sequences containing a 5- or 6-bp gap 
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Figure 2-7 
 
          
Figure 2-7: The distribution of the type of indels observed at the off-target sites (A) 
and the target site (B).  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between the ZFN half-sites (Figure 2-8).  Surprisingly, there was no significant 
correlation between the degree of identity and off-target activity (p-value = 0.48).  
Furthermore, the distribution of active sites with regard to homology to the target site 
simply reflected the general distribution of all prospective off-target sites (τ = 0.89, p-
value = 0.0367).  Thus, in this population of sites that are highly similar to the kdrl ZFN 
target sequence, the degree of identity is not a defining feature of activity. 
To better identify attributes that distinguish active from inactive off-target sequences, we 
constructed a frequency plot of the bases at each position in the sites from the active 
group (Figure 2-9a).  One striking characteristic of the active off-target sites is the 
complete conservation of a number of the guanines (7 of 10) in the composite ZFP 
recognition sequences.  These positions are typically more diverse in the inactive 
sequences (Figure 2-9a), suggesting that they represent critical features that define 
activity.  Examining this trend in greater depth, we find that 15 out of 23 off-target sites 
with all ten ‘G’ contacts were active, whereas only 3 out of 36 off-target sites lacking one 
or more of these ‘G’ contacts were active (Figure 2-9b).  This correlation was highly 
significant (p-value = 5.6e-6).  Using a B1H-based activity assay92, we directly 
determined the importance of the ‘G’ contacts in the kdrl-ZFPL and kdrl-ZFPR 
recognition sequences by mutating each base independently to cytosine and assaying the 
effect on ZFP-dependent cell growth.  Consistent with the in vivo data, we observed that 
mutation of any of the conserved Gs in the ZFPL or ZFPR binding site strongly reduced 
ZFP-dependent cell growth even at low stringency (1 mM 3-AT), where only the most 
important recognition positions should be detected (Figure 2-10).  Other positions within  
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Figure 2-8 
 
 
 
 
 
Figure 2-8: Characteristics of active off-target sites. The distribution of the number of 
matches to the target site for active (Grey) and inactive (black) off-target sites with 5- or 
6-bp spacing is shown.  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Figure 2-9 
 
 
Figure 2-9: Enrichment of Guanine-contacts in the active off-target sites. (a) Base 
frequency at each position in the ZFPL and ZFPR binding sites are displayed as a logo 
for (top) the group of 18-active off-target sites, (middle) the group of 41-inactive off-
target sites, and (bottom) all 59 sites together. Guanines at seven positions (red boxes) in 
the active off-target sites were absolutely conserved within the active sequences, but are 
more variable in the inactive sites. (b) The distribution of the number of active (grey) and 
inactive (black) off-target sites as a function of the number of guanines preserved in each 
recognition sequence. 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Figure 2-10 
 
 
 
Figure 2-10: Bacterial-one-hybrid based analysis of importance of positions within 
each ZFP binding site. Each base in the binding site of the ZFPL and ZFPR was 
independently mutated to cytosine, which is not found at any position in either of the ZFP 
recognition sequences. Its influence on ZFP binding was assayed using B1H-based 
activity assay performed92 at 1 mM 3-AT (a) to detect only the most important positions 
for recognition, and at 10 mM 3-AT (b) to detect other important positions for 
recognition, where a reduction in cell survival (plotted as the -log of surviving colonies) 
indicates a position important for recognition.  All of the absolutely conserved guanines - 
indicated by an asterisk (*) - are critical for activity. 
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each ZFP binding site also influence recognition, however the impact of mutations at 
some of these positions is only detected at higher stringency within the activity assay (10 
mM 3-AT, Figure 2-10).  Thus, for these ZFPs the conserved G contacts identified in 
this analysis appear to be necessary but not sufficient for efficient recognition of their 
sub-sites. 
Reduced off-target effects when employing ZFNs with improved specificity 
Having established a baseline of off-target events with our original kdrl ZFNs, we 
investigated the influence of the two distinct functional domains within the ZFN (the ZFP 
and the nuclease domain) on in vivo precision.  We focused initially on further 
optimization of the kdrl ZFPs since improving their DNA-binding specificity would be 
expected to have the greatest impact on off-target events.  Based on the determined 
specificity of these ZFPs (Figure 2-1), each ZFP displayed a strong preference for the 
desired base pair at ~7 of 9 positions within their target site.  However, in both ZFPs 2 
positions within the C-terminal finger (finger-3) recognition site were relatively poorly 
specified, which became our focus for improvement.  To identify ZFPs with improved 
specificity, additional clones generated from our original B1H selections were 
characterized using B1H-based binding site selections followed by sequencing of binding 
sites from a few surviving clones94.  This yielded an improved clone (nZFPL) for the left 
recognition site, but no obviously improved clone was identified for right recognition 
site.  Instead, a modestly improved clone (nZFPR) was generated by introducing 
previously defined specificity determinants that are compatible with T recognition at 
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positions 3 and 6 of the finger-3 recognition helix86.  Subsequent efforts to reselect finger 
3 of the ZFPR in a different context yielded an identical finger sequence (RSDALRK) 
(Zhu, C., Lawson and Wolfe, unpublished results).  Comprehensive binding motifs for 
the new ZFPs (nZFPs) were determined by B1H binding site selections followed by 
Illumina sequencing.  More than 1000 unique sequences were used to generate each 
recognition motif.  Comparison of the recognition motifs indicates improvements in the 
specificity of both nZFPs (Figure 2-11).  nZFPL displays a dramatic increase in the 
preference for adenine at position 2 (rising from 56% to 99%) and position 3 (rising from 
13% to 36%) within the recovered sequences.  Likewise, nZFPR displays a modest 
increase in the preference for thymine at position 2 (rising from 42% to 67%) within the 
recovered sequences. 
Although the improvements in specificity of the nZFPs appear modest, we assessed 
whether these differences would translate into improved ZFN precision in vivo.  We 
compared the in vivo activity and toxicity of the nZFNs (incorporating the new ZFPs) 
with original ZFNs (oZFNs).  mRNAs (either 10 or 20 pg dose) encoding each set of 
ZFNs were injected into zebrafish embryos.  After 24 hpf, treated embryos were scored 
as morphologically normal or deformed.  The nZFNs displayed markedly lower toxicity: 
~45% of the nZFN-treated embryos displayed normal morphology at the 20 pg dose 
whereas only ~17% of the oZFNs-treated embryos were normal (Figure 2-3). 
We reasoned that the reduced toxicity of the nZFNs was a consequence of decreased off-
target cleavage.  Therefore, we compared off-target lesion frequencies at the same 141 
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Figure 2-11 
                                                
Figure 2-11: Improved binding site specificities of the new ZFPs. (a) Binding site 
specificities of the new and old ZFPs determined using the B1H system are displayed as 
Sequence logos (Schneider et al  sequence logo and Weblogo reference).  The recognition 
helix sequences for each finger are displayed where the amino acids that differ in the 
nZFPs are indicated in red.  Red rectangles highlight the positions where information 
content of the desired base was higher in the improved ZFNs.  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sites characterized for the oZFNs in genomic DNA isolated from embryos treated with 
the nZFNs.  The nZFNs, at a dose of 10 pg, showed an on-target lesion frequency of 
~7.4% which was similar to that observed with an analogous dose of the oZFNs.  
Notably, even with similar on-target activity, nZFNs displayed significantly lower rates 
(p-value < 0.0001) of off-target cleavage at the majority (7 out of 8) of the active off-
target sites for the oZFNs in normal embryos (Figure 2-12 and Table 2-1).  Among the 
59 heterodimeric off-target sites with a 5 or 6 bp spacer, only 3 displayed lesions at a 
significant frequency based on our criteria (Table 2-1), which represented a reduction 
compared to the 8 active sites for the oZFNs.  Only one off-target site (OT3) showed an 
increase in the lesion frequency with the nZFNs.  This may be due to the presence of a 5’ 
guanine in the nZFPR OT3 half-site, as the nZFP recognition motif indicates a slight 
preference for ‘G’ at this position in the recognition sequence, which is absent in the 
oZFPR recognition motif.  Thus, based on this analysis even a modest improvement in 
ZFP specificity can result in dramatic reduction in ZFNs promiscuity. 
Examining the influence of the nuclease domain variant on ZFN promiscuity  
Although the primary determinant of ZFN specificity is the incorporated ZFP, there is 
ample evidence that the nuclease domain can also influence the cytotoxicity of 
ZFNs153,154.  Consequently, the influence of the FokI nuclease dimerization interface on 
ZFN activity and precision in vivo was investigated.  We compared the on- and off-target 
activity of the original kdrl ZFNs containing the engineered heterodimeric DD/RR 
nuclease domains (ZFNsDDRR) to the same ZFPs fused to the heterodimeric EL/KK 
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Figure 2-12 
 
Figure 2-12: The specificity of the ZFP domains influences the precision of ZFNs. 
Comparison of lesion frequencies at the on-target site and the 8 active off-target sites 
were plotted for oZFN- and nZFN-treated embryos. The color scheme remains same as in 
Figure 2.  Lesion frequency at the off-target sites in nZFN treated embryos was reduced 
at all but one off-target site.  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versions of the FokI nuclease domain (ZFNsELKK)154.  Although both nuclease variants 
have been successfully used on chromosomal targets in vivo153,154, there has not been a 
detailed study comparing their activity and their potential influence on ZFN specificity in 
vivo.  Notably, we found that the ZFNsELKK had a markedly lower activity such that 
injection of five to ten times more mRNA (50 pg and 100 pg doses) was required to 
achieve on-target lesion rates similar to the ZFNsDDRR (Figure 2-4). Consequently we 
performed lesion analysis for the EL/KK ZFNs at these higher doses, where we examined 
a subset of the previously characterized off-target sites (96 out of 141).  Unexpectedly, 
we found that the ZFNsELKK displayed reduced off-target lesion frequencies compared 
with the ZFNsDDRR (Figure 2-13).  At previously defined active off-target sites, normal 
embryos treated with 100 pg of ZFNsELKK displayed a significantly lower average off-
target lesion frequency (0.13%) than normal embryos treated with 10 pg ZFNsDDRR 
(0.37%, p-value < 0.0001).  Only one other off-target site (OT10, Table 2-1) displayed 
significant lesions in the ZFNsELKK treated embryo.  Notably, for this site all 10 of the 
target site guanines are retained.  Thus, for the original kdrl ZFNs, the choice of the 
engineered nuclease domain has a surprising impact on the ratio of on-target to off-target 
lesions in vivo. 
DISCUSSION 
Although ZFNs have been used to create genetically engineered organisms210,211 and 
initial clinical trials employing them as therapeutics are underway113,201,212, the 
characterization of ZFN-induced collateral damage to the genome of treated cells has  
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Figure 2-13 
 
 
 
Figure 2-13: Influence of the type of the engineered nuclease domain (DD/RR153 or 
EL/KK154) on the precision of the original ZFNs. The lesion frequencies for normal 
embryos treated with 10 pg dose of oZFNsDDRR, 50 pg dose of oZFNELKK or 100 pg dose 
of oZFNELKK were plotted for the on-target site and a subset (6 of 8) of the active off-
target sites for oZFNsDDRR that were assayed in this experiment.  Asterisks indicate 2 
positions in the 50 pg oZFNELKK where there were insufficient sequencing reads to 
provide a confident assessment of the lesion frequency (none were observed).  Normal 
embryos treated with 50 pg of oZFNsELKK, like the 100 pg of oZFNsELKK embryos, 
displayed a significantly lower average off-target lesion frequency (0.1%) than normal 
embryos treated with 10 pg oZFNsDDRR (0.3%, p-value < 0.0001) among the active off-
target sites with sufficient number of sequencing reads. 
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been limited primarily to indirect assays of toxicity168 and DSB foci113,159 or lesion 
analysis at a small number of potential off-target sequences114,174. In this study, we have 
performed the most detailed analysis to date of the off-target effects of ZFNs by 
characterizing lesion frequencies at 141 potential off-target sites from the genomes of 
ZFN-treated zebrafish embryos. Using the kdrl ZFNs as a model, we show that the B1H-
selected three-finger ZFNs preferentially cleave their target site to any assayed off-target 
site and thus, are sufficient for relatively precise gene modification. We also probed the 
influence of the components of kdrl-ZFNs on their precision. Surprisingly, both the 
choice of the nuclease domain and the specificity of the component ZFP domains dictate 
the accuracy of these ZFNs. 
Not unexpectedly, the thermodynamics of DNA recognition appear to dominate the 
impact of binding site mutations on ZFN activity.  Simply assessing the likelihood of 
ZFN activity at an off-target site based on the number of matches to the target sequence 
was a poor predictor, as evidenced by the absence of correlation within the data for our 
three-finger ZFNs (Figure 2-8). Off-target sites with as many as five mismatches to the 
target site contained indels at a statistically significant frequency, whereas other sites 
with just one or two mismatches were inactive.  Data from binding site selections 
provides a much better metric for defining critical positions for recognition.  The relative 
importance of individual positions within each ZFP binding site was initially defined by 
our high stringency B1H binding site selections (Figure 2-1), which provided a 
consensus recognition sequence for each ZFP.  The most critical positions were identified 
using the low stringency B1H activity assay, where we could examine the importance of 
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individual positions by mutating them independently (Figure 2-10).  In principle, 
information on the most critical positions could also be obtained through B1H binding 
site selections performed at low stringency.  In the case of kdrl ZFNs, the preservation of 
a subset of the arginine-guanine interactions in off-target sites was strongly correlated 
with ZFN activity at these sequences. Arginine-guanine interactions are typically 
important specificity determinants at the zinc-finger-DNA interface: abrogating similar 
contacts in the Zif268 recognition sequence results in a 100- to 400-fold decrease in its 
binding affinity213.  Based on these observations, we speculate that engineering ZFNs 
with specificity determinants that distribute the binding energy more uniformly over the 
entire recognition sequence - instead of employing a few critical Arginine-Guanine 
contacts - will result in ZFNs with improved functional specificity.  Achieving this goal 
may require increasing the number of fingers per ZFP as well as the use of appropriate 
linkers to attenuate ZFP affinity59, a hallmark of many of the ZFNs currently employed 
by Sangamo BioSciences113,114. However, a recent report demonstrated that subsets of 
fingers in a polydactyl ZFP can bind independently to target sites in the genome thus 
decreasing their on-target activity and possibly increasing their off-target effects214. 
The influence of ZFP specificity on the in vivo activity and toxicity of ZFNs was first 
demonstrated by Cornu et al. where they compared the activities of ZFNs containing 
modularly-assembled ZFPs to ZFNs containing ZFPs selected for the identical target 
sequences159.  The selected ZFPs displayed higher specificity as measured by the ratio of 
the affinity of each ZFP for its target site relative to bulk non-specific DNA.  When 
incorporated into ZFNs, the resulting nucleases generally showed higher activity and 
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lower toxicity in human cells than the nucleases containing their modularly-assembled 
counterparts.  In this study, we have performed a more in-depth analysis by defining the 
base-preferences at each binding site position for the employed ZFPs, which, unlike the 
bulk specificity, provides information about key sequence features likely to be shared by 
potentially active off-target sites.  This information coupled with a broad assessment of 
the frequency of ZFN-induced lesions at a number of off-target sites in the genome of 
zebrafish embryos reveals that even modest changes in the ZFP specificity can decrease 
off-target activity leading to improved functional specificity and reduced toxicity.  Thus, 
detailed specificity analysis of candidate ZFPs provides not only an estimate of key 
sequence features of potentially active off-target sites but also an assessment of the 
relative fitness of the candidate for utilization in ZFNs.  In cases where the DNA-binding 
specificity is sub-optimal, this information can be employed for focused optimization of 
suspect specificity determinants to obtain ZFPs with higher specificity and superior in 
vivo performance. 
Surprisingly, in addition to the influence of the ZFP specificity on ZFN activity, we 
observed that the type of the engineered nuclease domain influences ZFN precision.  We 
examined the influence of two pairs of FokI variants DD/RR and EL/KK on ZFN 
activity, both of which favor heterodimerization over homodimerization153,154 and display 
lower in vivo toxicity.  Although, Miller et al. reported that ZFNs incorporating these 
engineered FokI nuclease variants show two- to three- fold less activity than the wild type 
domain, there has been no detailed study comparing their relative precision.  In fact, 
conflicting data exists regarding the precision of these engineered nucleases.  Kim et al. 
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found that only the DD/RR nuclease variant appeared to reduce cellular toxicity relative 
to the WT nuclease domain161.  In our study the kdrl ZFNs harboring the EL/KK variant 
(ZFNsELKK) consistently show lower activity than the ZFNs harboring the DD/RR 
nuclease (ZFNsDDRR).  Consequently, a five-fold higher dose of ZFNsELKK was required 
to obtain an on-target lesion frequency similar to the ZFNsDDRR.  This result differs from 
a recent report by Guo et al. that the EL/KK-containing ZFNs are more active than 
DD/RR-containing ZFNs on an integrated target in 293 cells156. We cannot explain this 
discrepancy, however our observation of reduced activity for the EL/KK variants in 
zebrafish has been confirmed for a number of other ZFNs targeting different genomic 
loci (Smith, T., Wolfe, S. & Lawson N., unpublished observations) and in the recently 
published study155.  For the kdrl ZFNs, even though EL/KK variants were injected at an 
elevated dose the toxicity of ZFNsELKK and ZFNsDDRR was similar (Figure 2-3) and 
genomic analysis confirmed that the ZFNsELKK generate fewer off-target lesions than the 
ZFNsDDRR.  The decreased activity and toxicity of the ZFNsELKK could be the result of 
lower dimerization potential for the EL/KK nuclease domain, which would reduce the 
degree of cooperative binding between the two EL/KK monomers155.  As a result, 
stronger interactions between each ZFP monomer and its binding site would be required 
to achieve residence times necessary to generate a DSB.  Reduced cooperativity has been 
previously proposed as an explanation for the decreased toxicity of EL/KK variant as 
compared to the wild type nuclease domain154. However, the reduced toxicity of EL/KK 
variant in this study could have been associated with its limited homodimeric activity.  
By directly comparing the EL/KK and DD/RR nuclease variants, neither of which 
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displays significant homodimeric activity based on our analysis, it is readily apparent that 
the cooperativity between the nuclease monomers is an important feature of ZFN activity. 
These results suggest that further reduction in the dimerization potential of the nuclease 
domain coupled with specific zinc fingers with distributed binding affinity may lead to 
additional improvements in the precision of ZFNs.  Recent studies have identified 
mutations at the dimerization interface that when coupled with DD/RR or EL/KK 
nuclease variants can increase the dimerization energy thereby enhancing the activity of 
these nucleases155.  Moreover, mutations in the cleavage domain of the FokI nuclease 
have been identified that increase its activity156.  However, the off-target activity of these 
nuclease variants with enhanced activities has not been carefully examined.  
Another factor that may influence the off-target activity of ZFNs is the chromatin 
structure around the potential off-target loci.  A recent study demonstrated that the ZFN 
activity can also be influenced by the chromatin structure around the target site186.  
Therefore, similar to the on-target activity, off-target activity for ZFNs would be 
influenced by the chromatin structure making it difficult to predict the potential off-target 
sites based on just the binding site specificity data for ZFNs.  Including the DNaseI 
hypersensitivity data and the Micrococcal nuclease hypersensitivity data might help 
develop better prediction models for ZFN on- and off-target activity. 
ZFNs have been used to create genetically engineered organisms like zebrafish and rats 
where generating gene modifications with conventional homologous recombination based 
methods has not been feasible.  We and others have shown that these genetic 
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modifications created using ZFNs can be transmitted through the germline.  However, the 
degree of germline transmission of off-target lesions is an unaddressed concern for these 
ZFN-modified animals.  To assess this possibility, we outcrossed one founder fish 
generated in Meng et al. and examined the progeny for the presence of lesions at the 
active off-target sites identified in this report94.  Although we found lesions at the target 
kdrl site in ~50% of 35 offspring analyzed, we did not find evidence of lesions at any of 
the off-target sites (data not shown).  This result, although merely representing a single 
founder, suggests that using ZFNs generated via B1H-based selections, one can obtain 
lines of genetically engineered animals relatively free of background mutations without 
the need for extensive outcrossing of founder animals. 
Although this is the still the most detailed study where off-target activity of ZFNs has 
been examined in an organism but numerous questions remain to be addressed.  One of 
the key limitations of this study is its characterization of ZFNs specific for a single target 
sequence. Although this study has improved our understanding of the activity of ZFNs 
within the genome, further analysis of the activity of other ZFNs pairs will allow a more 
comprehensive understanding of ZFN activity in vivo.  This study is also biased by our 
choice of genomic sites for analysis based on the characterized specificity of our ZFPs.  
A more comprehensive survey of active ZFN targets could be obtained by performing a 
genome-wide analysis of ZFN occupancy using ChIP-seq in combination with lesion 
analysis, which might identify classes of active target sites (such as alternate spacings or 
registers of binding) that were uncharacterized in our survey.  Ultimately, understanding 
the parameters that influence the precision of ZFNs in vivo will lead to improved designs 
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facilitating the ease of creating genetically modified organisms as well as improved 
therapeutics for gene therapy. 
Comparison to recently published off-target studies 
Recently, two studies were published that characterized off-target cleavage of zinc finger 
nucleases in the K562 cell line184,185.   
Gabriel et al. following the ZFN treatment, mapped the integration sites of the co-
transfected IDLV-DNA (Integrase deficient lentivral virus) by (nr)LAM-PCR (non-
restrictive linear amplification-mediated PCR) coupled with deep sequencing to identify 
genomic locations of off-target activity for their CCR5 and IL2RG ZFNs185.  Pattanayak 
et al. on the other hand, first identified potential off-target sites for CCR5 and Vegf ZFNs 
from a library of ZFN sites using an in vitro selection system that identifies sequences 
that can be functionally cleaved at a specific ZFN concentration and then determined 
lesion frequency in K562 cells at the in vitro-identified potential off-target sites that were 
also present in the human genome184.  In general, results from both the studies were in 
concordance with our findings.  The off-target activity for ZFNs was lower than their on-
target activity and increased with the ZFN dose.  Although, the active off-target sites 
showed high homology to the target site but gross matches to the target site was not 
sufficient to predict off-target sites for ZFNs corroborating our findings. Although, both 
studies identified off-target sites for CCR5, not many active off-target sites were common 
between the two studies suggesting that identification by both methods are inefficient, 
which may result from the inherent limitations of the methods they employed.  The 
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IDLV-integration method used by Gabriel et al. relies on the NHEJ-mediated integration 
of the IDLV DNA into the site of the double strand break that may represent only a 
fraction of total NHEJ events resulting in low sensitivity of this method due to which it 
may not capture off-target sites that show low but significant activity185. Pattanayak et al. 
did not use a completely randomized library for their in vitro selection method to restrict 
the library size and the ZFN activity in vitro may differ from its activity in vivo184.  Thus, 
neither of these methods provides a complete assessment of off-target activity in vivo 
suggesting that the development of a better method to detect off-target activity for ZFNs 
in vivo would have useful application. 
METHODS 
Zebrafish husbandry 
Zebrafish adults and embryos were handled according to standard method215.  These 
studies were approved by the UMass Medical School IACUC.  The wild-type line used in 
this study (referred to as Crawfish) was established through several incross generations of 
wild-type fish originally obtained from Scientific Hatcheries. 
ZFN mRNA injections and on-target lesion analysis 
ZFPs were cloned into the pCS2 vector containing either DD/RR (R487D (DD) and 
D483R (RR))153 or EL/KK (Q486E; I499L (EL) and E490K;I538K (KK))154 variants of 
FokI nuclease as described94.  pCS2-ZFN constructs were linearized with NotI enzyme 
and mRNAs were transcribed using the mMessage mMachine SP6 kit (Ambion) followed 
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by DNAse treatment.  ZFN mRNAs were injected into one-cell-stage zebrafish embryos 
according to standard methods215.  ZFN-induced on-target lesions at the kdrl locus were 
detected by NspI digestion as described previously94. 
Identifying ZFPs with improved specificity 
The DNA-binding specificity of additional clones obtained from B1H-selections for 
ZFPL in Meng et al. were previously characterized using the 28 bp randomized library 
via omega-based B1H-selections94.  The improved ZFPR clone was generated by design 
incorporating specificity determinants into finger 3 that would be compatible with the 
desired DNA-binding specificity86 and its binding specificity was characterized with the 
B1H system using the 28 bp randomized library.  Binding sites from a few surviving 
clones were sequenced and motifs were generated using MEME216. Clones (nZFPs) for 
ZFPL and ZFPR showing improved specificity over the original ZFP (oZFPs) were used 
for further analysis. 
Selection of Off-Target Sites Stage I 
The zebrafish genome (Zv7 repeat masked) was scanned using a perl algorithm to 
identify off-target sites containing half-sites similar in sequence to the determined 
binding site specificities of the two ZFPs (oZFPL: GANGGTGTG; and oZFPR: 
NNGGTGGGA where N allows all bases) in proper orientation with either 5- or 6-bp 
spacing between the two half-sites.  The sites were ranked based on the number of 
matches to the target site with a score of 15 matches being the maximum.  Heterodimer 
off-target sites that match the target site at 14 of 15 positions were chosen for analysis 
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(kdrl exon 2 is the only 15-of-15-bp match). Homodimeric sites were derived from sites 
that match either the ‘GAXGGTGTG’ composite site at 14 or 15 out of 16 bp or the 
‘XXGGTGGGA’ composite site at 14 of 14 bp.  For the pilot scale analysis, a total of 20 
heterodimeric and 28 homodimeric sites were chosen.  The details for these sites are 
provided in the online table and are marked as “Off-Target Sites I” (online table 
available at http://nar.oxfordjournals.org/content/39/1/381/suppl/DC1). 
Selection of Off-Target Sites Stage II 
Computational analysis was performed to bin additional off-target sequences (identified 
as described above) based on the number of conserved guanines (maximum = 10) within 
the potential off-target sites.  A total of 47 sites that contain all 10 guanines were chosen 
for analysis with a range of total base matches to the target site (13 to 16 for 5- and 6-bp 
spacing sites and 14 to 17 for 14-, 15- and 16-bp spacing sites).  Another 47 sites that are 
missing one or more guanines were chosen for analysis with a range of total base matches 
to the target site (13 to 16 for 5- and 6-bp spacing sites and 14 to 17 for 14-, 15- and 16-
bp spacing sites).  Both groups are designated in the Online Tablea (“Off-Target sites II 
– 10g” & “Off-Target sites II – non-10g”).  One off-target site is identical between the 
sites analyzed in Stage I and Stage II. 
Solexa data analysis for off-target site lesions 
36bp sequence reads from the Illumina run (both stage I and stage II runs) were binned to 
different ZFN treatments based on the barcode sequence.  For each ZFN treatment, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  a	  Online Table available at http://nar.oxfordjournals.org/content/39/1/381/suppl/DC1	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sequences for different off-target sites and the target site were classified using a unique 
9bp “prefix” following the adapter sequence (Online Tablea)  
For each off-target site, insertions or deletions in the spacer region were defined based on 
the distance between the 9bp “prefix” at the 5’ end of each off-target site and a 6 bp (8 bp 
in one case) “suffix” at the 3’ end of each off-target site, where a more proximal suffix 
was employed to identify insertions and a more distal suffix for deletions. In some cases 
single nucleotide polymorphisms were present within the suffix sequences requiring a 
more relaxed suffix sequence definition. If the distance between the prefix and any suffix 
pair in each sequence matched the expected distance these sequences were binned as 
“correct (W)”, where a secondary distal suffix was also employed to identify sequences 
of the appropriate length.  Distances that were greater than expected were binned as 
“insertions (I)”, and distances that were shorter were binned as “deletions (D)” with the 
exception that 1bp insertions or deletions were ignored because of the noise in the 
sequencing data associated with 1bp frameshifts in sequences evident in uninjected 
samples. Reads that did not contain the suffix sequence were marked as undefined (U). 
This analysis will miss long insertions or deletions that alter either the prefix or suffix but 
it is robust to the bulk of sequencing errors yielding high-confidence indels. The number 
of sequencing reads that are correct and the number of reads containing indels (insertions 
plus deletions) at each analyzed site for each ZFN dose were computed for the 
subsequent statistical analysis. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  a	  Online Table available at http://nar.oxfordjournals.org/content/39/1/381/suppl/DC1	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All statistical analyses were performed using R, a system for statistical computation and 
graphics217. The lesion frequency and its 95% confidence interval for each off-target site 
and the target site within each treatment were estimated based on a binomial distribution. 
The Fisher Exact Test was applied to assess whether there is a significant difference 
between each individual ZFN treatment and the uninjected control in the indel rate for the 
on-target and off-target sites.  The odds ratio and its 95% confidence interval were 
computed for each ZFN dose using the fisher.test function based on conditional 
maximum likelihood estimation.  To adjust for multiple comparisons, p-values were 
adjusted using the Benjamini-Hochberg (BH) method209. 
Criteria for defining an active off-target site 
An off-target site was considered active only if the following criteria were fulfilled: a) 
indels occurred at a significant frequency in the injected sample relative to the uninjected 
control (BH adjusted p-value < 0.05)209; b) indels constituted ≥ 0.1% of the sequence 
reads in the average of the two replicates (when applicable); and c) more than one 
different indel sequence was observed (to avoid potential jackpot effects). 
Comparing the reproducibility between the two biological replicates of oZFN 
treatments  
To examine the reproducibility of the data, the Pearson correlation test was applied to 
common sequences between the replicate datasets (oZFN DD/RR replicate 1 and 2: 10 pg 
normal, 10 pg deformed, and 20 pg deformed) on the log odds ratio of ZFN treated 
sample vs. control sample (Figure 2-5). The indel rates for the two replicates were 
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averaged for further analyses.  If for any off-target site, there were <1000 sequences in 
one of the replicate, the frequency of lesions from the other replicate was used for 
analysis. 
Bacterial one-hybrid based Activity Assay 
To assay the importance of Guanine contacts for the binding of oZFPL and oZFPR to 
their respective binding sites, a B1H activity assay was performed.  The ZFP binding 
sites  (wild type or mutant) were cloned in the pH3U3 reporter vector. The oZFPL and 
oZFPR were cotransformed with plasmids bearing their binding sites in US0 cells and the 
activity assay was performed as described in Noyes et al.92.  From a stock of 109 cells/ml, 
the 10-fold serial dilutions were placed as 5 ul drops on 2XYT or NM selective media 
plates containing kanamycin (25ug/ml), carbenicillin (100ug/ml), 3-aminotriazole (1mM 
or 10mM) and IPTG (10uM). The colonies were grown at 37°C for 20hrs (1mM 3-AT 
plates) or 48hrs (10mM 3-AT plates).  The number of colonies were counted for the NM 
selective plates and reduction in colony counts was calculated as -log (number of 
colonies for the wild-type or mutant binding site/ number of colonies for the wild-type 
sequence). 
Binding site analysis using Illumina Sequencing 
Binding site selections were performed using the 28 bp randomized library as described 
previously89,92,94.  The colonies surviving on selective media plate containing 5mM 3-AT, 
10uM IPTG were counted and then washed off the plate.  The plasmid DNA from the 
pooled colonies was isolated and the binding site was PCR amplified using Phusion 
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(NEB) enzyme starting with 50ng plasmid DNA as template.  The PCR reaction 
conditions were as follows: 98°C 3 min; 25 cycles (98°C, 20 sec.; 60°C, 20 sec.; 72°C, 
30sec); 72°C 5min. The primer sequences employed were:  
Forward: 
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTGTGAACGCTCTCCTGA
GTAGG  
Reverse: CTGCTCTGTCATAGCTGTTTCC 
One of the Solexa adapter sequences (adapter-P2) was incorporated into the forward 
primer so that only single adapter ligations were required (see below). The PCR product 
(~1ug) was digested with 40 units of EcoRIHF (NEB) enzyme at 37°C and gel purified.  
The purified DNA was treated with Klenow Exo- (NEB) in the presence of 0.1mM 
dNTPs for 45min at 37°C.  The DNA was spin purified using QIAquick PCR purification 
kit (Qiagen) and barcoded adapters (Table A-5) were ligated using 20 units of T4 DNA 
ligase (NEB) at room temperature for 2hrs.  Important: the barcoded adapters should 
not be 5’ phosphorylated so that they will ligate to only the EcoRI digested end of 
the DNA molecule.  Following ligations, the DNA was PCR amplified (Phusion 
polymerase (NEB)) using in-house Illumina primers, where 20% of the ligation reaction 
was used as the starting template.  The reaction conditions are as follows: 98°C 3 min; 6 
cycles (98°C, 20 sec.; 60°C, 20 sec.; 72°C, 30sec); 72°C 5min. The primer sequences 
employed were: 
80
In-house Illumina P1 (Invitrogen): 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCC
GATCT 
In-house Illumina P2 (Invitrogen): 
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT 
Following PCR of the barcoded-adapter-ligated DNA, 20% of the reaction was run on an 
agarose gel containing ethidium bromide to estimate DNA quantity.  An equal amount of 
PCR-amplified DNA (~80ng) from different barcoded-adapter ligated samples was 
pooled.  The pooled DNA was run on gel and the adapter-ligated fraction of the DNA 
was gel purified.  This purified DNA (~25ng) was amplified by PCR using the Illumina 
Genomic DNA primers (1.1 and 2.1) and Phusion polymerase (NEB) using the follows 
conditions: 98°C 3 min; 9 cycles (98°C, 20 sec.; 60°C, 20 sec.; 72°C, 30sec); 72°C 5min.  
The PCR sample was gel purified and sequenced at 4pM concentration.  The sequences 
were binned according to their barcode.  For each ZFP, unique sequences were isolated 
and ranked according to their frequency of occurrence.  The top most frequent sequences 
(equivalent to the number of surviving colonies on the selective media plates) were 
analyzed by MEME to discover the recognition motif216.  The aligned sequences were 
then used to generate a Sequence logo207 using WebLogo208. 
Illumina sample preparation for lesion analysis at “Off-Target Sites I” 
For the “Off-Target Sites I” group and the on-target site (target site run 1), the Illumina 
sample was prepared as described previously 94. Genomic DNA from the following 7 
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samples were used: uninjected, oZFPs DD/RR 10pg normal Replicate 1, oZFPs DD/RR 
10pg deformed Replicate 1, oZFPs DD/RR 20pg deformed Replicate 1, nZFPs DD/RR 
10pg normal, nZFPs DD/RR 20pg normal, nZFPs DD/RR 20pg deformed.  The number 
of embryos used for isolating the genomic DNA is given in Figure 2-3.  The sequences of 
the primers used to PCR DNA flanking the off-target sites as well as the number of 
sequences with wild type sequence and indels recovered at each site are provided in the 
Online Table available at http://nar.oxfordjournals.org/content/39/1/381/suppl/DC1. 
 
Primer design for amplifying off-target sites 
The sequences for primers used to amplify the DNA flanking the off-target sites are listed 
in the Online Tablea.  For each primer pair, the proximal primer binds neighboring the 
off-target site while the distal primer binds ~150bp away.  The proximal primer contains 
an AcuI restriction site that following cleavage allows the Illumina adapter to be ligated 
within a few basepairs of the center of the putative off-target site. The distal primer 
contains the Illumina adapter (P2) sequence, and consequently Illumina adapter ligation 
is only necessary at the proximal end. 
Solexa Sample preparation for the Off-Target Sites II 
Lesion analysis at “Off-Target sites II” group (10g and non-10g) and the on-target site 
(target site run 2) was performed for the following 14 samples: uninjected, oZFPs DD/RR 	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10pg normal Replicate 1, oZFPs DD/RR 10pg deformed Replicate 1, oZFPs DD/RR 
20pg deformed Replicate 1, oZFPs DD/RR 10pg normal Replicate 2, oZFPs DD/RR 
10pg deformed Replicate 2, oZFPs DD/RR 20pg deformed Replicate 2, nZFPs DD/RR 
10pg normal, nZFPs DD/RR 20pg normal, nZFPs DD/RR 20pg deformed, oZFPs EL/KK 
50pg normal, oZFPs EL/KK 50pg deformed, oZFPs EL/KK 100pg normal, oZFPs 
EL/KK 100pg deformed.  Genomic DNA was isolated from the ZFN-injected or 
uninjected embryos 24-hpf using DNeasy Blood and Tissue Kit (Qiagen).  The number of 
embryos used for each group is listed in Figure 2-3. Using the isolated genomic DNA as 
template, the DNA flanking the off-target sites was PCR amplified with the primers listed 
in the Online Tablea.  For each of the 14 conditions mentioned above, PCR-amplified 
DNA for all 96 off-target sites was pooled.  The pooled DNA for the off-target sites was 
digested with 25 units of AcuI restriction enzyme for 4hrs at 37°C and gel purified using 
QIAquick Gel Extraction kit (Qiagen).  The purified DNA was treated with 1 unit of T4 
DNA polymerase at 12°C for 15min in the presence of 0.1mM dNTPs to polish the 3’ 
overhangs (from AcuI digestion).  The reaction was stopped immediately after 15min by 
adding EDTA (final concentration of 10mM) and heating it to 75°C for 20min.  DNA 
was then spin purified using Qiaquick PCR purification kit (Qiagen) and was treated with 
Klenow Exo- for 45min at 37°C in the presence of 0.1mM dATP to add 3’ A overhangs.  
The DNA was spin purified as described above and the barcoded adapters were ligated as 
described above (Binding site analysis using Illumina Sequencing).  The 14 off-target 
samples were ligated to the 2bp-barcoded-adapters and PCR amplified with in-house 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a	  Online Table available at http://nar.oxfordjournals.org/content/39/1/381/suppl/DC1	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Illumina primers as described above. 20% of the PCR reaction was run on an agarose gel 
containing ethidium bromide to estimate DNA quantity.  An equal amount of the PCR-
amplified DNA (~80ng) from 14 barcoded-adapter ligated samples was pooled (~1ug 
total).  
For the on-target site lesion analysis, the DNA flanking the kdrl ZFN site was PCR-
amplified from the genomic DNA samples from the uninjected or ZFN treated embryos 
(14 samples in total) using the following primers: 
kdrex2 solexa on-site 5p:  CCTGATCCACAACTGCTTCCTGATGGATATCCAC 
kdrex2 solexa on-site-P2 3p: 
CGGCATACGAGCTCTTCCGATCTATAAAGTGGCCATTGAACGTAGATGCAC 
The PCR amplified DNA was digested with EcoRV restriction enzyme and gel purified.  
The purified DNA was treated with Klenow Exo- as above and spin purified.  The 14 on-
target samples were ligated to the 2bp-barcoded-adapters, PCR amplified with in-house 
Illumina primers and pooled as described above. ~10ng of the pooled on-target DNA was 
added to ~1ug of the pooled off-target DNA and was run on gel.  The adapter-ligated 
DNA was gel purified and used as a template for PCR amplification with Illumina 
primers (1.1 and 2.1) as described above.  The PCR sample was gel purified, combined 
with the off-target site pool at the appropriate ratio, and then was sequenced at 4pM 
concentration. 
Comparisons of the off-target lesion frequency for different ZFN treatments 
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To compare the difference in lesion frequency in embryos from any two ZFN treatments 
(oZFN 10pg normal vs oZFN 10pg deformed; oZFNs vs nZFNs and oZFNsDDRR vs 
oZFNsELKK) the number of reads with wild type sequence for all analyzed off-target sites 
was combined as were all of the indel reads.  This provided an overall lesion frequency 
that could be compared between different ZFN treatments using the Chi-square test. 
Comparing the distribution of active and inactive off-target sites for the number of 
matches to the target sites 
Each heterodimeric off-target site containing a 5-or 6-bp spacing was scored based on the 
number of matches to the target site (considering only ZFPL and ZFPR half-sites) and, 
based on the criteria given above, off-target sites were divided into active and inactive 
off-target sites.  Kendall correlation tests were performed to determine the significance of 
the correlation between the number of active sites and the number of inactive sites, and 
the significance of the correlation between the number of matches to the target site and 
the ratio of active sites.  In addition, a two-tailed Fisher Exact Test was performed to 
determine whether the relative number of active off-target sites from two different groups 
of ZFN-treated embryos was significantly different. 
Comparing the distribution of active and inactive off-target sites for the number of 
conserved Guanines 
Each heterodimeric off-target site containing a 5-or 6-bp spacing was scored based on the 
number of positions that had a guanine found in the target sequence (GXXGGXGXG and 
XXGGXGGGX; 10Gs) and, based on the criteria given above, off-target sites were 
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divided into active and inactive off-target sites.  
Frequency Plots for ZFPL and ZFPR binding sites from Inactive, Active and All off-
target sites 
The ZFPL and ZFPR half-sites were extracted from the relevant (active, inactive and all) 
groups of heterodimeric off-target site containing a 5-or 6-bp spacing and aligned using 
MEME216.  Frequency-logos for each group of half-site sequences were generated using 
Weblogo208. 
Germline transmission of off-target lesions 
To assay germline transmission of off-target lesions, we crossed the kdrl founder 
zebrafish (889.7) obtained in Meng et al. with wild type zebrafish, which yielded 33 
surviving embryos.  These embryos were genotyped for the kdrl ZFN target site using the 
NspI digestion assay94.  Out of 33 embryos, 17 were found to be heterozygous for the 
kdrl mutation whereas 16 did not carry the mutant allele.  The genomic DNA from the 17 
heterozygous and 16 homozygous embryos were pooled as two separate groups.  To 
identify any lesions at the off-target sites, the kdrl ZFN active off-target sites were PCR 
amplified as described above from the two genomic DNA pools.  The following off-
target sites were analyzed: OT1, OT2, OT3, OT4, OT5, OT6, OT7, OT8, OT10, OT11, 
OT13, OT14, OT15, OT16, OT18, OT20.  The target site was also included in the 
analysis.  The Solexa sample was prepared and sequenced as described above. The 
sequences for each site were binned for analysis using the unique 9 bp “prefix” described 
above. 
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Chapter III: A modified bacterial one-hybrid system yields 
improved quantitative models of transcription factor specificity 
 
 
 
 
 
Contents of Chapter III have been published previously as: 
Christensen RG, Gupta A, Zuo Z, Schriefer LA, Wolfe SA, Stormo GD (2011) 	  	  
A modified bacterial one-hybrid system yields improved quantitative models of 
transcription factor specificity. Nucleic acids research 39, e83 
 
Ryan Christensen from Gary Stormo’s lab at the Washington University developed the 
GRaMS algorithm and preformed all the computational analysis. I created the 6-bp 
binding site library and performed CV-B1H-selections for Zif268. 
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Introduction 
The Cys2His2 zinc finger is the most frequently observed DNA binding domain family in 
the metazoan transcription factors (TFs)14.  In the canonical recognition each finger 
specifies 3 bp through specificity determinants present on the recognition helix of the 
zinc fingers45,48,58. Many laboratories have demonstrated that fingers with novel 
recognition preferences can be obtained from randomized libraries through various 
selection methodologies48,58,162.  Further, these synthetic zinc finger units can be 
assembled into tandem arrays known as ZFPs that can be fused to an effector domains to 
create artificial TFs, recombinases and nucleases (ZFNs).  The utility of artificial ZFPs is 
currently restricted by the limited availability of highly specific zinc finger units that can 
be reliably assembled to create artificial ZFPs.  Developing a method that can provide a 
rapid and accurate assessment of the binding site specificities of selected zinc finger units 
would represent an important advance for defining and engineering specificities of zinc 
finger units.  Ultimately, such a method would provide a high quality dataset of DNA-
protein interactions that can be utilized to create an accurate ‘recognition code’ for zinc 
fingers enabling rational design of artificial ZFPs as well as prediction of specificities of 
naturally occurring zinc finger containing TFs to elucidate gene regulatory networks. 
Several methods exist for determining the specificity of DNA binding proteins107.  
SELEX (Systematic Evolution of Ligands by EXponential enrichment) allows extraction 
of binding sites for a protein from an unbiased pool of oligonucleotides but involves 
multiple rounds of enrichment of bound sites and therefore provides only the highest 
affinity sites for a protein109-112.  A modified version of SELEX, HT-SELEX requires 
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only one round of enrichment and can be coupled with high throughput sequencing to 
develop energetic models that fit better than the conventional SELEX117.  However, like 
SELEX this method is in vitro and requires protein purification or in vitro protein 
expression.  Protein binding microarray (PBM) is a medium-throughput in vitro method 
for identifying binding site preferences for naturally occurring TFs or engineered ZFPs 
but is limited to proteins with binding sites shorter than ~10 bp 107,118,119. 
In comparison to these in vitro methods, bacterial-one-hybrid (B1H) based selection 
methods provide in vivo determination of binding site specificities of TFs as well as 
artificial DNA binding proteins19,89,90,92,93.  In this approach, the DNA binding domain 
(DBD) to be assayed is fused to an alpha-subunit (α-subunit) or in the recent versions the 
omega-subunit (ω-subunit) of the RNA polymerase19,92.  A randomized binding site 
library is used which is located upstream of a weak ‘lac’ promoter driving the expression 
of yeast HIS3 and URA3 reporter genes.  The selections are performed in the E. coli 
selection strain lacking the endogenous hisB (the bacterial homolog of HIS3) and pyrF 
(bacterial homolog of URA3) genes where one member of a library is compartmentalized 
with the α- or ω-fused DBD (Note: when using the ω-fused DBD, the endogenous rpoZ 
is also deleted).  Binding of the DBD to its binding sites with high affinity and specificity 
will activate the reporter genes allowing bacterial cells to form colonies on selective 
media.  The recovered binding sites can either be sequenced individually via Sanger 
sequencing or as a pool via high-throughput sequencing.  Since the B1H-selections are 
performed in E. coli, there is no need for protein purification or in vitro protein 
expression.  Further, the bacterial genomic DNA acts as competitor DNA allowing active 
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binding sites to be selected for both specificity and affinity.  Moreover, B1H system 
involves a single round of selection thus making the selection process easy and rapid. 
Here we describe a new version of B1H-based selection system, the constrained 
variation-B1H (CV-B1H) method that uses a randomized binding site library in a fixed 
register allowing a rapid and easy estimation of binding site specificities of two-finger 
zinc fingers units.  We have also developed a complementary algorithm, ‘Growth Rate 
Modeling of Specificity’ (or GRaMS) that models the relationship between binding 
energy and growth rate to increase the accuracy of the quantitative specificity model 
produced from B1H data. 
Results 
CV-B1H method 
To determine binding site specificities of two-finger zinc finger units (2F-modules), we 
constructed a 6 bp-randomized library adjoining a ‘GCG’ DNA triplet (NNNNNNGCG) 
(Figure 3-1).  We incorporated another randomized 4 bp element six base-pairs upstream 
of the 6 bp-randomized region that serves as an internal control to detect any sequence 
biases in the library before or after selections and any jackpot effects during PCR 
amplification of recovered sequences. Oligonucleotides encoding the binding site library 
were cloned into the reporter plasmid pH3U3 upstream of a weak promoter that drives 
expression of the yeast HIS3 and URA3 reporter genes (Figure 3-1). The library was 
counter-selected by growing the library-transformed cells on 5-FOA (5-Fluoroorotic  
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Figure 3-1
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Figure 3-1: CV-B1H method to determine DNA binding specificities of zinc fingers. 
The 2F-ZF unit is fused to an N-terminal finger (RSDTLAR) that binds to the ‘GCG’ 
triplet adjacent to the 6 bp randomized zinc finger binding region on the reporter plasmid. 
There is also a 4 bp randomized region (key region) that serves as an internal control to 
identify biases in the recovered DNA sequences due to jackpot effects.  Following 
selection, the surviving colonies are pooled and the distribution of bases recovered at 
each position within the selected binding sites can be evaluated in a single sequencing 
reaction.  To test this system we used the DNA binding domain of the Zif268 protein and 
performed CV-B1H selections to determine binding site specificity of fingers 2 and 3 of 
Zif268.  The results from Sanger sequencing are shown both before and after selections 
with Zif268.  The recovered binding sites are determined by Illumina sequencing and 
analyzed by the GRaMS (Growth Rate Modeling of Specificities) method that predicts 
binding energies as shown in the graph and provides a sequence logo for Zif268 fingers 2 
and 3.  The binding site model obtained using the and GRaMS method closely matches 
the motif obtained by HT-SELEX117.           
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acid) containing media to remove any self-activating sequences91,93.  To determine the 
binding site specificity of a 2F-module, it is fused to an N-terminal anchor zinc finger 
that binds to the GCG triplet adjoining the library. Apart from providing additional 
affinity to the 2F-module to be functional in the B1H-selection system, by binding the 
GCG DNA triplet the anchor finger fixes the register of the binding sites for the 2F-
module thus allowing the selected binding sites to be sequenced as a pool in a single 
reaction.  When sequencing the recovered binding sites individually, this property of the 
system eliminates the need to align the selected active binding sites.  Binding of the 2F-
module to its binding sites with high specificity and affinity allows the selection strain to 
grow on selective media plates lacking histidine and/or uracil.  The selection stringency 
of the B1H selections can be tuned by incorporating variable amounts of 3-Amino 
triazole (3-AT) (a competitive inhibitor of the HIS3 enzyme) and IPTG (which controls 
2F-module protein concentration) in selective media plates.  The binding sites from the 
surviving colonies can be sequenced in a pool either through Sanger sequencing or as a 
population through Illumina sequencing. 
Testing the CV-B1H method 
To test the utility of the CV-B1H system to determine binding site specificities we 
characterized Zif268, a three-finger protein with a well defined DNA binding 
specificity89,93,117.  Since the N-terminal finger-1 of the Zif268 is known to bind the GCG 
sequence, we fused the DNA binding domain of the wild type Zif268 protein to the ω-
subunit and determined the binding specificity of finger-2 and finger-3.  We co-
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transformed Zif268 with the library-containing reporter plasmid into bacterial cells and 
plated ~1 million double transformants onto selective media containing plates.  The 
selective media lacked histidine and contained nine different combinations of 3-AT (0.5, 
1.0 and 2.0 mM) and IPTG (0, 10 and 50 µM).  The plates were incubated at 37°C for 
different time points (4, 8, 12, 18 and 24 hours).  At the appropriate time point, bacterial 
cells were washed off the plate and plasmid DNA was isolated for a single selection 
condition in one tube.  The binding sites were sequenced as a pool in a single sequencing 
reaction via Sanger sequencing. The chromatograms at 4 hr did not show much 
enrichment of the Zif268 binding site sequences (Figure 3-2).  At the 8 hr time point, 
selections from no-IPTG conditions did not show any enrichment of Zif268 binding sites 
but selections containing 10 or 50 µM IPTG displayed some enrichment as estimated by 
the appearance of individual peaks for certain bases.  At 12 hr and 24 hr time points, the 
chromatograms showed clear enrichment of the Zif268 binding sites after selections 
(Figure 3-2).  Moreover, there were differences in the strength of enrichment at different 
stringencies imposed by 3-AT and IPTG concentrations; higher stringency selections (0 
µM IPTG and 2 mM 3-AT) showed stronger enrichment of bases at certain positions than 
lower stringency selections (50 µM IPTG and 0.5 mM 3-AT).  In sum, these results 
demonstrated that the CV-B1H selection system can be utilized to rapidly determine 
binding specificities of zinc fingers. 
Quantitative Motifs 
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Figure 3-2 
a) 4 hr                            
                                            
 
b) 8 hr
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c) 12 hr 
 
d) 24 hr 
 
 
Figure 3-2: Binding site profiles for Zif268 from Sanger sequencing.  After CV-B1H 
selections at different stringencies (3-AT and IPTG) and time points, surviving colonies 
were washed from the plate and the binding sites were sequenced as a pool via Sanger 
sequencing.  The chromatograms are displayed for 4 hr (only a few conditions) (a), 8 hr 
(b), 12 hr (c) and 24 hr (d) time points.  The selection condition ‘0.5 mM 3-AT and 50 
µM IPTG’ represents the least stringent condition and ‘2 mM 3-AT and 0 µM IPTG’ 
represents is the highest stringency condition.  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The chromatograms obtained from the Sanger sequencing post-CV-B1H selections 
provide qualitative information on binding preferences of a given zinc finger but 
quantitative assessment of binding site models require sequencing individual binding 
sites.  We performed Illumina sequencing of the pools of binding sites where DNA from 
each condition was barcoded and sequenced in a single lane. Forty-five different 
selection conditions (3-AT, IPTG and time points) were combined, where we obtained on 
an average 300,000 sequences for each condition.  We also sequenced the 6 bp library 
before selection (but after counter-selection) to construct a background model to define 
the enrichment of sequences from the library.  Motif comparisons for data generated from 
these experiments were made to the subset of published Zif268 high throughput-SELEX 
(HT-SELEX) data117 that contained the GCGG sequence in the last four positions on the 
binding site, to be consistent with the constraints in our 6 bp library selections.  The 
BioProspector218 and log-odds analyses on the recovered sequences from various 
conditions were highly variable, in particular for selections with short incubation times 
(Figure 3-3).  The constructed motifs predicted the HT-SELEX data with median R2 
values of only 0.52 and 0.54 for BioProspector and log-odds, respectively and the 
maximum values were only 0.71 and 0.74 (Figure 3-3).  These results are explained by 
the fact that the initial library, which has been counter selected to remove self-activating 
sequences, has a very low proportion of the consensus binding site and some other 
closely related sites.  Their low initial frequencies ensure that even after the 24 hour 
incubation they have not become the most abundant sites, therefore leading to 
construction of a PWM with sub-optimal parameters.  Although both the log-odds  
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Figure 3-3 
 
Figure 3-3: Performance of GRaMS on the CV-B1H data and comparison to other 
methods. Boxplot showing the ability of the 45 PWMs produced by each analysis 
method using each B1H data set as the training data to predict the HT-SELEX 
NNNNNNGCGG data117.  For each model, R2 was calculated to determine the correlation 
between the predicted and observed HT-SELEX counts.  
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method and BioProspector take the initial library into account through their background 
estimates they do not capture the explicit deficiency of specific binding sites, some of 
which are high affinity sites.   
Since the BEEML program117 takes into account each specific binding site in both the 
initial and selected libraries, we tested the BEEML program on the 45 data sets.  Based 
on a biophysical model for enrichment, BEEML performs a nonlinear regression to find 
the optimal parameters for a PWM.  While its performance is still quite poor on the 
earliest time points, its median R2 is 0.86 and its best is 0.92, both significantly better 
than the other methods (Figure 3-3). 
GRaMS analysis 
To improve the accuracy of the PWMs obtained from analysis of the B1H-based data we 
developed the ‘Growth Rate Modeling of Specificities’ (GRaMS) algorithm that would 
capture the differences in relative growth rate of the surviving colonies resulting from the 
differences in relative energy of binding sites.  The GRaMS model is described in the 
‘Methods’ section. For the ideal simulated data, the relative ratios of different binding 
sites as a function of their energetics at various time points fall on different lines, but 
when converted to growth rates they all converge to a single line that shows the 
relationship between growth rate and binding energy (Figure 3-4).  GRaMS was 
performed on all 45 selections and the binding energies were predicted (Figure 3-5).  
While obviously noisier than the simulated data, the curves are all very similar and are 
consistent with our model.  Figure 3-6 shows the logos for all 45 data sets. The PWMs  
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Figure 3-4 
(a) 
(b)  
 
 
Figure	  3-­‐4.	  Simulated	  Ideal	  B1H	  data.	  (A)	  Energy	  versus	  log2(counts)	  curves	  for	  5	  different	  simulated	  data	  sets.	  Each	  curve	  represents	  a	  B1H	  experiment	  that	  was	  run	  for	  a	  different	  amount	  of	  time:	  4,	  8,	  12,	  18,	  24	  hours.	  (B)	  Energy	  versus	  growth	  rate	  curves	  for	  the	  same	  five	  data	  sets:	  4,	  8,	  12,	  18,	  24	  hours.	  Energies	  are	  given	  in	  units	  of	  KbT.	  For	  these	  simulations,	  a	  μ	  value	  of	  3	  was	  used.	  	  All	  4096	  binding	  site	  alleles	  occurred	  once	  and	  each	  gave	  rise	  to	  a	  single	  simulated	  colony.	  Energies	  were	  assigned	  using	  the	  PWM	  of	  Zhao	  et	  al.117. 
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Figure 3-5 
           
Figure 3-5: Plots of predicted energy values versus B1H growth rates (shifted so that 
the median is set to zero) for all 45 conditions. The PWM of Zhao et al.117 was used to 
predict the energy of all 6mers. The growth rate is on the y-axis and the predicted energy 
on the x-axis.  The plots are organized in a 5-column by 9-row grid. Each column 
corresponds to one of the 5 different time points (4, 8, 12, 18 and 24 hours), in that order, 
from left to right.  Each row represents a combination of 3-AT and IPTG concentration 
mentioned on the left and right respectively. 
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Figure 3-6 
 
 
 
Figure 3-6: Sequence logos for all 45 PWMs produced using GRaMS on all of the 
HT-B1H datasets. The title of each sequence logo indicates (in order): the duration of 
each experiment in hours; the IPTG concentration (µM); the concentration of 3-AT 
(mM).  All sequence logos were produced using in-house software, svgSeqLogo, written 
by Ryan Christensen.  The y-axis of each logo is in units of bits. 
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obtained from GRaMS show a high correlation with the HT-SELEX data (median R2 = 
0.92). Note that the models from different conditions are very similar indicating that with 
GRaMS analysis the resulting models are relatively insensitive to the exact experimental 
protocol.  Motifs constructed from the 4 h time points remain the least accurate and those 
from the late time points have slightly reduced accuracy probably due to the onset of 
colony saturation for the highest affinity binding sites (figure 3-7).  At the earlier times 
points increased stringency, using higher concentrations of 3-AT, improved the quality of 
the motifs somewhat but the results are relatively insensitive by the concentration of 
IPTG. 
 
Discussion 
We have developed a CV-B1H method that combines the advantages of B1H assay with 
a fixed register library, for rapidly determining DNA binding specificities of zinc finger 
proteins.  This method is based on the ‘profiling’ system developed by Wolfe and 
colleagues93 and offers several advantages over the original system.  In the CV-B1H 
system we fuse the zinc fingers to the ω-subunit of the RNA polymerase instead of the α-
subunit used in the profiling system.  This allows us to perform the selections in a ω-
deficient strain of E. coli (ΔrpoZ) which results in a uniform incorporation of the ω-fused 
zinc fingers in the RNA polymerase thus increasing the sensitivity of the detection of 
DNA-protein interactions19,92.  Further, instead of using a 5 bp-randomized library, we 
created a 6 bp randomized library that allows evaluating specificities of two-finger zinc 
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Figure 3-7 
 
 
Figure 3-7: Plot showing the ability to predict the training data, as measured by R2, 
of all GRaMs models, as a function of time. Points show the average R2 value per time 
point. Error bars indicate the range of the nine different IPTG and 3-AT concentrations 
for each time point.  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finger units instead of 1.5 fingers.  Finally, the 6 bp library is flanked with restriction 
sites that allow ease of sample preparation for Illumina sequencing.  Deep sequencing of 
the binding site pools enables us to build accurate quantitative binding energy models 
from a large population of recovered binding sites. 
To analyze the CV-B1H data, we have developed the GRaMS algorithm that measures 
growth rates of cells across the distribution from high affinity to low affinity sites and 
uses a biophysical model for the relationship between growth rate and binding energy. 
GRaMS is able to obtain more accurate models from B1H data than any other approach 
we tested. We obtained good models under all of the variations that we tested except for 
the very early time point (4 h) where we believe that the non-dividing cells make a 
significant proportion of total cells on the selection plate and contribute to the high 
background in the dataset.  The 10 and 50 µM IPTG conditions worked better at early 
time points than the 0 µM IPTG probably due to insufficient protein expression at the 0 
µM IPTG condition for maximal reporter expression resulting in somewhat random 
growth at early time points thus increasing the noise in the data.  Although, at later time 
points there were minor differences in the motifs obtained from lower stringency and 
higher stringency, the GRaMS analysis was fairly insensitive to the selection conditions.  
Finally, at 24 h the accuracy of GRaMS started to decrease probably due to saturation of 
the colony size of high-affinity binding sites, suggesting that post-CV-B1H the colonies 
should be harvested before 24 hours of incubation. 
105
The log-odds and BioProspector models performed poorly on the CV-B1H data (Figure 
3-3).  One of the reasons could be an under-representation of the high energy Zif268 
binding sites in the initial library which would in turn result in their under-representation 
in the final binding site pools.  This underrepresentation of the high energy binding sites 
for Zif268 in the initial library could result from a minor contamination of the library 
plasmid with the Zif268 expression plasmid during counter-selection that would 
eliminate these sequences from the initial library.  However, since the growth rate of the 
consensus site would be higher than the non-consensus (but similar) sites, GRaMS would 
assign it higher energy yielding a more accurate PWM. 
As shown in Chapter IV, the CV-B1H system can be employed to rapidly determine 
binding site specificities of the 2F-modules obtained from zinc finger selections, choose 
the highly specific 2F-modules for use in creating ZFNs and perform focused alterations 
to improve the specificities of proteins that show suboptimal specificities.  Although, we 
utilized this method to determine the binding site specificities of 2F-modules, it can be 
modified to assay single zinc fingers by combining them with another anchor finger 
besides the ‘GCG’-binding anchor finger.  Ultimately, a large amount of DNA-protein 
recognition data can be obtained using this medium-throughput method that will facilitate 
building more accurate ‘recognition codes’ for zinc fingers. 
METHODS 
Zif268 B1H selections  
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All of the B1H binding site selections were performed as described previously using an 
ω-Zif268 fusion protein expressed from a UV2 promoter in the plasmid p135292.  Zif268 
was used for these experiments because it has been thoroughly characterized by a number 
of other methods allowing comparison of the recognition models we obtain to its 
previously defined specificity.  
Randomized 6bp binding site library 
 The binding site library 
(GCGGCCACTGGGCAGCTGGCCANNNNAAAAATNNNNNNGCGGTACCTAGGT
TCTTCGAATTC) cloned between the EcoRI and NotI sites in pH3U3 contains two 
different randomized regions: a 6bp element (bold underlined) that is associated with the 
four 3’ bases of the Zif268 recognition sequence (GCGG, underlined), and a 4bp 
randomized region (italics) that serves as an internal control to identify sequences that 
may be enriched in the selections or preparation for sequencing sample due to jackpot 
effects. We did not observe any evidence of a jackpot effect.  Self-activating clones 
within this library were removed by 5-FOA counter-selection as previously described92.  
Approximately 106 co-transformed cells containing the library and the ω -Zif268-
expression plasmid were plated under each selection condition on selective media plates 
containing 0.5, 1 or 2 mM 3-AT and 0, 10 or 50 µM IPTG, where these selections were 
incubated at 37 °C for 4, 8, 12, 18 or 24 hours. This was a total of 45 independent 
selections.  At the desired time-point surviving cells were washed off the plate as a pool. 
Isolated plasmid DNA from the pooled cells was prepared for Illumina sequencing as for 
the 28bp library. Using barcodes for each experiment, sequences from all 45 experiments 
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were obtained from a single Illumina sequencing lane that contained over 15 million 
reads, leading to an average of about 300,000 binding sites per experiment. There are 
only 4096 different 6mer sites so this quantity of sequences is sufficient for good 
coverage of all possible binding sites.  We also performed CV-B1H from the same initial 
library in liquid media with 5 mM 3-AT and 50 µM IPTG. After 4 hrs the cells were 
pelleted, plasmids isolated and they were prepared for Illumina sequencing as with the 
experiments on plates. We independently sequenced the counter selected library, which 
was the input to each of the binding site selection experiments, to define the initial 
frequency of each 6mer.  More than 16 million reads were obtained and every 6mer was 
observed at least 472 times.  This allowed us to determine the enrichment of each site 
after selection. The sequences from each dataset are available at 
http://ural.wustl.edu/htb1h_zif68 and from the GEO database (GSE26767). 
Binding site modeling using existing programs 
We model the binding energy of Zif268 for any sequence using a position weight matrix 
(PWM)219. We used four different motif discovery methods on the different datasets. 
BioProspector218 was used on the 6bp datasets with a site size of 6bp and a fixed 
orientation.  A 3rd-order Markov model, based on the sequences of the respective initial 
libraries, was used for the background model.  BEEML117 was used with the background 
model derived from the 6mer counts in the initial library. We also tested a simple Log-
Odds method that determines the value of each PWM element from the ratio of the 
observed frequency of each base at each position in the aligned binding sites to the 
108
observed frequency of each base at each position in the initial library (from the 
randomized region). 
 
Binding site modeling based on growth rate analysis 
We model protein-DNA binding using a biophysical model described previously117. 
Briefly, the probability that the sequence Si is bound at equilibrium is: 
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where Kd is the dissociation constant and square brackets indicate concentrations. It is 
convenient to express the energy of binding, Ei, relative to the Gibbs free energy of 
binding to a reference sequence; we use the consensus sequence, in units of RT, with its 
energy defined as, Eref = 0 :  
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In order to grow and replicate, cells must express sufficient His3 enzyme to meet their 
histidine requirements. We define the growth rate of an allele as the number of doublings 
that a cell possessing it undergoes each hour during exponential growth phase.  The 
equation 
 ( ) (0)2 ir ti iN t N=  (5) 
describes the exponential growth of a colony, where t is the number of hours, Ni(t) is the 
final number of cells possessing site Si present at time t, ri is the growth rate for cells 
containing that site in doublings/hr, and Ni(0) is the initial number of cells with that site 
at time 0.   
Histidine is a rate limiting reagent, and we make the simplifying assumption that the 
amount of histidine is directly proportional to the occupancy of the His3 promoter by the 
TF (up to some saturating level) and that the growth rate, ri, of cells possessing Si is 
directly proportional to the amount of histidine produced, up to a level where it is no 
longer limiting.  The relationship between binding energy of the TF for site Si and the 
growth rate is then: 
  (6) 
where M is the maximum growth rate for these cells under the same conditions but with 
histidine not being limiting.  Supplemental figure 1A shows a simulated ideal experiment 
where the counts for each sequence depend on the binding energies as described in the 
biophysical model of the preceding equations.  Data taken at different time points will 
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fall on different curves, but when converted to growth rates all of the data sets converge 
to a common curve describing the relationship between growth rate and binding energy 
(Supplemental figure 1B).   
We are only able to determine the frequency of each allele from the Illumina reads.  In 
order to convert these frequencies into numbers of cells, we need to know the initial 
number of cells plated, nI, and the final number of cells on the plate, nF, at time t.  The 
growth rates determined by the frequencies at time t will be off by a constant 
  (7) 
such that 
  (8) 
where fi(t) is the frequency of site Si at time t, and fi(0) is the initial frequency of Si 
before selection.  We refer to the quantity 
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as the enrichment of site Si at time t. For a given experiment, every growth rate will be 
off by the same constant.  If we assume that the minimum growth rate is 0 (cells may not 
divide but they do not disappear from the plate) we can determine the constant by 
assuming the plateau of high energy binding sites represents a growth rate of 0.  For the 
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remainder of the paper, including all of the figures, the calculated growth rates for each 
site have been adjusted such that the median of the high energy plateau is defined as 0. 
For a given PWM, the predicted growth rates, iˆr , depends on the energy model via: 
  (10) 
where iS
r
 is the encoded sequence, Si, and W
r
 is the PWM.  In this analysis, M was fixed 
to the maximum growth rate for each data set.  We use the Levenberg-Marquardt 
algorithm220-222 in a program called GRaMS (Growth Rate Modeling of Specificity) to 
perform a least squares fit between the measured and predicted growth rates in order to 
find the optimum PWM. 
Assessment of different protocols and analysis methods 
For each experimental dataset and each analysis method we obtain a position weight 
matrix (PWM). We adjust the elements such that those corresponding to the reference 
sequence are assigned 0, and the other elements are estimates of the binding energy 
differences for each other base at each position in the binding site, as proposed by Berg 
and von Hippel223.  We determine the accuracy of each method by measuring, using the 
squared Pearson Correlation Coefficient (R2), how well it predicts the binding data from a 
single-round SELEX experiment117. In that experiment a large library of random 10mers 
were bound to Zif268 and the bound fraction as well as the initial library were Illumina-
sequenced. For each PWM the values of µ and a non-specific binding energy, Ens, are 
found that maximize the fit for that model so that the comparisons are strictly between 
ˆ
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how well the PWMs capture the energy differences for each base at each position. 
BEEML117  was developed specifically to model that SELEX data so we determined its 
R2 value when trained on the SELEX data directly as the maximum that any other PWM 
could be expected to obtain. This was 0.93 and 0.96 for the 10bp PWMs and 6bp PWMs, 
respectively. The remaining variance is probably due to experimental noise as well as 
binding energy contributions not captured by the simple PWM which are known to exist 
but be small for Zif268224. 
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CHAPTER IV 
AN OPTIMIZED TWO-FINGER ARCHIVE FOR ZFN-MEDIATED GENE 
TARGETING 
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Ryan Christensen from Gary Stormo’s lab at the Washington University performed the 
W-log Odds and the GRaMS analysis for the 2F-modules and created sequence logos.  
Amy Rayla performed some of the B1H-selections. Abirami Lakshmanan performed the 
analysis of ZFN sites in zebrafish and human genomes. 
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Introduction 
 
Targeted genome editing is an essential technology for reverse genetic analysis of gene 
function and for the creation of disease models.  Custom-designed zinc finger nucleases 
(ZFNs) facilitate targeted genome modification in a variety of organisms and cell types 
by creating site-specific double strand breaks in DNA.  Repair of ZFN-induced double-
strand breaks by the error-prone non-homologous end joining (NHEJ) pathway leads to 
efficient introduction of insertion or deletion mutations (InDels) at the site of the double-
strand break often resulting in loss of gene function.  Alternatively, repair of a double-
strand break by homology-directed repair with an exogenously introduced donor template 
can promote efficient and precise introduction of custom designed alterations at or near 
the break site.  This technology has been successfully applied in a variety of cell 
lines62,63,113,115,168-171 and organisms such as drosophila167, zebrafish94,114,172, C. elegans173, 
rats174, mice65,175, pigs116,176, arabidopsis177, maize178 and tobacco179,180 many of which 
previously lacked efficient tools for targeted genome editing162. Due to their demonstrated 
utility and minimal off-target effects160,184,185, ZFN-based therapies are being evaluated in 
clinical trials.  Currently, widespread utilization of ZFNs is hindered by the challenge of 
designing zinc finger proteins (ZFPs) with sufficient affinity and specificity for a 
majority of DNA sequences within a genome. 
ZFNs are engineered endonucleases that are composed of two domains: a DNA binding zinc 
finger protein (ZFP) and a C-terminal cleavage domain from the FokI endonuclease. The 
incorporated ZFP is a tandem array of 3-6 zinc fingers each of which recognizes a roughly 3 
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bp DNA element.  Since the nuclease activity requires dimerization of the FokI domain, two 
ZFPs are designed where each binds to a total of 9-18 bp of DNA and combined they bind 
18-36 bp of DNA specifying a unique address even in a complex genome.  The ZFN activity 
and precision in vivo depends on the DNA binding specificity and affinity of the incorporated 
ZFPs104,159,160,185 demonstrating the need for the ability to create highly specific ZFPs.  ZFPs 
that are highly specific for a desired target site can be selected from randomized finger 
libraries using phage or bacterial selection systems81,85,94,98, however this process is labor 
intensive.  By contrast, modular assembly, wherein pre-characterized single zinc finger 
(1F) modules are joined into ZFPs, rapidly yields ZFNs53,82,83,161,202.  Although 1F-
modules have been described for almost all 64 DNA triplets75,82,83, modular assembly has 
been successful only for a limited number of binding sites mostly consisting of ‘GNN’ type 
DNA triplets or ‘N-G’ type of 2 bp junctions between the finger subsites53,100,103,104 (Figure 
4-1).  The low success rates are presumably due to unfavorable interactions between the 
amino-acid residues at the finger-finger interface resulting in ‘context-dependent’ 
specificity of zinc fingers104.  Apart from the labor-intensive selection of compatible 
fingers in their respective contexts81,94,98, efforts to minimize unfavorable finger-finger 
interactions have focused on randomizing the interface residues and selection of two-
finger (2F) modules that have compatible residues at the interface84,85.  These 2F-modules 
have been used by Sangamo BioSciences to build highly specific ZFPs and active 
ZFNs114,162, however, their archive is proprietary limiting its use to ZFNs purchased 
through Sigma-Aldrich.  Recently, the Zinc Finger Consortium (ZFC) described a 
Context Dependent Assembly (CoDA) approach whereby 2F-modules selected from 
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Figure 4-1 
 
 
Figure 4-1: Schematic representation of the two-finger-ZFP library. Two orthogonal 
2F-libraries were constructed each containing randomized amino acids at the finger-
finger interface positions 5 and 6 of F1 (VNS randomization scheme) and positions -1, 1 
and 2 of F2 (NNW randomization scheme). Amino acids at the remaining positions were 
fixed as following: F1: -1 = R, 1 = S, 2 = D, 3 = T, 4 = L; F2: 3 = N (Asn+3F2-library) or 
H (His+3F2-library), 4 = L, 5 = T, 6 = R. The F1 residues (R, S and D) at positions -1, 1 
and 2 together represent the N-terminal cap. Fixed amino acids were chosen so as to bind 
GAN-NCG 6bp sites where N-N represents all 16 possible 2bp junctions. 
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 OPEN pools are assembled into three-finger ZFNs100.  CoDA-derived ZFNs constructed 
from prescreened ZFAs displayed higher success rates (~50%) than modularly assembled 
ZFNs, but the assayed ZFNs were almost entirely constructed from 2F-modules that 
recognize ‘GNN-GNN’ 6bp sites with ‘N-G’ type junctions that are not the limiting 
factor for advancing ZFN design (Figure 4-2). 
In this study we have applied the bacterial-one-hybrid (B1H) based selections to create an 
archive of 87 two-finger modules that recognize 162 6-bp target sites. These 2F-modules, 
bind all possible 2 bp junctions including the ‘non-N-G’ junctions with high specificity 
and provide units for creating ZFNs.  To assess their functional utility, we combined 
these 2F-modules with each other or with available 1F-modules53 to create 3- or 4-finger 
ZFNs that demonstrated high success rate of gene editing in zebrafish. 
 
Results 
Selecting 2F-modules using B1H-based selections 
We focused on selecting 2F-modules that recognize 2 bp interfaces in the ‘GAN-NCG’ 
context where ‘N-N’ represents the 2bp junction (Figure 4-1).  We constructed two two-
finger libraries with randomized amino acids at the interface recognition positions; one 
with Asparagine (Asn+3F2 library) and the other with Histidine (His+3F2 library) at the 
position 3 of F2 for the recognition of Adenine at the second base position (Figure 4-1).  
Both zinc finger libraries were fused with the engrailed homeodomain instead of a  
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Figure 4-2  
 
 
 
 
 
 
 
Figure 4-2: Comparison of target site composition for CoDA-ZFNs against ZFNs 
described herein. The half sites for ZFNs constructed in Sander et. al. using the CoDA 
strategy100 and ZFNs constructed in this paper were compiled by aligning their 5’ ends. 
Frequency plots and Sequence Logos displaying information content on a 2-bit scale 
were generated for each set of sites using Weblogo208. 
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conventionally employed third anchor zinc finger (Figure 4-3)19,84,85,100.  The fused 
homeodomain provides sufficient affinity to the two-fingers and avoids any interfering 
interactions from the anchor fingers.  The selections were performed via bacterial-one-
hybrid (B1H) based assay at multiple stringencies, modulated by 3-Amino triazole (3-
AT), IPTG and uracil, to assess their influence on the distribution of selected residues.  In 
general, higher stringency selections yielded fewer surviving colonies implying 
enrichment for clones that have higher specificity and affinity for the binding site.  For 30 
of 32 selections analysis of recovered clones revealed that a partial or full consensus 
sequence was obtained even at lower stringency, and seven of these selections displayed 
a tighter consensus at higher stringency (Figure 4-6 and Table A-1).  For two interfaces 
‘C-T’ and ‘T-T’, selections with the His+3F2 library did not yield any consensus.  
Moreover, for 10 of 16 2bp interfaces, selections with both Asn+3F2 and His+3F2 
libraries yielded similar clones suggesting that residues specifying these interfaces might 
be less dependent on the +3 residue of F2.  Finally, achieving high stringency in the ‘G-
G’ interface selections with the Asn+3F2 library required mutation of the anchoring 
homeodomain binding site, presumably to require greater specificity from the attached 
2F-module.  Future implementations of this selection scaffold can use this approach to 
further tune the selection of desired ZFP activities45,225. 
Examining the binding site specificities of 2F-modules 
Previously it has been shown that the selected ZFPs might prefer a different binding site 
that the desired one 82,83,86.  To confirm that the recovered 2F-modules are specific for the  
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Figure 4-3 
 
 
    
 
 
Figure 4-3: Schematic representation of bacterial-one-hybrid (B1H) based selections 
for 2F-modules. The B1H based zinc finger selection system employed here is a 
modified version of the one previously described123.  The 2F-zinc finger libraries were 
fused to the DNA-binding domain of the Engrailed homeodomain on the C-terminus and 
the w-subunit of the RNA polymerase on the N-terminus. The fixed 6bp zinc-finger 
binding site is present on the His3/Ura3 reporter plasmid 3bp downstream of the 
homeodomain binding site and 9bp upstream of the -35 box. 
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desired interface, we determined the binding site specificities of 87 selected two-finger 
modules using the ‘constrained variability-B1H (CV-B1H)’ method123 (Chapter III, 
Figures 4-4 and 4-5).  For 19 of 32 junctions, including 11 of 24 ‘non N-G’ junctions, 
we identified 2F-modules that preferred the desired binding site (Figure 4-6).  As 
anticipated, most modules isolated from the His+3F2-library recognized both G and A at 
the second position of their 6bp binding sites (Figure 4-6).  Similarly, Threonine at the 
position 3 of finger-1 showed a preference both for C and T at the second position of the 
finger-1 target site.  For the seven 2F-selections that displayed a more constrained 
consensus at higher stringency, clones from the higher stringency displayed improved 
sequence selectivity suggesting that increasing the stringency of selections yields 
modules with higher specificity (Figure 4-7).  We also observed covariation of the 
residues at the interface for some of these selections indicating interactions across the 
finger-finger interface and selection of compatible groups of residues (Figure 4-7).  
Interestingly, clones with similar interface residues obtained from the Asn+3F2- and 
His+3F2-library selections showed similar sequence preferences for 9 of 10 2-bp 
junctions corroborating that the DNA recognition at the 2 bp junction by these residues 
might be less prone to influence by the type of residue at position 3 of finger-2 (Figure 4-
6). 
Improving the specificity of 2F-modules through rational design 
A few selections yielded 2F-modules that, although compatible with the desired target 
site, preferentially recognized a different DNA sequence, a phenomenon that has been  
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Figure 4-4 
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Figure 4-4: Identification of DNA binding specificity for 2F-modules using the CV-
B1H method123.  The 2F-module is fused to an N-terminal finger (RSDTLAR) that binds 
to the ‘GCG’ triplet adjacent to the 6bp randomized zinc finger binding region on the 
reporter plasmid. There is also a 4bp randomized region (key region) that serves as an 
internal control to identify biases in the recovered DNA sequences due to jackpot effects. 
Following selection, the surviving colonies are pooled and the distribution of bases 
recovered at each position within the selected binding sites can be evaluated in a single 
sequencing reaction as shown here for fingers 2 and 3 of Zif268. The recovered binding 
sites are determined by Illumina sequencing and then a binding site motif is calculated 
from these sequences using either log-odds-like or GRaMS (Growth Rate Modeling of 
Specificities) method123. For Zif268 F2 and F3, the binding site model obtained using the 
log-odds-like and GRaMS method closely matches the motif obtained by HT-SELEX117. 
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Figure 4-5 
(a) 
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Figure 4-5 (a) contd. 
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Figure 4-5 (b)
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Figure 4-5: Binding site specificities of the B1H-selected 2F-modules. The binding site 
specificities as determined by CV-B1H followed by log-odds-like and GRaMS modeling 
are shown for the B1H-selected 2F-modules obtained from the Asn+3F2 library (a) and 
His+3F2 library (b). The recognition helix sequences (positions -1, 1, 2, 3, 4, 5 and 6) for 
the F1 and F2 are shown. The selected interface residues are shown in red. The target 2bp 
junction is listed above each motif. 
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Figure 4-6 
 
Figure 4-6: Montage showing the binding site specificities of the best 2F-modules 
selected from the Asn+3F2 and the His+3F2 library for each 2bp junction. The 2F-
modules are designated as having ‘preferential specificity’ (black box), ‘compatible 
specificity’ (cyan box) or ‘poor specificity’ (magenta box) for the desired target 
sequence.  The interfaces where ZFP selections with Asn+3F2 and His+3F2 libraries 
yielded clones with similar sequences are underlined. 
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Figure 4-7 
A      B   GACTCG - 5 mM 3-AT             GACTCG - 10 mM 3-AT 
         F1                F2                        F1                  F2                    
-1123456 -1123456   -1123456 -1123456
              
 RSDTLKG DRSNLTR   RSDTLKL CGSNLTR    
 RSDTLAV DRSNLTR   RSDTLRL CSSNLTR 
 RSDTLVR DPCNLTR   RSDTLVL CKSNLTR 
 RSDTLRD CRSNLTR   RSDTLKL CASNLTR 
 RSDTLSL CRANLTR   RSDTLQL CRSNLTR 
 RSDTLKL GGSNLTR   RSDTLAL CRCNLTR 
 RSDTLKM NASNLTR   RSDTLKG DRCNLTR 
 RSDTLKE GRSNLTR   RSDTLAG DRSNLTR 
 RSDTLKE SKSNLTR 
 
C 
     
Figure 4-7: Enrichment of higher specificity 2F-modules at higher selection 
stringency. Displayed is the list of recognition helix sequences and frequency logos for 
the 2F-modules obtained from selections for the GA’CT’CG 6 mer with the Asn+3F2 
library where the selections were performed at 5 mM 3-AT (a) and 10 mM 3-AT (b).  
Residue at positions (in red) 5 and 6 of finger 1 and -1, 1 and 2 for finger 2 were 
randomized. Clones that were selected for binding site specificity assessment are shown 
in bold.  c) Comparison of specificities of 2F-modules selected at low stringency (5mM) 
and high stringency (10mM) for the ‘CT’ junction sequence. 
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observed in other zinc finger selections 82,83,86.  To improve the specificity of these 2F-
modules, we employed rational design utilizing principles of DNA recognition derived 
from our B1H-selections.  This successfully expanded the number of 2F-modules that 
preferentially bind the desired junction sequence to 24 with an additional 6 junctions that 
can be recognized by 2F-modules with ‘compatible’ specificity (Figures 4-8, 4-9, 4-10 
and Table A-2).  Altogether, these 2F-modules can recognize a set of 60 ‘GRN-NYG’ 6 
bp sites owing to the specification of both A and G by Histidine at position 3 of finger-2 
and C and T by Threonine at position 3 of finger-1. 
Employing site-directed mutagenesis to expand the archive 
Next, we hypothesized that if the combinations of interface residues specifying the 2 bp 
junctions are independent, we can increase the breadth of our 2F-modules simply by 
changing the specificity determinants fixed in our zinc finger libraries.  First, we replaced 
the interface neighboring residues at position 3 of finger-2 (Asn and His) and finger-1 
(Thr) with different residues for five different 2F-modules recognizing the ‘N-A’ 
junctions to obtain desired specificities at the positions neighboring the 2 bp junction.  In 
many instances, desired alterations in specificity, as determined by the CV-B1H method, 
could be obtained through substitutions at specificity determinant positions (e.g. Figure 
4-11) but majority of substitutions resulted in the alteration of specificity at the 2 bp 
junction suggesting non-independence of interface recognition (Figure 4-12).  In general, 
position 3 of finger-2 was more accommodating to substitutions that preserved the 
junction specificity than position 3 of finger-1 (Figure 4-12).  Using this approach we  
131
Figure 4-8  
 
 
Figure 4-8:  DNA-binding specificities for rationally designed 2F modules. The 
binding site specificities as determined by CV-B1H followed by log-odds-like and 
GRaMS modeling are shown for the rationally designed 2F-modules. The selected 
interface residues are shown in red. The target 2bp junction is listed above each motif. 
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Figure 4-9 
                        
Figure 4-9: DNA binding specificities of selected and designed 2F-modules 
recognizing GRN-NYG sequences. Displayed is the montage of DNA-binding 
specificities for the most favorable 2F-modules with specificity for GAN-NYG and 
GGN-NYG sequences where N-N represents the sixteen 2bp junctions. The 2F-modules 
are designated as having ‘preferential specificity’ (black dinucleotide), ‘compatible 
specificity’ (blue dinucleotide) or ‘poor specificity’ (magenta dinucleotide) for the 
desired target sequence.  Further details on these clones are found in Figure 4-10. 
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Figure 4-10 
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Figure 4-10 contd. 
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Figure 4-10 contd. 
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Figure 4-10 contd. 
 
Figure 4-10: DNA-binding site specificities for 2F modules that bind GAN-NYG and 
GGN-NYG sequences. The 2F modules obtained via B1H-selections or rational design 
that bind each of 16 GAN-NYG and GGN-NYG sequences with highest specificity are 
displayed. The recognition helix sequences (positions -1, 1, 2, 3, 4, 5 and 6) for the F1 
and F2 are shown. The selected interface residues are shown in red. Binding site 
specificities were determined using the CV-B1H method. The chromatograms 
representing the binding site profiles were obtained via Sanger sequencing of the pools of 
selected binding sites. Binding site logos were obtained via log-odds-like and GRaMS 
modeling post Illumina sequencing. 
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Figure 4-11 
 
Figure 4-11: Expanding the archive of targetable sequences through rational design. 
The specificity determinants that were constant in the original libraries were replaced by 
other residue to expand the repertoire of targetable sequences. DNA binding specificity 
of new 2F-modules was determined using CV-B1H method and the logos were obtained 
using GRaMS modeling. (a) Examples of the influence of substitution of determinants at 
position 3 of finger-2 (shown in blue) on the specificity of the 2FM-25 2F-module.  In 
three instances this results in a desired change in the specificity only at base 2, however 
in 2FM-1101 the introduction of Asp results in a change in the preference of base 
position 3, akin to the effects observed for the D20A mutation in Zif268225. (b) 
Substituting the N-terminal cap residues in finger-1 (RSD at positions -1, 1 and 2) with a 
QRG cap results in a concomitant change in base preference from G to A at the 6th base 
position without severely compromising the specificity for the junction sequence. 
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Figure 4-12 
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Figure 4-12 contd. 
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Figure 4-12 contd. 
 
 
 
Figure 4-12: Specificities of all 2F-modules created by determinant substitution at 
position 3. 2F-modules with altered specificity were created by changing the residue 
(shown in blue) at position 3 of F1 or F2 to accommodate different bases at the 2nd or 5th 
position, respectively of the target site.  DNA-binding specificities of the 2F modules 
were determined using CV-B1H method. The recognition helix sequence and specificity 
of each parent 2F module is displayed for comparison. 
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identified 2F-modules with substitutions at the position 3 residues on either finger-2 or 
finger-1 that recognize an additional fourteen 6-bp binding sites. 
We also examined the impact of replacing  distal residues (-1, 1 and 2) of finger-1 with 
motifs (N-terminal caps) that have been previously reported to bind different bases at the 
3’ position of the finger-1 triplet.  CV-B1H Specificity analysis revealed that the QRG 
cap was the most reliable in both preferentially binding to Adenine at the 3’ position and 
preserving the specificity at the 2 bp junction (Figure 4-11 and Figure 4-13).  Other 
substitutions either did not reliably specify the desired base and/or altered the specificity 
at the 2 bp junction.  Employing these focused substitutions following B1H-selections 
and rational-design we identified 87 2F-modules that recognize a total of 162 6bp sites 
(Table A-2). 
Comparison to the CoDA 2F-modules published by the ZFC 
While some of our 2F-modules contain previously observed residues at the finger-finger 
interface84,100, many contain novel combinations of residues. Of note, some CoDA 2F-
modules recognizing ‘N-A’ junctions overlap in target preference with our 2F modules, 
yet display interface residues that might prefer alternate junction sequences100. We 
assessed five of these CoDA 2F-modules to investigate their sequence preferences using 
B1H binding site selections and activity assays. In this context the CoDA modules prefer 
‘N-G’ instead of ‘N-A’ junctions highlighting the advantage of explicit optimization of 
the finger-finger interface for the generation of highly specific ZFAs (Figure 4-14). 
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Figure 4-13  
     
Figure 4-13: Specificities of all 2F-modules created by changing the N-terminal cap. 
2F-modules with altered specificity at the 6th base position were created by substitution at 
positions -1, 1 and 2 of finger-1 (N-terminal cap shown in blue).  DNA-binding 
specificity of each module was determined using CV-B1H method. The recognition helix 
sequence and specificity of each parent 2F module is displayed for comparison. 
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Figure 4-14
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Figure 4-14: Comparison of specificities of CoDA-2F modules100 and our 2F 
modules. Five CoDA 2F modules were fused to the ‘GCG’-binding finger-1 followed by 
their binding site analysis via the CV-B1H assay. The binding site logos obtained through 
GRaMS analysis are displayed for both the CoDA modules and the equivalent B1H-
selected modules, where the recognition helices are shown for comparison. A B1H-
activity assay was performed for the CoDA and B1H-selected 2F modules (in 
combination with the ‘GCG’-binding F1) against fixed binding sites with either Adenine 
or Guanine at the 4th position (GAXYCG, where Y is either A or G) to determine the 
relative activity of the 2F module on each sequence variant. Each row in the assay 
represents 10-fold dilution of bacterial cells on plates containing the His3 inhibitor 3-AT 
to provide a stringent challenge to ZFA-driven reporter activity. 
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Assembling ZFNs using 2F-modules to target genes in zebrafish 
To demonstrate the utility of these 2F-modules for gene disruption they were combined 
with each other or with published single finger (1F)-modules53 to create ZFNs (3 pairs of 
3-finger ZFNs and 8 pairs of 4-finger ZFNs) targeting 11 sites in the zebrafish genome, 
where each site contains at least one ‘non-N-G’ junction (Table 4-1).  ZFNs targeting 
dclk2 and zgc:77041 genes were constructed exclusively from 2F-modules where the two 
2F-modules were linked either with a conventionally used canonical ‘TGQKP’ linker or a 
non-canonical ‘TGSQKP’ linker that presumably shows better discrimination between 
consensus and mutant target sites and has been employed by Sangamo BioSciences to 
connect 2F-modules in their ZFNs59-65,162.  The DNA-binding specificities of these 
assembled zinc finger proteins, as determined using B1H-based selections, revealed that 
the recognition preferences of most of the incorporated 2F-modules were consistent with 
the CV-B1H analysis (Figures 4-15 and 4-17a). 
Activity of these ZFNs was initially tested using a published yeast based reporter assay114 
and compared to the activity of a positive control ZFN pair that shows high activity in 
both yeast assay and zebrafish.  The yeast assay demonstrated that 9 of 11 ZFNs were 
active and the majority displayed activities comparable to the positive control ZFN 
(Figure 4-16).  Although, lepr ZFNs showed low activity at increased ZFN 
concentration, rock1 ZFNs remained inactive even at higher ZFN concentration.  
Moreover, inserting the ‘TGSQKP’ non-canonical linker in one or both ZFN monomers 
favorably impacted both the activity and the toxicity of dclk2 and zgc:77041 ZFNs  
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Table 4-1: List of all ZFNs and their target sites. 
 
Gene Target site ZFNL binding site 
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F1 
ZFNR-
F2 
ZFNR-
F3 
dab2ip GTCCGAGTCcctgtaGACATGGAC GACTCGGAC GACATGGAC 6 2 2   LKGNLTR RSDTLKG DRCNLTR   LKGNLTR  RSDTLKQ  DKGNLTR 
hey2 AACCATACCgaccgtGGGGAACTG GGTATGGTT GGGGAACTG 6 2 2   TSGSLSR  RSDTLKQ AAGHLTR   RSDTLVE  QRGNLTR  RSDHLTR 
rock1 CGTGCCAGCtgctccGACTCGGCC GCTGGCACG GACTCGGCC 6 2 2  RSDTLQE  TARNLTR HRQSLTR   DRSDLSR  RSDTLKG  DRCNLTR 
zgc77041 CAACTCCAGTTCattttgGACATGGGTACG GAACTGGAGTTG GACATGGGTACG 6 4 4 RSDTLKE KGCNLTR RSDTLVE QRGNLTR RSDTLKD LKRHLTR RSDTLKQ DKGNLTR 
dclk2 CCATTCCGGCTCtcgggGAAACGGGATCG GAGCCGGAATGG GAAACGGGATCG 5 4 4 RSDHLTQ QRGNLTR RSDTLKE RSSNLTR RSDTLKG QRCHLTR RSDTLTQ QRGNLTR 
mc4r TTCATCTGCAGCttggctGTAGCAGACTTG GCTGCAGATGAA GTAGCAGACTTG 6 1 1 QKCNLVR HRNNLTR         QSGDLTR       HRQSLTR      RSDTLKG DRCNLTR      QSGDLTR        QSGALTR       
lrp8 GCCTGCCCCGACagcatgGAACTGGGCCCG GTCGGGGCAGGC GAACTGGGCCCG 6 2 2 EKSHLTR QSGDLTR   RSDHLTR DRSALAR    RSDTLMV DRSHLTR     RSDTLVE     QRGNLTR    
mc3r CAGCTCCACGTCagcgtaGCTGCATGAAGG GACGTGGAGCTG GCTGCATGAAGG 6 3 3 RSDTLKE RSSNLTR         RSDTLER       ESGNLTR      RSDHLTQ QSSHLTQ         QSSHLTQ  HRQSLTR       
apoeb AACCTACGCACCtctctGGAGGGCCGTGT GGTGCGTAGGTT GGAGGGCCGTGT 5 3 3 TSGSLSR  RSDNLTQ RSDTLRR IRFHLTR LRHHLVG RSDTLKE         RSSHLTR       QRGHLTR      
lepr ATCCAATTCCTTgcttcaGCAGTGGAAGGT AAGGAATTGGAT GCAGTGGAAGGT 6 2 1 TSGNLTR RSDTLKG QRCNLTR RSDNLTQ CAHHLTR QKCNLVR RSDALTR QRSTRKR 
irs2 TACCATGCCCCTctgtatCAGGAAAAGGTA AGGGGCATGGTA CAGGAAAAGGTA 6 4 2 QSGALTR RSDTLKE ARRNLTR RSDHLTQ QSGALTR RSDNLTQ QRGNLTR RSDNLSE 
 
For each ZFN target site, the ZFNL and ZFNR sites are shown in uppercase letters whereas the spacer sequences are shown in 
lowercase letters. The number of non-GNN and non-N-G junctions in each target site is provided. Also the recognition helix 
sequences (-1, 1, 2, 3, 4, 5, 6) for each ZFN are provided with the sequences of 2F-modules highlighted in bold. 
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Figure 4-15  
 
Figure 4-15: Binding site specificities of ZFAs incorporated into each ZFN pair. The 
binding site specificities for the ZFAs incorporated into ZFNs were determined via a 
B1H assay using the randomized 28bp library followed by Illumina90. The desired target 
sites are provided below each Sequence logo here the portion recognized by a 2F-module 
is highlighted in bold.  The target gene is listed to the left of each ZFN pair. 
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Figure 4-16 
 
 
 
 
Figure 4-16: Assessment of ZFN activity using the yeast based chromosomal 
reporter assay. The test ZFN target site along with the target site for the positive control 
ZFN was integrated into the yeast genome where ZFN activity is measured by the 
reconstitution of a-galactosidase activity114. ZFN expression was induced by treating 
yeast cells with galactose for 30min. The activity relative to the positive control ZFN pair 
that yields ~10% lesion frequency in zebrafish is displayed as a mean of three 
experiments. Bars represent standard deviation. The rock1 and lepr ZFNs (shown in red) 
were inactive based on comparison to a GFP control. 
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Figure 4-17  
 
 
 
Figure 4-17: Influence of non-canonical linker on ZFN specificity and activity. (a) 
For 4 4F-ZFNs, the canonical linker (‘C’) between the 2nd and the 3rd finger was replaced 
by a non-canonical linker (‘N’; TGSQKP). DNA binding specificities were determined 
for the modified ZFNs using the B1H assay as previously described. (b) The activity of 
the modified ZFNs with non-canonical linker was assessed using the yeast based reporter 
assay. The activities are relative to the positive control ZFN activity and is displayed as a 
mean of three experiments. Bars represent standard deviation and * indicates P < 0.05 as 
determined by paired student’s t-test. 
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presumably by moderating the ZFN activity at non-target sequences (Figure 4-17b).  
Consequently, we substituted the linker to ‘TGSQKP’ for lepr ZFNs that initially showed 
low activity and for irs2 ZFNs that displayed high toxicity.  In both the cases, the activity 
and toxicity were improved, although not as dramatically, by the linker substitution 
suggesting that the non-canonical linker might help improve the efficiency and precision 
of some ZFNs (Figure 4-17b).   
Next, we injected mRNAs encoding these ZFN into zebrafish embryos and then 
evaluated the induction of insertions and deletions (InDels) at the target site.  9 of 11 
ZFNs induced InDels (>1bp) at the target sites at >0.5% frequency (Table 4-2). 
Consistent with the yeast assay, lesion frequency in zebrafish was also improved for 
certain ZFNs when incorporating the non-canonical ‘TGSQKP’ linker (Table 4-3).  
Further, we also tested the influence of the DNA binding specificity of individual 2F-
modules on the specificity of the assembled ZFPs and activity of the ZFNs.  For the 
dab2ip ZFNR monomer, we incorporated five different 2F-modules that were either 
selected or rationally designed to bind to the same ‘C-A’ junction but display different 
specificities for the ‘GAC-AYG’ sequence (Figure 4-18).  The specificity of the 
assembled ZFPs as determined using B1H-selections on the 28 bp library92, displayed a 
high correlation (R2 = 0.86) with the specificity of the individual 2F-modules.  Moreover, 
as ZFNs their activity in the yeast assay as well as in zebrafish correlated with their 
specificity both as individual 2F-modules and as assembled ZFPs implicating the need for 
highly specific ZFPs to create highly active ZFNs (Figure 4-18). 
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Table 4-2  
Gene 5p ZFP binding site 
3p ZFP 
binding site 
Spacer 
length 
(bp) 
Number of 
Sequences 
with Indels 
Number of 
wild type 
sequences 
Lesion 
Frequency   
(%) 
Most 
frequent 
Deletion 
Most 
Frequent 
Insertion 
dab2ip GACTCGGAC GACATGGAC 6 26703 334851 8.0 9bp (9198) 4bp (1471) 
hey2 GGTATGGTT GGGGAACTG 6 3438 552924 0.6 4bp (706) 4bp (1234) 
rock1 GCTGGCACG GACTCGGCC 6 191 384243 0.0 3bp (182) None 
zgc77041* GAACTGGAGTTG GACATGGGTACG 6 49640 317017 15.7 9bp (7255) 2bp (8403) 
dclk2* GAGCCGGAATGG GAAACGGGATCG 5 2370 212738 1.1 2bp (656) 4bp (164) 
mc4r GCTGCAGATGAA GTAGCAGACTTG 6 128638 998060 12.9 5bp (31856) 4bp (12193) 
lrp8 GTCGGGGCAGGC GAACTGGGCCCG 6 53297 732947 7.3 9bp (6780) 4bp (3534) 
mc3r GACGTGGAGCTG GCTGCATGAAGG 6 24520 792371 3.1 5bp (5209) 4bp (5012) 
apoeb GGTGCGTAGGTT GGAGGGCCGTGT 5 11180 396708 2.8 2bp (3507) 2bp (185) 
lepr* AAGGAATTGGAT GCAGTGGAAGGT 6 12264 1412846 0.9 4bp (8617) 4bp (266) 
irs2* AGGGGCATGGTA CAGGAAAAGGTA 6 2634 742945 0.4 6bp (969) 4bp (235) 
 
Table 4-2: Analysis of ZFN-induced lesions in zebrafish.  
ZFN target sites and the genes are shown. ZFNL and ZFNR sites are given wherein the 6bp subsites for the 2F-
modules are represented in bold. Lesion frequencies and the most frequent insertion and deletion are shown where 
the number in parentheses shows their frequency. An asterisk indicates targets where a non-canonical linker 
(TGSQKP) between the second and the third finger was employed to increase ZFN activity, where the position of 
the non-canonical linker is underlined in each half-site where it is present. 
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Table 4-3    
 
 Lesion Frequency (%)  
 TGQKP (C) TGQKP (C) TGSQKP (N) TGSQKP (N) 
ZFNL 
Linker 
Target gene TGQKP (C) TGSQKP (N) TGQKP (C) TGSQKP (N) 
ZFNR 
Linker 
zgc77041 4.4 4.1 12.3 15.7  
dclk2 0.1 0.5 0.3 1.1  
 
Table 4-3: Influence of non-canonical linker on ZFN activity in zebrafish.  
The lesion frequencies (in %) in zebrafish are shown for different combinations of 
ZFNL and ZFNR with canonical (TGQKP; C) and non-canonical (TGSQKP; N) 
linkers for zgc77041 and dclk2 ZFNs. 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Figure 4-18 
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Figure 4-18: Influence of specificity of 2F-module on ZFN specificity and activity. 
(a) For dab2ip ZFN, five ZFNRs were constructed using different 2F-modules 
(recognition helices in bold and interface residues in red) that show different specificities 
(GRaMS logos shown on the left). These 2F-modules were attached to the same ‘GAC’ 
binding N-terminal finger to create ZFNRs and their specificities (shown on the right) 
were determined via B1H selections using the 28bp randomized library90 (b) 
Quantification of specificity of 2F-modules is displayed as the frequency of expected 
target sequences (GACAYG) within the recovered sequences from the binding site 
selection. (c) Quantification of specificity of ZFNRs for dab2ip ZFNs. Top 1000 
sequences obtained via B1H selections were aligned using MEME and then were 
separated based on their matches to the expected target site. Frequency of sequences in 
each category is displayed in the graph where 9 indicates a perfect match. The specificity 
of the ZFNRs correlates with the specificities of the individual incorporated 2F-modules 
(R2 = 0.86). (d) Activity of different dab2ip ZFNs (constant ZFNL and different ZFNRs) 
was assayed using the yeast based reporter assay.  Activity relative to the positive control 
is displayed as a mean of three experiments. Bars represent standard deviation and * 
indicates P < 0.05 as determined by paired student’s t-test. ZFN activity correlates with 
the specificities of ZFNRs (R2 =0.95) as well as individual 2F-modules (R2 =0.95). (e) 
The mRNAs for dab2ip TAR, CKP and DKG ZFNRs were co-injected with the ZFNL 
mRNA and lesion analysis was performed. 
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Germline Transmission of ZFN induced lesions 
Finally, we injected mRNAs for 4 of 11 ZFNs and assayed ZFN-injected adults for 
germline transmission of mutant alleles.  In all cases we identified founder animals from 
a small number of screened animals that carried a mutant allele for these targets (Table 
4-4).  Many of these mutations that were observed are expected to cause a frameshift in 
the reading frame and may disrupt the function of the target gene.  
Web interface for identification of ZFN sites within query sequences 
To facilitate public use of our archive, we have developed a web interface that allows 
users to search for potential ZFN sites within an input sequence 
(http://pgfe.umassmed.edu/ZFPmodularsearchV2.html).  Our website allows a user to 
input a single sequence or multiple sequences in FASTA format for the identification of 
sites that can be targeted with ZFNs constructed from our single finger53 and two finger 
archives.  This website is completely anonymous; no login is required to use the 
interface.  Users can choose from multiple formats (browser, text file, word document or 
excel file) for the output from the initial analysis.  Potential ZFN sites are ranked based 
on their overall score (the scoring metric is described in Methods).  Additional 
information is provided regarding the position of the site within each input sequence, the 
target sequence for each ZFN monomer, the gap separating these sites, whether there is a 
restriction enzyme (RE) site within this spacer, and the identity of the finger modules that 
comprise each ZFA monomer.  Each ZFA has four potential fingers (F3, F2, F1, & F0), 
where the fourth finger (F0 in our nomenclature) if absent is indicated by ‘XXX’.  
Modules appearing in UPPERCASE are from the single finger module archive53, while  
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Table 4-4 
 
Gene 
Name 
Number of 
ZFN 
injected Fish 
Screened 
Number of 
Founders 
Identified 
Size of insertions or 
deletions at target site 
(+/-bp) 
ZFN Lesion 
Frequency 
in embryos 
mc4r 9 2 -5, -5 12.9 
lrp8 17 8 +5, -3, -7, -8, -10,-12, -21 7.3 
mc3r 5 2 +4, -11 3.1 
apoeb 11 3 -4, -37, +9 2.8 
 
Table 4-4: Germline transmission of ZFN-induced lesions.  
ZFN-injected embryos for four ZFNs were grown till maturity and crossed with wild type 
zebrafish. The progeny was screened for lesions to identify founders. The mutant alleles 
were cloned and sequenced to determine the mutation. Types of lesions obtained are 
shown. 
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modules appearing in lowercase are from the archive described in this study and will 
occur in pairs (e.g. grn & nyr pairs).  Within the initial browser output, more detailed 
information on each ZFN can be output using a button at the end of each column.  Again 
there is a choice of output formats, where for each ZFN additional pertinent information 
is provided: the ZFP amino acid and DNA sequences for gene synthesis, modules IDs 
within our archive for PCR-based construction, recognition helix sequences, and 
information on RE sites that overlap with the spacer region for genotyping.  The DNA 
sequences that are provided include KpnI and BamHI sites at their termini for cloning 
into our pCS2 vectors (DD/RR or EL/KK versions) that are available from addgene. 
ZFAs can be either be assembled using the detailed protocol described in methods and 
available for download from the home page or can be synthesized which is recommended 
due to its affordability and ease. 
 
Discussion 
In this study we report a unique set of 87 validated 2F-modules that recognize 162 six 
base-pair target sites with high specificity.  These 2F-modules can be readily combined 
together or with available single finger modules53 to rapidly create active ZFNs that can 
even target sequences containing ‘non-N-G’-junctions in vivo. Our combined archive 
allows targeting of ~95% of the protein-coding genes (exons, Zv9) in the zebrafish 
genome, with an average density of one unique ZFN site every ~140 bp, which is a ~5-
fold higher density than available through the CoDA archive100.  We have also developed 
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a web interface that allows users to search for potential ZFN sites that can be targeted 
within an input sequence (http://pgfe.umassmed.edu/ZFPmodularsearchV2.html). 
Comparison to previously described Finger Archives 
A number of different systems have been described for assembling Zinc Finger Arrays 
(ZFAs) from one-finger (1F) 53,75,82,83,88,161,226-229 or two-finger (2F) 100,230 archives.  These 
archives display diversity in the number of fingers, the base composition of their 
recognition sequences and the strategies for their assembly.  The quality of many of these 
archives have been assessed on a moderate to large scale through characterization of the 
constructed ZFAs99,102,103,202 or assessment of the activity of ZFNs containing these ZFAs 
in cell lines or in vivo53,100,103,161,230.  Since the utility of an archive is dependent mainly 
on the success rates of the ZFNs derived from them and their target site density in a 
genome, we compared these factors for these five archives: B1H 1/2FM (this study), B1H 
1FM53, CoDA 2FM100, Kim 1FM161 and Kim 1/2FM230; Table 4-5).  The success rates 
for ZFNs derived from 1F archives are below 30% and those from two-finger archives 
are generally higher, 50% for CoDA 2FM and 82% for B1H 1/2FM (Table 4-5).  To 
compare the targeting densities of these archives, we determined the number of potential 
target sites in protein-coding exons within the zebrafish (Zv9) and human (GRCh37.p5) 
genome.  We focused our comparisons on the two-finger module archives because they 
generally have higher success rates (B1H 1/2FM, CoDA 2FM100 and Kim 1/2FM230; 
(Table 4-5). The combination of our 2FM archive with our previously described 1FM 
archive (Zhu 1FM53) expands the targeting density of our original archive by 3-fold,  
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Table 4-5 
 
 Gupta 
1/2FM 
CoDA 
2FM 
Kim 
1/2FM 
Zhu 
1FM 
Kim 
1FM 
Archive Reference A B C D E 
Number of Unique ZFN sites 
in zebrafish protein-coding 
exons (25090 unique genes 
Zv9.64) 
608,081 110,629 8,645,342 182,698 n.d. 
Fraction of zebrafish protein-
coding genes containing ZFN 
site 
95.0% 79.2% 98.8% 85.9% n.d. 
Average density of ZFN sites 
(# bp/site) 132 722 10 438 n.d. 
Number of Unique ZFN sites 
in human protein-coding exons 
(20236 unique genes 
GRCh37.p5) 
1,384,075 269,242 14,669,536 444,163 n.d. 
Fraction of human protein-
coding genes containing ZFN 
site 
96.7% 92.2% 97.8 94.5% n.d. 
Average density of ZFN sites 
(# bp/site) 123 633 12 383 n.d. 
 Tested ZFNs 
Number of ZFN pairs tested in 
Archive Reference 11 38 13 29 315 ^ 
Number "active" ZFNs 9 19 3 8 23 
Percent active ZFNs 82% 50% 23% 28% 7% 
Percent GNN modules in 
ZFNs 64% 99% 63% * 86% 40% 
ZFNs sites with non-GNN 
finger (active) 11 (9) 2 (1) (3) * 17 (2) 33 (8) ^ 
ZFN sites with non-N-G 
junctions (active) 11 (9) 1 (0) (3) * 10 (1) 33 (8) ^ 
 
A = this manuscript 
B = Sander, J. D. et al. Nature methods 8, 67-69 (2011) 
C = Kim, S. el al. Nature methods 8, 7 (2011) 
D = Zhu, C. et al. Development 138, 4555-4564 (2011) 
E = Kim, H. J., et al. Genome Res 19, 1279-1288 (2009) 
n.d. = not determined 
* = only target sequences for successful ZFNs reported 
^ = multiple zfn pairs were tested at each target site 
 
Table 4-5: Metrics for comparison of different ZFN assembly systems. 
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while creating ZFNs with promising activity.  This combined archive has a ~5-fold 
higher density of ZFN sites than the CoDA archive, with an average of one unique ZFN 
site every ~140 bp.  The Kim 1/2FM archive has the highest targeting density of the three 
archives due to the large number of 2F-modules it contains with an average of one unique 
ZFN site every 10 bp, albeit with a lower overall success rate. 
While the targeting density provides one important reflection on the utility of an archive, 
its flexibility can be inferred from the composition of target sequences evaluated in 
studies validating its efficacy. Although, the CoDA archive contains a combination of 
GNN and non-GNN finger sets (74 non N-G junction 2F-modules), the ZFNs that were 
evaluated by Sander and colleagues were composed almost entirely of GNN finger sets 
(99%).  This may reflect the fact that only 3 of 10 ZFAs containing non N-G junction 2F-
modules were functional in their bacterial activity-assay100, which was used for 
prescreening modules employed in their ZFNs.  Our ZFNs contain a more diverse set of 
fingers where roughly two-thirds (64%) were GNN finger sets (Table 4-5).  Of the 39 
CoDA ZFNs that were evaluated, only one target contained a finger set recognizing a 
non-N-G junction between fingers, whereas all 11 of our evaluated ZFNs contained non-
N-G junction, demonstrating the breadth of sequences that can be effectively targeted 
using our system (Table 4-5). For the ZFNs evaluated in the Kim 1/2FM archive 
analysis, only the sequences of the three active ZFNs were reported limiting the 
comparisons that can be drawn between it and the other archives230. 
Choice of ZFN target sites 
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The ZFNs evaluated in our study were chosen to serve a number of different goals. 
Foremost, ZFNs were chosen to assay different numbers of fingers per ZFN and different 
mixtures of 2F- and 1F-modules, where all of the ZFN pairs contain at least one non-
GNN finger and one non-N-G interface.  While there is some bias in the composition of 
the fingers comprising the ZFNs that were evaluated, many of the choices were driven by 
the desire to inactivate specific target genes in zebrafish that if successful could 
potentially yield useful disease models (atherosclerosis (apoeb, lrp8), obesity (lepr, mc3r, 
mc4r), and diabetes (irs2)).  Nonetheless, we believe that the 82% success rate achieved 
in this sample set will not be completely representative of ZFNs constructed from this 
archive.  For example, this archive is a mixture of 2F-modules and 1F-modules, where 
about 30% of the identified ZFNs are composed of only 1F-modules.  Based on our prior 
evaluation, we would anticipate only about one-fourth of these ZFNs to be active53.  To 
aid the user in the choice of ZFNs for specific target genes we have constructed a scoring 
function that weights the 2F-modules based on their specificity in the B2H system.  This 
has been integrated with our previously described 1F-module scoring function53. 
Effect of linker on ZFN activity and toxicity 
In this study we demonstrated that employing a non-canonical TGSQKP linker to connect 
2F-modules might have beneficial effects on activity and toxicity for some of the ZFNs.  
This non-canonical linker has been used in a large number of active ZFNs published by 
Sangamo BioSciences62,113,114.  Pioneering work from the Klug lab demonstrated that 
incorporating this non-canonical linker between 2F-units may improve discrimination of 
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the target site as compared to a mutant site with a different finger-subsite, while 
maintaining high affinity for the target site59.  Since we observed reduced toxicity for 
some of the ZFNs with the non-canonical linker as compared to the canonical linker, we 
believe that the ZFNs with the non-canonical linker show reduced affinity towards the 
non-specific binding sites thus decreasing their off-target activity and increasing their 
availability on the target site resulting in higher activity.  A detailed analysis of the linker 
length and composition will help increase not only the activity of the ZFNs but also their 
targeting density by allowing skipping bases between otherwise adjacent zinc fingers 
subsites. 
CV-B1H method for determining binding site specificities 
As has been previously noted, selections might not always yield highly specific 
modules82,83,86.  We employed the CV-B1H method to identify the 2F-modules that show 
high specificity for the desired binding sites.  The CV-B1H method offers several 
advantages: since the binding site library is in a fixed register, it allows rapid and cheap 
semi-quantitative assessment of binding specificities of 2F-modules via Sanger 
sequencing of a single sample.  Moreover, binding site pools for multiple (>100) 2F-
modules can be indexed and sequenced into a single lane of Illumina sequencing that 
allows a more quantitative estimate of binding specificities for 2F-modules.   
The importance of using the binding site specificity validation was emphasized by the 
fact that the 2F-modules obtained from the same selection condition differed in their 
ability to specify the desired interface and sometimes even preferred binding sites 
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different than the desired ones.  Further, incorporating 2F-modules with different 
specificities in the ZFNR monomer of the dab2ip ZFNs influenced their activity and 
toxicity that correlated with the specificity of the individual 2F-modules (Figure 4-18).  
This observation might also explain the low success rate for some of the CoDA 2F-
modules that were selected to specify a non-N-G interface100.  When incorporated into 3 
finger zinc finger proteins, these 2F-modules showed poor activity in the B2H system 
where only 3 of 10 tested ZFPs were active above their threshold100.  Also, when we 
tested some of their 2F-modules in the B1H assay, they preferred the N-G junction 
instead of the desired N-A junction suggesting that some of the CoDA 2F-modules that 
recognize non-N-G junctions might not specify the desired target sites thus highlighting 
the need for validating the binding site specificities of 2F-modules post selections 
(Figure 4-14). 
DNA Recognition by the residues at the finger-finger interface 
The DNA recognition at the 2 bp junction of the zinc finger subsites by the interface 
residues of a multifinger protein is not well understood.  Our zinc finger selections in two 
fixed contexts (Asn at position 3 of finger-2 or His at position 3 of finger-2) followed by 
DNA binding specificity analysis have provided some insights into the DNA recognition 
by the residues at the interface of two zinc fingers.  For 10 of 16 ‘2 bp junctions’, 
selections with both the Asn+3F2 and the His+3F2 libraries yielded similar residues at 
the interface suggesting similar mechanisms of DNA recognition at the interface by these 
residues without much interference from the neighboring residue at position 3 of finger-2.  
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Indeed, the binding site selections showed similar specificities for 9 of 10 of these 2 bp 
junctions (Figure 4-6).  However, for the other 6 of 16 interfaces where different residues 
were obtained post B1H selections, we expect greater influences from the residue at 
position 3 of finger-2.  The influence of DNA recognition at the 2 bp junction by the 
residue at position 3 of finger 2 was confirmed from our focused substitution experiments 
where changing the residue at the position 3 of finger-2 altered the specificity at the 2 bp 
junction.  Interactions between the residue at position 3 and the interface have been 
observed before; for example in the Zif268 D20A mutant where Asp at position 2 that 
stabilized the Arg at position -1 in the wild type protein, was mutated to Ala resulting in 
the rearrangement of the side chains of Glu at position 3 and Arg at position -1 allowing 
them to form hydrogen bonds in the mutant protein and affecting the specificity at the 3’ 
base in the finger subsite225.  These interactions from the residue at position 3 to the 
interface limit the scope of the conclusions that can be drawn from	  the study by Isalan et 
al. for understanding DNA recognition at the interface where along with the residues at 
the interface, the residue at position 3 of the C-terminal finger was also randomized84.  
These neighbor effects influence recognition along the entire finger-DNA interface, as 
the type of residue at the position 2 influenced that specificity of the residue at position 3.  
For example, the preference of His at position 3 for base G or A was influenced by the 
amino acid at position 2 where a branched amino acid shifts the preference to A and an 
aromatic residue shifts it to G (Figure 4-19b). 
Moreover, the B1H selections emphasized the importance of non-independent 
interactions for zinc fingers-DNA recognition.  The frequency logo of 87 2F-modules in 
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Figure 4-19
 
Figure 4-19: Examples of context dependent specificities within zinc finger pairs. (a) 
DNA binding specificities for 4 2F-modules each with Glu at position 6 of F1 are shown. 
The base preferred at the 4th position opposite the Glu is different in each of the 4 2F-
modules revealing context dependent that is likely influenced by the residue at position 2 
of F2.  In the case of 2FM-25, substitution of R for G (blue residue rightmost logos) at 
position 3 of F2 results in a change in specificity at base position 4 from A to C. (b) The 
specificity of His at the position 3 of F2 is influenced by the neighboring residue at 
position 2 where a branched amino acid shifts the base preference of His towards 
Adenine and an aromatic residue at the position 2 shifts it towards Guanine displaying an 
influence of residue at position 2 on the specificity of residue at position 3. 
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our archive shows 3 most frequent residues at each of the base specifying positions -1 of 
finger 2 and +6 of finger 1: Arg which specifies ‘G’, Gln that specifies ‘A’ and Glu or 
Asp that provide some selectivity for ‘C’, where the specificities were obtained from the 
available recognition codes48,84,126 (Figure 4-20).  On the surface, it looks as if these 
residues act independently of residues at other positions to specify each of these bases.  
However, comparing the binding site specificities of the B1H-selected 2F-modules and 
their variants from the mutagenesis experiments highlights the importance of other 
residues especially the residue at position 2 on the specificity at the 2 bp junction.  For 
example, the base preferred opposite Glu at position 6 of finger 1 was not always a 
Cytosine at the 5’ position of the finger 1 DNA triplet.  In fact, the identity of the base 
preferred opposite Glu at position 6 was greatly influenced by the residue at position 2 of 
the neighboring position; with an Arg at position 2, the base preferred is ‘A’ and with an 
aromatic residue at position 2 it is ‘G’ (Figure 4-19a).  Consequently, replacing the Arg 
at position 2 with Gly shifts the preference from Adenine to Cytosine for some of the 2F-
modules but not all, suggesting that residues at other positions might also influence the 
preference opposite Glu at the position 6 (Figures 4-19a and 4-21).  Structures of zinc 
fingers have provided examples where the amino acid at position 2 of the C-terminal 
finger can influence the specificity not only at the 5’ base of the subsite of the N-terminal 
finger but also at other positions45,52,66,225.  These observations suggest that non-
independent inter-finger interactions may be rampant in zinc fingers especially in the 
non-GNN recognizing set and thus the identity of one finger may affect the specificity of 
the neighboring fingers.  Therefore, development of recognition codes with better 
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Figure 4-20 
                  
 
Figure 4-20: Frequency logo for 87 2F-modules. The recognition helix sequences ( 
residues -1, 1, 2, 3, 4, 5 and 6) from the final list of 87 2F-modules were used for 
constructing the frequency logo.  Residues (in red) at positions 5 and 6 of finger-1 and 
positions -1, 1, and 2 of finger-2 were randomized in the original libraries. 
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 Figure 4-21  
 
 
Figure 4-21: Influence of amino acid at position 2 of F2 on the specificity at the 2bp 
junction. For four 2F modules the amino acid at position 2 of F2 was replaced with an 
alternate amino acid, where all sequence changes are indicated in blue. The specificities 
of the original and the mutated 2F modules are displayed. 
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predictive capabilities would require incorporating non-independent interactions from 
residues of the same finger and from the residues of the neighboring fingers. 
Although our archive represents the largest set of ‘non-N-G’-junction recognizing 2F-
modules described to date, it comprises only 132 of the possible 3072 non-N-G junction 
sites. Additional archives of ‘non-N-G’-junction 2F-modules exist; for example, sixty-
one are found in the CoDA archive, but the specificity and activity of these modules have 
not been characterized in detail100.  Thus, there is a need to expand the set of quality 2F-
modules covering these junctions to further increase the targeting resolution of ZFNs. 
However, as observed in our study, selections alone may not always be sufficient to 
obtain highly specific modules for a given target sequence since the isolation of precise 
modules can be confounded by the roles that both affinity and specificity play in activity 
in the selection system that is employed.  Consequently, the continued development of 
more accurate predictive models of DNA recognition for zinc fingers will likely be 
needed to continue to inform design efforts.  Ultimately, these efforts should lead to 
important advances in nuclease precision and activity not only for engineering model 
systems, but also for creating therapeutic reagents for the treatment of disease.  
 
Materials and Methods: 
Animal husbandry: Zebrafish were handled according to established protocols215 and in 
accordance with Institutional Animal Care and Use Committee (IACUC) guidelines of 
the University of Massachusetts Medical School. 
170
2F-Library construction: 2F-libraries were constructed in two stages. First, individual 
F1 and F2 libraries were independently constructed via cassette mutagenesis of annealed 
randomized oligonucleotides into pBluescript vector containing the appropriate zinc 
finger backbone derived from Zif268. The sequences for the randomized oligonucleotides 
are given below where lowercase letters denote the randomized bases.:  
F1 library top oligo: 
CCTGCGACCGCCGCTTCTCCAGATCTGAyACnCTnvnsvnsCATATACGTATTCACAC 
F1 3’ complement bottom oligo:  
GCCGGTGTGAATACGTATATG 
F1 5’ complement bottom oligo: 
AGATCTGGAGAAGCGGCGGTCG 
F2 library top oligo (His+3F2): 
CTGCATGAAGGCCTTCTCTnnwnnwnnwCAyCTnACACGTCACATCAGGACCCACAC 
F2 library top oligo (Asn+3F2): 
CTGCATGAAGGCCTTCTCTnnwnnwnnwAAyCTnACACGTCACATCAGGACCCACAC 
F2 3’ complement bottom oligo:  
GCCGGTGTGGGTCCTGATGTGACGTGT 
F1 5’ complement bottom oligo:  
AGAGAAGGCCTTCAT 
Individual finger library diversity greatly exceeded the theoretical library size; ~1x105 
transformed cells were obtained for the F1 library (>100 times theoretical size) and 
~1x106 transformed cells for the F2 library (30 times theoretical size of the library).  
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Constructed libraries were grown at low density on 2xYT plates containing 100 µg/ml 
carbenicillin at 37 °C for 14 hours. Individual F1 and F2 libraries in pBluescript were 
harvested from pooled cells from these surviving colonies. 
The 2F-library was constructed from the single finger libraries by PCR assembly, 
individual F1 and F2 libraries were separately amplified from the pooled pBluescript 
clones by PCR and then joined via overlapping PCR, where the number of amplification 
cycles in both steps was minimized by employing high concentrations of template DNA.  
This 2F-library was then cloned into the B1H expression vector 1352-omega-UV2 
between unique BssHII and Acc65I restriction enzyme sites such that the w-subunit of 
the RNA polymerase is fused at the N-terminus of the zinc fingers and the Engrailed 
homoeodomain at the C-terminus. Following electroporation into bacterial cells, 1x108 
cells (5 times the theoretical size of the library) were plated on 10 2xYT-carbenicillin 
plates (150 x 15 mm) and grown at 37 °C for 14 hours.  1352-omega-UV2 plasmids 
containing the 2F-library were isolated from pooled surviving colonies and used for 
selections. 
Zinc finger Binding site cloning: The 16 GANNCG zinc finger binding sites 
(ggccTAATTACCTGANNCGGacg) were cloned between the EcoRI and NotI sites in 
the pH3U3-mcs reporter vector. The Homeodomain (Engrailed) binding site TAATTA 
(underlined) is present 3 bp away and on the strand opposite to the zinc finger binding 
site to minimze any interference between the Homeodomain and the zinc fingers. For 
selecting 2F-modules from the Asn+3F2 library that recognize the ‘G-G’ interface, 
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sufficient stringency could not be obtained to narrow the selected clones merely through 
increased 3-aminotriazole (3-AT) concentration or reduced inducer (isopropyl-b-D-
thiogalactoside; IPTG) levels.  To reduce the activity of the ZFP-HD construct the 
homeodomain site was mutated to TAAAGG to increase the dependence on zinc finger 
binding. 
2F B1H Selections: Selections for 2F-modules were performed as described 
previously94. The zinc finger library (20 ng) and the reporter vector (1 µg) containing the 
zinc finger target site were cotransformed via electroporation in the selection strain that 
lacks endogenous expression of the w-subunit of RNA polymerase 
(US0∆hisB∆pyrF∆rpoZ). 2x107 cotransformed cells were plated on selective NM 
minimal medium plates (where stringency was controlled via 3-AT and IPTG 
concentration) and grown at 37 °C until moderate number of colonies (typically 100s) 
were visible. Post-selection, 2F-modules from 6-10 surviving colonies were sequenced to 
identify functional amino acid sequences for further evaluation. The success of the 
selection was judged on the diversity of sequences obtained from these selections, with 
the expectation that successful selections will converge on a small number of functional 
residues at the critical recognition positions. 
Cloning B1H-selected 2F modules into 3F F1-GCG constructs: To determine the 
binding specificities of 2F-modules a ‘GCG’ binding anchor zinc finger (recognition 
helix: RSDTLAR) was fused at the N-terminus of the 2F-module via overlapping PCR.  
173
GCG-for: CCATGGTACCTCTAGACCC                               
GCG-rev: GGGCAAGCATACGGTTTTTCACCGGTATGA                 
2F-module for: GTGAAAAACCGTATGCTTGCCCTGTCGAGTC                       
2F-module rev:          
TTACTGTGCAGAGGATCCCCTCAGGTGGGTCCTGATGTGACG  
Following overlapping PCR, the 3F-ZFA was cloned into 1352-omega-UV2 vector 
between the Acc65I and BamHI sites for expression as an omega fusion. 
CV-B1H method: To determine binding site specificities of 2F-modules, the CV-B1H 
assay was performed as described before123. Post-transformations into the selection strain, 
1x106 cells containing the zinc finger plasmid (1352-omega-UV2-ZFP) and the 
randomized binding site library plasmid (pH3U3) were plated on selective NM minimal 
medium plates (100 x 15 mm) containing 50 µM IPTG and 1 or 2 mM 3-AT and grown 
at 37 °C for 22-30 hrs.  The surviving colonies were pooled and the binding site plasmid 
was isolated for identification of the functional DNA sequences.  The binding site region 
was PCR amplified and Sanger sequenced to rapidly obtain binding site profiles for each 
2F-module.  For quantitative modeling, the binding site pools for multiple 2F-modules 
were barcoded and sequenced via Illumina sequencing, and then binding specificities 
were modeled from this data using both W log-odds and GRaMSc methods (below).	  
GRaMSc: In the original implementation of GRaMS123, nonlinear regression was 
employed to parameterize a model consisting of a PWM and a parameter, which 
describes the degree of saturation of each binding site due to the free concentration of the 
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TF. We used the same model for this study, but re-arranged the objective function. 
Instead of fitting to the observed growth rate of each site, we fit to the observed counts 
per site. We call this version of the program GRaMSc. 
Many of the Zif268 mutants in this study are more specific than wild type the Zif268 for 
their preferred sequences. We found in practice that for very specific proteins that 
resulted in only a handful of sites with growth rates significantly larger than the median 
growth rate, the most accurate recognition model was generated by re-arranging the 
GRaMS objective function to fit directly to the observed counts per site. Otherwise, when 
there were very few appreciably enriched sites (few informative data points), there was a 
tendency to over fit to the noise in the growth rate data. We found it also helped to adjust 
M, the maximum observed growth rate by a factor of 1.02. This prevented a single site 
from dominating the motif completely when only very few sites had growth rates 
appreciably larger than the median growth rate and one site clearly had a much higher 
growth rate than the other enriched sites. The following equations describe the adjusted 
model.  The observed growth rate (ri), or enrichment, of each site is given by: 
!! = !"#2 !!(!)!!(0) /!  (1) 
where t indicates the duration of the selection experiment, i is an index over all 46 6mers, 
fi(t) is the frequency of site i at time t, and fi(0) is the initial frequency of site i at time 0. 
The growth rate of a site, Si, is a sigmoid function of µ, the chemical potential of the TF, 
and the Gibbs free energy of the TF binding to the site as well as the maximum and 
minimum possible growth rates: 
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!! = !!!1!!!!!!! + !  (2) 
where W is the PWM and Si*W yields the Gibbs free energy of binding to Si. The 
variables M and D determine the upper and lower plateaus of the sigmoid curve.  M is set 
to the maximum observed growth rate times a scalar of 1.02, and D is set to the median 
observed growth rate. The total number of times each site was observed is modeled by 
the following equation:  
!! =   !!!! 0 2 !!!1!!!!!!!!! ! (3) 
where NF is the total number of sequenced sites. The Levenberg-Marquardt algorithm 
was used to fit the parameters of the PWM and the µ parameter.  Regularization was used 
to prevent over fitting. 
W log-odds: The W log-odds (‘W’ stands for ‘word based’ log-odds) method more 
accurately reflects our knowledge of the initial frequency of each 6mer in the library than 
a simple log-odds weight matrix. Generally, the following formula is used to compute 
log-odds PWMs: 
 !!" = −log   !!"!!   (4) 
where Wbj is the log-odds matrix, Pbj is the probability after selection of observing base b 
at position j in the binding site, and Pb is the initial probability of observing base b before 
selection.  Because the initial frequency of each 6mer binding site prior to selection was 
known from deep sequencing of the initial counter selected library, the enrichment of 
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each site after selection was calculated directly. The enrichment ratio of the ith site is 
given by the equation 
 !!(!)!!(0)  (5) 
where t is the final time or duration of the selection experiment, fi(t) is the final frequency 
at time t, fi(0) is the initial frequency at time 0, and i is an index over all 46 6mers. A 
site’s enrichment ratio can be thought of as the Ka of that site. A pseudo count of one was 
added to all final and initial counts when calculating the initial and final frequencies.  The 
sum of all the enrichment ratios for all 6mers containing base b at position j was used to 
calculate each element of the W log-odds matrix: 
 !!" = −log   !!!",!!4096!!1 !!(!)!!(0)  (6) 
where Sij indicates the base at position j of site i, b is an index over the four nucleotide 
bases, Bb returns base b and δx,y is the Kronecker delta function which returns 1 if the 
bases x and y are identical and zero otherwise. For example, to determine the energy 
contribution of an A in the first position of the binding site (W1,1) the set of all 1024 
6mers that have an A at position 1 was determined and the enrichment ratios for all of 
these sites were summed and the negative of the log of this value was taken.   
Rating of 2F modules: For every 2F-module, the frequency of each of the 16 possible 
2bp-junctions was determined in the binding sites that were recovered by Illumina 
sequencing. The 2F-modules for which the frequency of the desired 2bp-junction was the 
highest among all 16 2bp-junctions were designated as possessing ‘preferential 
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specificity’. If the frequency of the desired 2bp-junction was the second highest and 
represented more than 20% of the dinucleotide population, the 2F-module was designated 
as having ‘compatible specificity’. The remaining 2F-modules were designated as having 
‘poor specificity’. 
Comparison of CoDA-2F modules and B1H-selected 2F-modules: The CoDA 2F-
modules were created using overlapping PCR where the desired recognition helix 
sequences were introduced into the Zif268 finger 2 backbone. The 2F-modules were 
fused to the N-terminal ‘GCG’ binding finger and CV-B1H assay was performed 
followed by binding site modeling using the W log-odds and GRaMS methods as 
described above. B1H-based activity assay were performed as described previously160. 
Creating ZFAs: Three Finger (3F) and Four Finger (4F) ZFAs for use in ZFNs were 
assembled from the 2F-module archive described herein and a 1F-module archive that we 
recently described53 using overlapping PCR. The primer sequences used for these 
different assemblies are listed in Table A-3.  If desired these ZFAs can also be 
synthesized from the DNA sequence output from our website application. 
For amplifying individual 1F and 2F modules, the following PCR conditions were used: 
10 ng DNA template, 1 µM each of forward and reverse primer, 200 µM dNTPs and 0.5 
unit of Phusion High Fidelity DNA polymerase (New England Biolabs) in 25 µl reaction 
volume. PCR cycles: 98 °C 3 min, [98 °C 15 sec, 50 °C 15 sec, 72 °C 30 sec] 6 repeats, 
[98 °C 15 sec, 56 °C 15 sec, 72 °C 30 sec] 24 repeats, 72 °C 5 min, 4 °C. 
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For ZFA assembly from the individual 1F and 2F module amplicons was mediated by 
overlapping PCR under the following conditions: 1-5ng DNA for each component, 200 
µM dNTPs and 0.5 unit of Phusion High Fidelity DNA polymerase (New England 
Biolabs) in 25 µl reaction volume. PCR cycles: 98 °C 3 min, [98 °C 15 sec, 50 °C 15 sec, 
72 °C 30 sec] 6 repeats 72 °C 5 min. Following this initial assembly step the forward and 
reverse primers (final concentration of 1 µM each) were added to the reaction and PCR 
amplification proceeded using the following cycles: 98 °C 3 min, [98 °C 15 sec, 56 °C 15 
sec, 72 °C 30 sec] 25 repeats, 72 °C 5 min. Post-amplification, the 3F/4F PCR products 
were digested with Acc65I and BamHI enzymes and cloned into appropriate vectors. 
Note: The QRG cap is introduced into the 2F module using a special QRG(X) primer set 
that substitutes the RSD cap with the QRG cap in F1. When Thr is present at position 3 
of F1 use the QRG(T) primer, when Asn is present at position 3 of F1 use the QRG(N) 
primer, and when His is present at position 3 of F1 use the QRG(H) primer.  For ZFNs 
recognizing a seven base pair gap utilize the F3RnTGPGAAGS or 2FM-
F3RnTGPGAAGS instead of the F3RnLRGS or F3RnLRGS primers to incorporate the 
longer linker associated with increased activity. To incorporate the non-canonical linker 
(TGSQKP) between F1 and F2 fingers of a 4F construct, the sequences for F2-forward 
primer and F1-reverse primer were modified to introduce the additional Serine in the 
linker. 
3F-ZFAs assemblies from F1, F2 and F3 1F-modules: The single fingers are amplified 
individually and then assembled. F1 was amplified using the F1(noF0)Fn and F1Rn 
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primers. F2 was amplified using the F2Fn and F2Rn primers. F3 was amplified using 
F3Fn and F3RnLRGS primers. The amplified DNA was gel purified using a Qiagen gel 
purification kit. For finger assembly, 5ng of the F1, F2 and F3 amplicons were combined 
and assembled as described above, where the F1(noF0)Fn and F3RnLRGS primers were 
added to the PCR reaction for the final amplification. 
3F-ZFAs assemblies from F1 1F-module and 2F-module: F1 was amplified using the 
F1(noF0)Fn and F1Rn primers. 2F-module was amplified using 2FM-F2Fn and 2FM-
F3RnLRGS primer. The amplified DNA was gel purified and the finger amplicons were 
assembled as described above, where the F1(noF0)Fn and 2FM-F3RnLRGS primers were 
added to the PCR reaction for the final amplification. 
3F-ZFAs assemblies from a 2F-module and F3 1F-module: 2F-module was amplified 
using the 2FM-F1(noF0)Fn and 2FM-F2Rn primers and F3 was amplified using the F3Fn 
and F3RnLRGS primers. The amplified DNA was gel purified and the finger amplicons 
were assembled as described above, where the 2FM-F1(noF0)Fn and F3RnLRGS primers 
were added to the PCR reaction for the final amplification. 
3F-ZFAs assemblies from a F1 1F-modules and 2F-module-QRG cap: F1 was 
amplified using the F1(noF0)Fn and F1Rn primers. 2F-module was first amplified with 
2FM-F1Fn and 2FM-F2Rn primers, gel purified and then 1-5ng of gel purified DNA was 
used as template for amplification with 2FM-F2-QRG(X)Fn and 2FM-F3RnLRGS 
primers to substitute the RSD N-terminal cap with the QRG-N-terminal cap. The 
amplified 2F-module-QRG and F1 module were gel purified and the finger amplicons 
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were assembled as described above, where the F1(noF0)Fn and 2FM-F3RnLRGS primers 
were added to the PCR reaction for the final amplification. 
3F-ZFAs assemblies from a 2F-module-QRG cap and F3 1F-modules: 2F-module 
was first amplified with 2FM-F1Fn and 2FM-F2Rn primers, gel purified and then 1-5ng 
of gel purified DNA was used as template for amplification with 2FM-F1(noF0)-
QRG(X)Fn and 2FM-F2Rn primers. F3 was amplified using the F3(noF0)Fn and 
F3RnLRGS primers. The amplified 2F-module-QRG and F3 module were gel purified 
and the finger amplicons were assembled as described above, where the 2FM-
F1(noF0)Fn and F3RnLRGS primers were added to the PCR reaction for the final 
amplification. 
4F-ZFAs assemblies from F0, F1, F2 and F3 1F-modules: F0 was amplified using the 
F0Fn and F0Rn primers. F1 was amplified using the F1Fn and F1Rn primers. F2 was 
amplified using the F2Fn and F2Rn primers. F3 was amplified using F3Fn and 
F3RnLRGS primers. The amplified DNA was gel purified and the finger amplicons were 
assembled as described above, where the sF0Fn and F3RnLRGS primers were added to 
the PCR reaction for the final amplification. 
4F-ZFAs assemblies from F0 and F1 1F-modules, and 2F-module: F0 was amplified 
using the F0Fn and F0Rn primers. F1 was amplified using the F1Fn and F1Rn primers. 
The 2F-module was amplified using 2FM-F2Fn and 2FM-F3RnLRGS primer. The 
amplified DNA was gel purified and the finger amplicons were assembled as described 
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above, where the F0Fn and 2FM-F3RnLRGS primers were added to the PCR reaction for 
the final amplification. 
4F-ZFAs assemblies from F0, 2F-module and F3: F0 was amplified using the F0Fn 
and F0Rn primers. 2F-module was amplified using the 2FM-F1Fn and 2FM-F2Rn 
primers and F3 was amplified using the F3Fn and F3Rn primers. The amplified DNA 
was gel purified and the finger amplicons were assembled as described above, where the 
F0Fn and F3RnLRGS primers were added to the PCR reaction for the final amplification. 
4F-ZFAs assemblies from 2F-module, F2 and F3: The 2F-module was amplified using 
the 2FM-F0Fn and 2FM-F1Rn primers. F2 was amplified using the F2Fn and F2Rn 
primers. F3 was amplified using the F3Fn and F3Rn primers. The amplified DNA was 
gel purified and the finger amplicons were assembled as described above, where the 
2FM-F0Fn and F3RnLRGS primers were added to the PCR reaction for the final 
amplification. 
4F-ZFAs assemblies from N-terminal-2F-module, C-terminal-2F-module: The N-
terminal 2F-module was amplified with the 2FM-NT-in-Fn and 2FM-F1Rn primers and 
the C-terminal 2F-module was amplified with the 2FM-F2Fn and 2FM-F3RnLRGS 
primers. The amplified products were gel purified and the finger amplicons were 
assembled as described above, where the 2FM-NT-out-Fn and 2FM-CT-out-Rn primers 
were added to the PCR reaction for the final amplification. 
4F-ZFAs assemblies from F0, F1 and 2F-module-QRG: F0 was amplified using the 
F0Fn and F0Rn primers. F1 was amplified using the F1Fn and F1Rn primers. 2F-module 
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was first amplified with 2FM-F1Fn and 2FM-F2Rn primers, gel purified and then 1-5ng 
of gel purified DNA was used as template for amplification with 2FM-F2-QRG(X)Fn and 
2FM-F3RnLRGS primers to substitute the RSD N-terminal cap with the QRG-N-terminal 
cap. The amplified 2F-module-QRG, F0 and F1 modules were gel purified and the finger 
amplicons were assembled as described above, where the F0Fn and 2FM-F3RnLRGS 
primers were added to the PCR reaction for the final amplification. 
4F-ZFAs assemblies from F0, 2F-module-QRG and F3: F0 was amplified using the 
F0Fn and F0Rn primers. 2F-module was first amplified with 2FM-F1Fn and 2FM-F2Rn 
primers, gel purified and then 1-5ng of gel purified DNA was used as template for 
amplification with 2FM-F1-QRG(X)Fn and 2FM-F2Rn primers. F3 was amplified using 
the F3Fn and F3Rn primers. The amplified the F0, 2F-module-QRG and F3 modules 
were gel purified and amplicons were assembled as described above, where the F0Fn and 
F3RnLRGS primers were added to the PCR reactions for the final amplification 
4F-ZFAs assemblies from 2F-module-QRG, F2 and F3: The 2F-module was first 
amplified with 2FM-F1Fn and 2FM-F2Rn primers, gel purified and then 1-5ng of gel 
purified DNA was used as template for amplification with 2FM-F0-QRG(X)Fn and 2FM-
F1Rn primers. F2 was amplified using the F2Fn and F2Rn primers. F3 was amplified 
using the F3Fn and F3Rn primers. The amplified DNA was gel purified and the finger 
amplicons were assembled as described above, where the 2FM-F0Fn and F3RnLRGS 
primers were added to the PCR reaction for the final amplification. 
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4F-ZFAs assemblies from N-terminal-2F-module-QRG, C-terminal-2F-module: The 
N-terminal 2F-module was amplified with 2FM-F1Fn and 2FM-F2Rn, gel purified and 
then 1-5ng of gel purified DNA was used as template for amplification with 2FM-F0-
QRG(X)Fn and 2FM-F1Rn primers. This amplified 2F-module-QRG was again gel 
purified and PCR amplified with 2FM-NT-in-Fn and 2FM-F1Rn primers. The C-terminal 
2F-module was amplified with 2FM-F2Fn and 2FM-F3RnLRGS. The amplified N-
terminal and C-terminal 2F-modules were gel purified and the finger amplicons were 
assembled as described above, where the 2FM-NT-out-Fn and 2FM-CT-out-Rn primers 
were added to the PCR reaction for the final amplification. 
4F-ZFAs assemblies from N-terminal-2F-module, C-terminal-2F-module-QRG: The 
N-terminal 2F-module was amplified with 2FM-NT-in-Fn and 2FM-F1Rn. The C-
terminal 2F-module was amplified with 2FM-F1Fn and 2FM-F2Rn, gel purified and then 
1-5ng of gel purified DNA was used as template for amplification with 2FM-F2-
QRG(X)Fn and 2FM-F3RnLRGS primers. The amplified N-terminal and C-terminal 2F-
modules were gel purified and the finger amplicons were assembled as described above, 
where the 2FM-NT-out-Fn and 2FM-CT-out-Rn primers were added to the PCR reaction 
for the final amplification. 
4F-ZFAs assemblies from N-terminal-2F-module-QRG, C-terminal-2F-module-
QRG: The N-terminal 2F-module was amplified with 2FM-F1Fn and 2FM-F2Rn, gel 
purified and then 1-5ng of gel purified DNA was used as template for amplification with 
2FM-F0-QRG(X)Fn and 2FM-F1Rn primers. This amplified 2F-module-QRG was again 
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gel purified and PCR amplified with 2FM-NT-in-Fn and 2FM-F1Rn primers. The C-
terminal 2F-module was amplified with 2FM-F1Fn and 2FM-F2Rn, gel purified and then 
1-5ng of gel purified DNA was used as template for amplification with 2FM-F2-
QRG(X)Fn and 2FM-F3RnLRGS primers. The amplified N-terminal and C-terminal 2F-
modules were gel purified and the finger amplicons were assembled as described above, 
where the 2FM-NT-out-Fn and 2FM-CT-out-Rn primers were added to the PCR reaction 
for the final amplification.  
ZFN website scoring function: Our new ZFN site identification tool 
(http://pgfe.umassmed.edu/ZFPmodularsearchV2.html) uses 2F-modules from this study 
and 1F-modules from our previous archive53 to define favorable combinations of these 
modules for constructing active ZFNs.  These ZFNs are designed to target sequences with 
5, 6 or 7 bp gaps between the monomer recognition sequences, where each ZFN 
monomer can contain three or four fingers.  ZFNs with higher scores are more likely to 
be active, where the current 2F-modules are scored based on their DNA-binding 
specificity (as determined in the B1H system) where good, fair and poor represent 4, 3 
and 2 points respectively.  If the modules utilize an A-cap (QRG at the N-terminus of the 
2F-module) instead of the standard RSD sequence for G-recognition one point is 
subtracted from the score.  The 1F-modules are scored as previously described53.  ZFNs 
containing 2F-modules are readily identified in the output from the website by the 
presence of lowercase triplet sequences in the site breakdown, and by the presence of 
“2FM-#” in the output Module ID information. 
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B1H-binding site selections using the 28bp library: The selections for 3F and 4F ZFAs 
were performed as previously described160. 1-5x107 selection strain cells transformed 
with the 1352-omega-UV2 ZFA expression plasmid and the 28 bp pH3U3 library 
plasmid were plated on NM minimal medium selective plates lacking uracil and 
containing 3-AT (2.5, 5 or 10 mM) as the competitor and grown at 37 °C for 36-72 hours. 
The number of surviving bacterial colonies on each plate was estimated and then these 
colonies were pooled and the population of recovered DNA sequences was determined 
via Illumina sequencing. Unique sequences were ranked based on the number of 
recovered reads.  From this list an overrepresented sequence motif was determined with 
MEME216 using as input the number of unique sequences from the top of the list that 
correspond to the estimated number of colonies on the selection plate (typically >1000). 
The aligned sequences were then used to generate Sequence logos using Weblogo208. 
Yeast-based ZFN activity assay: To assess the activity of our ZFNs in an independent 
system we employed a Mel1-based yeast activity assay114. The target sites for test ZFNs 
and the positive control ZFN were cloned in the modified ySSA vector and then 
integrated into the yeast genome (BY4741 strain) at the HO locus. The ZFAs were cloned 
at the N-terminus of the wild type FokI nuclease domain in the pYHis3 and pYLeu2 
vectors in between the Acc651 and BamH1 sites. Test ZFNs, positive control ZFN and 
negative control (EGFP containing pYHis3 and pYLeu2 vectors) were transformed in the 
yeast strain containing the ZFN target site. ZFN expression was induced by 2% galactose 
treatment for 30 min. The activity assay was performed ~16 hours post-induction as 
previously described231. In brief, yeast cultures were diluted to an OD600 of 0.4-0.6. 950 
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µl of diluted cells were centrifuged and the pellet was resuspended in 200 µl of 20 mM 
HEPES (pH 7.5)–10 mM dithiothreitol–0.002% sodium dodecyl sulfate. 10 µl of 
chloroform was added to cells and vortexed for 10 s. After a 5 min pre-equilibration at 30 
°C, 800 µl of a 7 mM solution of PNPG (4-Nitrophenyl α-D-galacto-pyranoside; Sigma) 
in 61 mM citric acid–77 mM Na2HPO4 (pH 4) was added and incubated at 30 °C for 30 
min. Following incubation, 100 µl aliquot was added to 900 µl of 0.1 M Na2CO3 to stop 
the reaction and the OD405 was recorded. a-galactosidase units were calculated as 
follows: a-gal = (OD405*1000)/(OD600*tpnpg) where tpnpg is the time of incubation with 
PNPG. Relative activity for test ZFNs was calculated as follows: (100*a-galtest ZFN)/ a-
galpositive control. 
ZFN injections and lesion analysis: For gene targeting in zebrafish, ZFAs were cloned 
in pCS2 vectors containing the DD/RR obligate heterodimer version of the FokI nuclease 
domain153,154. pCS2-ZFN constructs were linearized with NotI and mRNA was 
transcribed using the mMesagemMachine SP6 kit from Ambion. ZFN mRNAs were 
injected into the blastomere of one-cell-stage zebrafish embryos as previously 
described94. ZFN-injected embryos with normal appearance (8-30) and uninjected 
embryos were collected 24 hpf and incubated in 50 mM NaOH (15 µl/embryo) for 15 
min at 95 C to isolate genomic DNA and then neutralized with 0.5 M Tris-HCl (4 
µl/embryo). The DNA solution was centrifuged for 1 min at 13,000 rpm and supernatant 
was taken for lesion analysis. For initial validation of ZFN activity, the region flanking 
the ZFN target site was amplified using the Phire Hot Start DNA Polymerase 
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(Finnzymes) and RFLP analysis or Cel I nuclease assay (Transgenomics) was performed 
as described previously94. For Illumina sequencing, the region flanking the ZFN sites was 
amplified using the primers listed in Table A-4 and then digested with the appropriate 
restriction enzyme (listed in Table A-4). The ends for the digested DNA were polished 
using Klenow exo- enzyme (New England Biolabs) or T4 DNA polymerase (New 
England Biolabs) and A-tailed using Klenow exo- enzyme (New England Biolabs). The 
barcoded adapters (Table A-4) were ligated to each DNA pool and then PCR amplified 
with the Illumina genomic primers 1.1 and 1.2. Following sequencing, identification of 
InDels was performed as described previously160. Briefly, two tags unique to a ZFN 
target site were employed, a 5’ tag and a 3’ tag (Table A-4) and the distance between the 
tags was used to distinguish wild type sequence from the InDel containing sequence. 
Lesion frequency was calculated as follows:  Lesion frequency = (100*NInDels)/Ntotal 
where, NInDels represents number of sequences containing InDels that are >1bp in length 
and Ntotal represents number of total sequences. 
Genomic analysis of ZFN target sites: The targeting density and overlap of ZFN sites 
were determined for three archives (Gupta 1/2FM, CoDA 2FM100 & Kim 1/2FM230) on 
the unique protein-coding exons zebrafish (Zv9) and human (GRCh37.p5) Ensembl 
genes 64.  Target sites for each finger archive were determined using custom perl scripts, 
where only ZFN sites that map to a single unique gene were counted in this analysis.  
This analysis provides information on the fraction of genes that can be targeted and the 
density of the sites per base pair.   
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Germline Transmission Analysis: ZFNs were injected at optimal doses in wild type 
zebrafish embryos. Injected embryos were grown to maturity and crossed with wild type 
zebrafish to identify carriers. PCR products spanning the target loci in F1 embryos were 
screened using Cel1 surveyor nuclease assay for presence of lesions94. The compositions 
of these lesions were characterized through cloning and sequencing PCR products 
spanning the ZFN target site for each gene (Table A-4). 
 
  
189
 CHAPTER V 
DISCUSSION 
 
 
 
 
 
The work in this chapter has not been published and is still ongoing.  Our collaborators, 
the Stormo lab at Washington University, are developing the zinc-finger predictive 
model.  The Joung lab at Massachusetts General Hospital provided the B2H-selected 2F-
modules.  Heather Bell, an undergraduate student at Worcester Polytechnic Institute 
(WPI), performed the CV-B1H-selections for B2H-selected 2F-modules.  Cong Zhu 
performed the selection and characterization of ANNA-2F-modules.  Victoria Hall is 
providing support with developing the zebrafish disease models. 
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Creating predictive models for zinc fingers 
The Cys2His2 zinc finger is the most frequently utilized DNA binding domain (DBD) 
family in metazoan transcription factors (TFs)14.  Since their discovery in 1985 29, there 
has been a continuous effort to understand DNA recognition by zinc fingers, spurred on 
in part by the X-ray crystal structure of Zif268, which revealed a rather simple pattern of 
DNA recognition where a few amino acids on the recognition helix recognize a 3 bp 
DNA core element45.  Supported by the structural studies, finger swapping experiments 
revealed some degree of modularity for zinc fingers71.  Together, these results triggered 
a series of novel phage display experiments utilizing randomized zinc finger libraries 
coupled with SELEX-based DNA specificity determination that not only yielded zinc 
fingers with novel specificities but also improved the understanding of their underlying 
principles of DNA recognition48,58,78,79,82,83,101,108,162,232. These principles of zinc finger 
recognition, ‘Recognition Codes’, provided a Rosetta stone that enabled prediction of the 
DNA binding specificity for a zinc finger based on its sequence.  This code could be used 
to predict binding sites for naturally occurring zinc finger proteins or design of artificial 
zinc finger proteins with novel DNA-binding specificity.  Unfortunately, the recognition 
codes based on this experimental data have only limited predictive capacity for multiple 
reasons126,233,234.  Structures of both naturally occurring ZFPs and synthetic ZFPs 
demonstrated existence of a more complex pattern of DNA recognition where the 
specificity of one finger is influenced by the neighboring fingers through inter-finger 
interactions (concept termed as context-dependent recognition)52,66,69.  Consequently, 
recognition models incorporating non-additivity of individual contacts perform better 
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than those assuming independence of contacts233,234.  Moreover, both phage display and 
SELEX involve multiple rounds of selections and therefore sometimes yield only the 
highest affinity interaction partners with little or no data on the lower affinity interactions 
that is critical for obtaining accurate binding energy profiles.  Finally the available dataset 
is small and highly biased towards zinc finger that recognize ‘GNN’ triplets, which limits 
its utility for other recognition elements. 
The development of more accurate recognition models requires a large, unbiased DNA-
protein interaction dataset to allow incorporation of non-independent interactions.  One of 
the ways to obtain such a dataset is by selecting zinc fingers from randomized libraries 
that bind a diverse set of DNA sequences.  However, to select zinc fingers while taking 
into account the context dependence, one will have to randomize specificity determinants 
of multiple fingers (at least two) that would require building and searching a large library 
of zinc fingers (> 1012 members), which is not feasible by currently available in vivo 
methods.  In the orthogonal approach, a large dataset of DNA-protein interactions can be 
obtained by defining DNA binding profiles of zinc fingers that have a wide variety of 
specificity determinants.  The CV-B1H method that we have developed provides a 
medium-throughout system to rapidly characterize DNA binding specificities of zinc 
fingers and when combined with Illumina sequencing, it provides information on high- as 
well as low-affinity binding sites for a given zinc finger.  Also, the CV-B1H method 
involves a single round of selection, which is performed in the presence of competitor 
DNA in the form of the bacterial genome thereby giving B1H an edge over the SELEX, 
and phage display based methods.   In our study, we have also used the B1H system to 
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select two-finger zinc finger units (2F-modules) that bind a wide variety of desired target 
sites many of which contain non-GNN finger subsites.  Using the CV-B1H selections 
followed by the GRaMS analysis, we characterized the binding site specificities of ~200 
2F-modules.  These 2F-modules in general recognize GRN-NYG sequences and show a 
high diversity of amino acid residues at the interface recognition positions -1, 1 and 2 of 
finger-2 and position 5 and 6 of finger-1.  However, there is only limited diversity at the 
other positions.  Additionally, using the CV-B1H method and GRaMS analysis, we have 
characterized the DNA binding specificities of ~100 2F-modules that were selected in the 
bacterial-two-hybrid (B2H) system using the OPEN (Oligomerized Pool Engineering) 
method (Table A-6 and Figure A-1)99.  These modules were selected to bind GNN-GNG 
sequences.  The combined dataset of the DNA binding specificities on the B1H- and 
B2H-selected 2F-modules is by far the largest dataset of DNA-protein interactions for 
zinc finger proteins.  To develop predictive models for zinc fingers, in collaboration with 
the Stormo lab we will use the ‘Random Forest’ method, which is an ensemble 
classification method that requires minimum information regarding the parameters it 
needs to calculate and is easier to implement when compared to other predictive 
methods235.  Stormo and colleagues recently employed the RF method to develop 
predictive models for homeodomains and demonstrated that RF is superior to the k-
nearest neighbor based methods (Christensen et al., unpublished data).  We recently 
developed a preliminary RF-based predictive model for zinc fingers that uses the DNA 
recognition residues (-1, 2, 3, and 6) of each finger of the 2F-module as input and 
predicts their DNA binding specificities.  When used to predict specificities of a subset of 
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our 2F-modules that were not used to train the model, it performed well where, for the 
majority of the 2F-modules the predictions had a low mean squared error (MSE < 0.01).  
However, almost all 2F-modules used to build this model recognize GNN-NNG sites 
resulting in lower accuracy of the model at the edges of the predicted binding specificities 
when the corresponding specificity determinants are not ‘G’-recognizing.  Therefore, 
further modifications to the model will be needed to improve its predictive capabilities.  
Nevertheless, in its current form, the model can be utilized to predict specificities of a 
subset of CoDA 2F-modules that were selected to bind GNN-NNG sequences100.  Once 
completely developed, we can use this model to predict specificities of 2F-modules 
obtained from other methods such as the B2H-selected CoDA modules100 or phage 
display selected 2F-modules employed by Sangamo BioSciences85.  We will also be able 
to predict the specificities of multi-finger artificial zinc finger proteins and design fingers 
with novel specificities.  Ultimately, we would predict specificities of naturally occurring 
zinc finger proteins. 
 
ZFNs: increasing their activity, precision and targeting density 
Owing to their semi-modular nature and ability to recognize a wide range of DNA 
sequences, the Cys2His2 zinc finger has been the DNA binding domain of choice for 
creating artificial DNA binding domains.  Numerous studies have demonstrated their use 
in creating artificial transcription factors, recombinases, histone modifying enzymes, and 
nucleases (ZFNs)58,127,138,162,171.  Synthetic ZFNs have been the most popular application 
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of artificial zinc finger proteins mainly because they provide a universal tool for targeted 
gene editing that further offers a wide range of applications for reverse genetics as well as 
gene therapy.  Improving the activity and precision of ZFNs has value in all applications, 
but is especially critical for their application as therapeutics. 
The main determinants of activity and specificity for ZFNs are the incorporated zinc 
finger proteins.  In our study, we demonstrated that even modest improvements in the 
specificity of ZFPs can increase the precision of the ZFNs160.  However, current modular 
assembly methods often result in sub-optimal specificity of the assembled ZFPs, which 
presumably is due to the context-dependent recognition of zinc fingers that arise from the 
poorly understood interactions at the finger-finger interface.  Using B1H-based selections 
we have identified two-finger zinc finger modules (2F-modules) that have optimized 
groups of residues at the interface of neighboring fingers and can recognize 162 unique 6 
bp DNA sequences (Chapter IV).  These 2F-modules can be combined with themselves 
or with published 1F-modules such that the context of their interface residues is 
preserved and the unfavorable context-dependent effects are avoided, therefore rapidly 
yielding highly specific artificial ZFPs.  Moreover, when incorporated into ZFNs, these 
assembled ZFPs demonstrated high success rate of activity in zebrafish.  Our archive of 
2F-modules, in combination with the published single finger modules, can target ~95% of 
the zebrafish genes, with a density of 1 ZFN site every 142 bp.  However, the current 
archive recognizes only 162 of 4096 possible 6 bp sequences and we believe that 
expanding the archive to recognize a wider range of sequences is necessary to increase 
the activity and targeting density of ZFNs.  Our initial efforts to expand the archive 
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through rational design failed in most instances demonstrating that the residues 
neighboring the interface that were fixed in our zinc finger library can influence the 
specificity at the 2 bp junction of the zinc finger subsites (Chapter IV).  Therefore, to 
effectively expand the 2F-module archive, new 2F-modules will have to be selected from 
either expanded zinc finger libraries where the residues neighboring the interface are also 
randomized or from libraries where the interface residues are randomized in different 
contexts.  We have employed the latter approach where we randomized the interface 
residues in the context of Asparagines at position 3 of both finger-1 and finger-2 (instead 
of Thr at position 3 of finger-1 and Asn at position 3 of finger-2 in the original library) 
and performed B1H-selections for all 16 GAN-NAG sites (instead of GAN-NCG sites).  
The specificities of selected 2F-modules (ANNA-2F-modules) were determined using 
CV-B1H and validated, high specificity modules were included in the archive.  In 
addition to conventional modular assembly where these new modules can be combined 
with other 2F-modules and single finger modules53 as described in Chapter IV, we are 
exploring new strategies of combining 2F-modules such that the interface residues and 
their context can be preserved  (Figure 5-1).  Since these ANNA-2F-modules recognize 
GANNAG sequences, where the underlined Adenines are recognized by Asparagines at 
position 3 of finger-2 and finger-1, we hypothesized that we can consider interfaces as 
modules and create chains of interfaces keeping the neighboring Asn common (Figure 5-
1).  Initial attempts to assemble ZFPs with both the conventional modular assembly 
method and this new interface stitching method have shown promising results 
demonstrating that stitching is a viable method for assembling ZFPs and ZFNs.   
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Figure 5-1 
 
 
Figure 5-1: ZFN-assembly approaches for the ANNA-2F-modules. The ANNA-2F-
modules are depicted by their 6 bp binding sites GANNAG, where the NN represents the 
di-nucleotide junction specified by the interface residues and are flanked by adenines that 
are recognized by the asparagines at positions 3 of fingers-1 and -2.  In the modular 
assembly approach (a) the ANNA-2F-modules can be combined either with ANNA-2F-
modules (shown as red ovals), GANNCG-binding 2F-modules (or ANNC-2F-modules) 
described in chapter IV (shown as red ovals) or with published single finger modules 
(represented by a green oval)53.  In the interface stitching approach (b) the interface 
residues from the ANNA-2F-modules or from the ANNC-2F-modules are stitched using 
the common Asn at position 3 such that the interface residues specifying the NN di-
nucleotide junction and their contexts are preserved. Although 3-finger proteins are 
shown in the figure, longer proteins can be constructed using multiple 2F-modules.   
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However, with the current archive 2F-modules, only a few sites in the zebrafish genome 
can be targeted and further expansion of 2F-modules will be required to increase the 
targeting density of ZFNs assembled using the stitching method. 
 Another approach to increase the activity and precision of ZFNs would involve 
identifying optimal linkers between two 2F-modules.  Moore et al. demonstrated that 
linking 2F-modules with a non-canonical linker where an extra amino acid residue is 
inserted in the canonical linker (TGQKP) may allow the assembled ZFPs to discriminate 
better the cognate and the non-cognate binding sites when larger arrays of fingers are 
employed59.  In agreement with their results, incorporating the non-canonical linker 
(TGSQKP) influenced the activity and toxicity of the ZFNs that were assembled from our 
two 2F-modules.  Therefore, selecting for alternate linkers connecting 2F-modules might 
yield an improved linker that allows the 2F-modules to discriminate the non-cognate sites 
better while maintaining high affinity to their cognate site.   
Further, we can use the selections to identify longer, more rigid linkers that allow 
skipping one or more bases between the two 6 bp sites for individual 2F-modules.  This 
will not only increase the number of potential ZFN target sites in the genome but may 
also minimize interface interactions between the two 2F-modules.  Although, longer 
linkers that skip one or two nucleotides between two 2F-module binding sites have been 
described and incorporated in ZFNs59-65, they are generally flexible linkers and therefore 
allow multiple spacings between the 2F-module sites that may result in greater off-target 
cleavage.   
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Another potential way to increase the targeting range of the available 2F-modules is by 
fusing them with a dimerization domain such as a coiled coil domain that would allow 
cooperative binding of 2F-modules as well as skipping bases between the two half 
sites236,237. 
In summary, there is both room and need for the improvement in the zinc finger design to 
enhance the activity and precision of ZFNs. 
Gene Targeting in zebrafish using ZFNs: new strategies 
Zebrafish is as a model system for studying embryonic development.  Until recently, 
targeted gene manipulation in zebrafish was limited to ZFN-mediated gene disruption.  
ZFNs have been employed in zebrafish to induce double strand breaks (DSB) and 
introduce non-homologous end joining (NHEJ) mediated insertions and deletions often 
resulting in targeted gene disruption53,94,172,187,189,96,100,114,188.  However, targeted insertion 
and deletion of desired sequences via homologous recombination (HR) has been elusive 
in zebrafish.  Attempts for targeted knock-in of desired sequences using conventional HR 
following ZFN treatment did not yield favorable results (McNulty et al., unpublished 
results).  Based on a recent publication where single stranded DNA oligonucleotides 
(ssODNs) were employed in human cell lines to insert and delete desired DNA elements, 
we designed ssODNs to introduce a new restriction enzyme site at the site of a ZFN-
induced DSB.  Although, low activity insertions could be achieved at very high doses of 
ssODNs, high toxicity was observed in embryos. This toxicity can be somewhat 
ameliorated by knocking down p53-mediated apoptosis with morpholinos. Further 
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standardization of conditions will be required to increase the HR rates and decrease the 
toxicity of ssODNs.  This low level of HR-mediated insertions raises questions over the 
activity and presence of the HR machinery in early zebrafish embryos that opens the 
possibility of triggering HR rates by exogenously adding a few components of HR or 
repressing the NHEJ pathway. 
Comparison of ZFNs with TALENs 
Transcription activator-like (TAL) DNA binding domains are found in naturally 
occurring virulence factors, TAL effectors, encoded by the Xanthomonas plant pathogens 
194,195,238.  These virulence factors, containing long repeats of the TAL domains, bind to 
promoters of the target genes in the host organism and activate their expression affecting 
the disease process.  The TAL effectors naturally comprise multiple repeats of 34 amino 
acid long TAL domains arranged in tandem where each repeat binds one base-pair of 
DNA194,195.  The amino acids at positions 12 and 13 (known as repeat variable di-residues 
or RVDs) dictate the identity of the recognized nucleotide where the RVDs specifying 
each of the four bases have been identified194,195,239,240.  Creating artificial nucleases 
(TAL effector nucleases or TALENs) by fusing the TAL repeats to the cleavage domain 
of the FokI nuclease has met with promising success173,191,192,241-244.  A recent large-scale 
study demonstrated activity for 84 of 96 TALENs constructed to target 96 endogenous 
genes in the human cell line244.  The ease of assembly of TALENs, their high success rate 
and their ability to target almost any DNA sequence give them an edge over the ZFNs for 
gene targeting.  However, the detailed DNA binding specificities and thermodynamics of 
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DNA binding for TALENs have not been characterized.  Further, except for it being less 
toxic than ZFNs, there is no information available about its off-target activity.  Moreover 
unlike ZFNs, TALENs are much larger in size and contain highly repetitive modules that 
may pose a concern of viral packaging and delivery for gene therapy based applications.  
 
Creating disease models in zebrafish 
Zebrafish has served as an excellent model system for studying development.  In the past 
15 years, zebrafish has also been utilized for modeling human diseases mainly through 
reverse genetics, transgenesis, chemical treatments, and nutritional control245.  The 
emergence of ZFNs has opened possibilities for creating disease models through targeted 
gene disruption in zebrafish.  Using our archive of 2F-modules described in Chapter IV 
in combination with the published single finger modules53 we intend to create zebrafish 
models of type 2 diabetes and obesity and atherosclerosis. 
Metabolism is one of the most fundamental systems for organism survival, dysfunction 
of which can result in an array of diseases collectively termed as metabolic disorders.  In 
2008 more than 30% of the population in US suffered from atleast one of the metabolic 
disorders and the subsequent disease complications, which is a significant increase from 
19% in 1997 (The Social Report, 2010).  The ever-increasing rate of metabolic disorders 
warrants a deeper understanding into their molecular mechanisms and development of 
novel therapeutics for combating these disorders.  Although mouse models have greatly 
contributed to our understanding of metabolic disorders, performing large-scale genetic 
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and chemical screens in this model is both challenging and expensive.  In contrast, 
zebrafish are small sized vertebrates that closely resemble humans in development and 
metabolic processes. Owing to their small size, zebrafish can be stored at higher densities 
than mice and therefore are more economical to raise in large numbers.  Further, over 
their lifetime, zebrafish can produce thousands of offspring that are optically clear during 
early developmental stages allowing high-resolution visualization of biological processes.    
These features make zebrafish a valuable system for creating metabolic disease models.  
In this direction, we created ZFNs and TALENs to mutate several genes in zebrafish that 
when knocked-out in mice induce obesity, type 2 diabetes and atherosclerosis.   
We demonstrated activity of ZFNs for targeting mc3r (melanocortin receptor 3) and 
mc4r (melanocortin receptor 4) genes in zebrafish in Chapter IV and identified founders 
that harbor mutations in these genes.  In mice, mc4r deletion leads to increased food 
uptake resulting in increased adiposity and linear growth246,247.  Although mc3r has been 
shown to play a role in energy homeostasis, its exact function is still unknown247.  In 
zebrafish, overexpression of agrp (agouti-related peptide), an antagonist of melanocortin 
receptors, results in increased body weight248.  Also, the mc4r mutant fish obtained 
through TILLING show increased linear growth as compared to the wild type 
demonstrating that the melanocortin system is conserved in the zebrafish and when 
blocked can disturb the energy homeostasis247-249.  Moreover, polymorphisms and copy 
number variations in the mc4r gene have been linked to body size and onset of maturity 
in the fish from the Xiphophorus genus250. Therefore, we expect that the mc4r and mc3r 
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mutants created using ZFNs would induce obesity in zebrafish upon feeding a high-fat 
diet or ad libitum (Table 5-1). 
To create other models of obesity we employed TALENs to disrupt the lepa and lepb 
genes that presumably code for leptin.  Leptin, a hormone secreted predominantly by the 
adiopocytes, is important for the regulation of food intake and energy homeostasis in 
mice and humans251,252.  leptin knockout in mice results in excessive food uptake, leading 
to obesity251.  Humans deficient in leptin show early onset of obesity, high fat mass, and 
impaired satiety with marked hyperphagia253.  Unlike humans and mice, zebrafish have 
two copies of leptin (lepa and lepb) that are only 18% similar to the human leptin254.  
Since the functions of the two leptin genes have not been characterized in fish, we 
mutated both of them using TALENs.  The double mutants of leptin genes are expected 
to be hyperphagic and thus obese. 
We mutated another component of the leptin signaling, the leptin receptor (lepr) using 
ZFNs which is expressed mainly in the hypothalamus and is required for leptin 
signalling255.  lepr mutants in mice are severely diabetic and also develop obesity255. 
In our attempts to create diabetes models and simultaneously disrupt micro-RNA 
function in zebrafish, we constructed ZFNs that could mutate miR-375-1 and miR-375-2.  
In mice, miR-375 knockout results in hyperglycemia, increased pancreatic α-cell mass 
and decreased β-cell mass256.  In zebrafish, somewhat consistent with the mouse 
knockout results, inhibition of miR-375-1 and miR-375-2 by morpholinos affects  
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Table 5-1 
Gene Disorder Status 
mc4r Obesity Heterozygous animals available 
mc3r Obesity Heterozygous animals available 
lepa / lepb Obesity Active TALENs available 
lepr Type 2 Diabetes Active ZFNs available 
miR-375-1 / miR-375-2 Type 2 Diabetes Active ZFNs available 
apoeb Atherosclerosis Founders Identified 
 
Table 5-1: Summary of genes successfully targeted using ZFNs or TALENs to create 
zebrafish metabolic disease models. 
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pancreatic islet development.  Therefore, the ZFN-induced mutants of miR-375-1 and 
miR-375-2 would be used to study diabetes and pancreatic development. 
Finally, to create atherosclerosis models, we intend to mutate the apolipoproteinE genes 
(apoEa and apoEb).  Mice and humans harbor a single copy of the apoE gene deletion of 
which results in hypercholesterolemia and aortic atherosclerotic plaque formation.  
Zebrafish model of atherosclerosis would provide advantage over mouse models since 
aortic plaques in fish can be visualized in live animals as compared to post-mortem in 
mice257.  Although we could create active ZFNs for targeting apoEb gene, apoEa gene 
may also have to be disrupted to model atherosclerosis. 
Since nutrition can have a dramatic influence on the progression and control of each of 
these diseases, we will test different feeding regimens ranging in fat and protein contents 
and the type of fats on these mutants.  Moreover, for the atherosclerosis model, we will 
feed high cholesterol diet supplemented with fluorophore-labeled cholesterol that would 
help visualize lipid deposition in zebrafish vasculature257.  This ‘nutrition screening’ 
would also allow us to study the effect of diet on early adipogenesis258258.  Finally, these 
mutants can be utilized to perform both forward-genetic screens and small-chemical 
screens to identify new drug targets and therapies for control of metabolic disorders. 
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Summary 
Zinc finger nucleases have shown a tremendous potential for gene targeting in a variety 
of cell lines and model organisms.  Consequently, their use in gene therapy based 
applications is currently being evaluated in clinical and preclinical trials.  Our efforts to 
optimize the inter-finger interactions between zinc fingers improved both the success rate 
and the targeting range of ZFNs resulting in ~80% success rate and more than 5-fold 
targeting density than the previously published zinc finger archives. However, there is 
both room and need for the improvement in the zinc finger design to enhance the activity 
and precision of ZFNs.  Recently, TALENs have emerged as another tool for targeted 
gene editing that appear to be free of the limitations of context dependent interactions.  
Owing to their high success rate and virtually unlimited targeting range, TALENs may 
outperform ZFNs for gene targeting in model organisms but ZFNs will continue to be 
employed in gene therapy based applications. 
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1352 lib 
Asn+3F2/
His+3F2
Homeodomain 
Binding 
site
ZFP 
Binding 
site
3-AT 
conc  
(mM)
IPTG 
(uM)
Clone  
#
Recognition helices      
F1(VNS)// F2(NNW)
-1123456//-1123456
Asn TAATTA gaAAcg 5 10 1 RSDTLEA// QRGNLTR
Asn TAATTA gaAAcg 5 10 2 RSDTLMV// QRGNLTR
Asn TAATTA gaAAcg 5 10 3 RSDTLVA// QRGNLTR
Asn TAATTA gaAAcg 5 10 4 RSDTLNA// QRGNLTR
Asn TAATTA gaAAcg 5 10 5 RSDTLAA// QRGNLTR
Asn TAATTA gaAAcg 5 10 6 RSDTLRV// QRGNLTR
Asn TAATTA gaAAcg 5 10 7 RSDTLLA// QRGNLTR
Asn TAATTA gaAAcg 5 10 8 RSDTLKA// QTGNLTR
Asn TAATTA gaAAcg 5 10 9 RSDTLKA// QRGNLTR
Asn TAATTA gaAAcg 5 10 10 RSDTLKQ// QVGNLTR
Asn TAATTA gaAAcg 10 10 1 RSDTLQA// QRGNLTR
Asn TAATTA gaAAcg 10 10 2 RSDTLQA// QRGNLTR
Asn TAATTA gaAAcg 10 10 3 RSDTLQQ// QRGNLTR
Asn TAATTA gaAAcg 10 10 4 RSDTLMA// QRGNLTR
Asn TAATTA gaAAcg 10 10 5 RSDTLVQ// QRGNLTR
Asn TAATTA gaAAcg 10 10 6 RSDTLMA// QRGNLTR
Asn TAATTA gaAAcg 10 10 7 RSDTLAQ// QRGNLTR
Asn TAATTA gaAAcg 10 10 8 RSDTLAA// QRGNLTR
Asn TAATTA gaAAcg 10 10 9 RSDTLAQ// QSGNLTR
Asn TAATTA gaAAcg 10 10 10 RSDTLTQ// QRGNLTR
His TAATTA gaAAcg 2 0 1 RSDTLLV// VLQHLTR
His TAATTA gaAAcg 2 0 2 RSDTLDA// GLEHLTR
His TAATTA gaAAcg 2 0 3 RSDTLVQ// QRGHLTR
His TAATTA gaAAcg 2 0 4 RSDTLDQ// QRIHLTR
His TAATTA gaAAcg 2 0 5
His TAATTA gaAAcg 2 0 6 RSDTLRV// QVGHLTR
His TAATTA gaAAcg 2 0 7 RSDTLAG// ESSHLTR
His TAATTA gaAAcg 2 0 8 RSDTLRT// QRVHLTR
His TAATTA gaAAcg 2 0 9 RSDTLKQ// QRVHLTR
His TAATTA gaAAcg 2 0 10 RSDTLRV// QSGHLTR
His TAATTA gaAAcg 5 10 1 RSDTLKQ// QRIHLTR
His TAATTA gaAAcg 5 10 2
His TAATTA gaAAcg 5 10 3 RSDTLTQ// QRGHLTR
His TAATTA gaAAcg 5 10 4 RSDTLQQ// QRVHLTR
His TAATTA gaAAcg 5 10 5 RSDTLRQ// QRVHLTR
His TAATTA gaAAcg 5 10 6
His TAATTA gaAAcg 5 10 7 RSDTLTQ// QRGHLTR
His TAATTA gaAAcg 5 10 8
Asn TAATTA gaACcg 5 1 RSDTLDA// QSSNLTR
Asn TAATTA gaACcg 5 2 RSDTLIT// QGGNLTR
Asn TAATTA gaACcg 5 3 RSDTLAD// QAGNLTR
Asn TAATTA gaACcg 5 4 RSDTLKA// VRGNLTR
Asn TAATTA gaACcg 5 5 RSDTLKE// QRANLTR
Asn TAATTA gaACcg 5 6 RSDTLAD// QHGNLTR
Asn TAATTA gaACcg 5 7 RSDTLDA// QAGNLTR
Asn TAATTA gaACcg 5 8 RSDTLVA// QRGNLTR
Asn TAATTA gaACcg 10 10 1 RSDTLMA// QSGNLTR
Table A-1: 
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1352 lib 
Asn+3F2/
His+3F2
Homeodomain 
Binding 
site
ZFP 
Binding 
site
3-AT 
conc  
(mM)
IPTG 
(uM)
Clone  
#
Recognition helices      
F1(VNS)// F2(NNW)
-1123456//-1123456
Asn TAATTA gaACcg 10 10 2 RSDTLTA// QKCNLTR
Asn TAATTA gaACcg 10 10 3 RSDTLKQ// QCGNLTR
Asn TAATTA gaACcg 10 10 4 RSDTLKQ// QCGNLTR
Asn TAATTA gaACcg 10 10 5 RSDTLKE// QHSNLTR
Asn TAATTA gaACcg 10 10 6 RSDTLVE// QRGNLTR
Asn TAATTA gaACcg 10 10 7 RSDTLLQ// QRSNLTR
Asn TAATTA gaACcg 10 10 8 RSDTLIE// QRGNLTR
HIS TAATTA gaACcg 2 10 1 RSDTLAT// QRGHLTR
HIS TAATTA gaACcg 2 10 2 RSDTLTA// QGGHLTR
HIS TAATTA gaACcg 2 10 3 RSDTLRE// QRGHLTR
HIS TAATTA gaACcg 2 10 4 RSDTLRA// QGGHLTR
HIS TAATTA gaACcg 2 10 5 RSDTLKA// QGGHLTR
HIS TAATTA gaACcg 2 10 6 RSDTLQA// QQGHLTR
HIS TAATTA gaACcg 2 10 7 RSDTLTQ// QSGHLTR
HIS TAATTA gaACcg 2 10 8 RSDTLLD// QRGHLTR
His TAATTA gaACcg 5 10 1 RSDTLKE// QRIHLTR
His TAATTA gaACcg 5 10 2 RSDTLKA// QGGHLTR
His TAATTA gaACcg 5 10 3 RSDTLAA// QSGHLTR
His TAATTA gaACcg 5 10 4 RSDTLKA// QGGHLTR
His TAATTA gaACcg 5 10 5 RSDTLRA// QRGHLTR
His TAATTA gaACcg 5 10 6 RSDTLAE// QRGHLTR
His TAATTA gaACcg 5 10 7 RSDTLKI// QRGHLTR
His TAATTA gaACcg 5 10 8 RSDTLRA// QGGHLTR
Asn TAATTA gaAGcg 10- URA 0 1 RSDTLVR// QLSNLTR
Asn TAATTA gaAGcg 10- URA 0 2 RSDTLAR// QGCNLTR
Asn TAATTA gaAGcg 10- URA 0 3 RSDTLLR// QKCNLTR
Asn TAATTA gaAGcg 10- URA 0 4 RSDTLVR// QEGNLTR
Asn TAATTA gaAGcg 10- URA 0 5 RSDTLKK// QTCNLTR
Asn TAATTA gaAGcg 10- URA 0 6 RSDTLDR// QGGNLTR
Asn TAATTA gaAGcg 25-URA 0 1 RSDTLQR// QKSNLTR
Asn TAATTA gaAGcg 25-URA 0 2 RSDTLLR// QNSNLTR
Asn TAATTA gaAGcg 25-URA 0 3 RSDTLRR// QGANLTR
Asn TAATTA gaAGcg 25-URA 0 4 RSDTLQR// QGANLTR
Asn TAATTA gaAGcg 25-URA 0 5 RSDTLAR// QCSNLTR
Asn TAATTA gaAGcg 25-URA 0 6 RSDTLLR// QGANLTR
Asn TAATTA gaAGcg 25-URA 0 7 RSDTLLK// QSCNLTR
Asn TAATTA gaAGcg 25-URA 0 8 RSDTLKR// XXCNLTR
His TAATTA gaAGcg 5 10 1 RSDTLKR// QVAHLTR
His TAATTA gaAGcg 5 10 2 RSDTLVR// QSSHLTR
His TAATTA gaAGcg 5 10 3 RSDTLVR// QNGHLTR
His TAATTA gaAGcg 5 10 4 RSDTLLR// QSVHLTR
His TAATTA gaAGcg 5 10 5 RSDTLRR// QCYHLTR
His TAATTA gaAGcg 5 10 6 RSDTLRR// QRGHLTR
His TAATTA gaAGcg 5 10 7 RSDTLER// QRGHLTR
His TAATTA gaAGcg 5 10 8 RSDTLIR// QAGHLTR
His TAATTA gaAGcg 10 10 1 RSDTLVR// QSGHLTR
His TAATTA gaAGcg 10 10 2 RSDTLRR// QAYHLTR
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His TAATTA gaAGcg 10 10 3
His TAATTA gaAGcg 10 10 4 RSDTLKK// QSGHLTR
His TAATTA gaAGcg 10 10 5 RSDTLAR// QGGHLTR
His TAATTA gaAGcg 10 10 6 RSDTLRR// QSYHLTR
His TAATTA gaAGcg 10 10 7 RSDTLAR// QSHHLTR
His TAATTA gaAGcg 10 10 8 RSDTLAR// QQYHLTR
Asn TAATTA gaATcg 10 10 1 RSDTLRL// QRGNLTR
Asn TAATTA gaATcg 10 10 2 RSDTLKV// QYGNLTR
Asn TAATTA gaATcg 10 10 3 RSDTLTV// QRSNLTR
Asn TAATTA gaATcg 10 10 4 RSDTLEA// QRSNLTR
Asn TAATTA gaATcg 10 10 5 RSDTLAA// QGGNLTR
Asn TAATTA gaATcg 10 10 6 RSDTLAA// QSGNLTR
Asn TAATTA gaATcg 10 10 7 RSDTLKI// VRSNLTR
Asn TAATTA gaATcg 10 10 8 RSDTLTA// QKGNLTR
Asn TAATTA gaATcg 25 10 1 RSDTLRT// QRSNLTR
Asn TAATTA gaATcg 25 10 2 RSDTLRA// QRGNLTR
Asn TAATTA gaATcg 25 10 3 RSDTLKA// QRSNLTR
Asn TAATTA gaATcg 25 10 4 RSDTLKQ// QSSNLTR
Asn TAATTA gaATcg 25 10 5
Asn TAATTA gaATcg 25 10 6 RSDTLQ(A/G)// QXSNLTR
His TAATTA gaATcg 5 10 1 RSDTLVI// QRIHLTR
His TAATTA gaATcg 5 10 2 RSDTLKV// QRCHLTR
His TAATTA gaATcg 5 10 3 RSDTLKA// QRIHLTR
His TAATTA gaATcg 5 10 4 RSDTLKT// QRIHLTR
His TAATTA gaATcg 5 10 5
His TAATTA gaATcg 5 10 6
His TAATTA gaATcg 5 10 7
His TAATTA gaATcg 5 10 8
His TAATTA gaATcg 10 10 1 RSDTLKI// QKVHLTR
His TAATTA gaATcg 10 10 2 RSDTLKI// QRVHLTR
His TAATTA gaATcg 10 10 3 RSDTLKV// QRIHLTR
His TAATTA gaATcg 10 10 4 RSDTLKV// QRIHLTR
His TAATTA gaATcg 10 10 5 RSDTLKI// QGIHLTR
His TAATTA gaATcg 10 10 6 RSDTLKV// QRIHLTR
His TAATTA gaATcg 10 10 7 RSDTLKV// QRIHLTR
His TAATTA gaATcg 10 10 8 RSDTLKV// QRIHLTR
Asn TAATTA gaCAcg 5 10 1 RSDTLAE// CARNLTR
Asn TAATTA gaCAcg 5 10 2 RSDTLAE// SRRNLTR
Asn TAATTA gaCAcg 5 10 3 RSDTLAE// VARNLTR
Asn TAATTA gaCAcg 5 10 4 RSDTLML// CRSNLTR
Asn TAATTA gaCAcg 5 10 5 RSDTLSE// AARNLTR
Asn TAATTA gaCAcg 5 10 6 RSDTLME// CRSNLTR
Asn TAATTA gaCAcg 5 10 7 RSDTLAE// TTRNLTR
Asn TAATTA gaCAcg 5 10 8 RSDTLRE// VSRNLTR
Asn TAATTA gaCAcg 10 10 1 RSDTLKE// VGRNLTR
Asn TAATTA gaCAcg 10 10 2 RSDTLKE// VLRNLTR
Asn TAATTA gaCAcg 10 10 3 RSDTLGR// ARRNLTR
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Asn TAATTA gaCAcg 10 10 4 RSDTLAE// VRRNLTR
Asn TAATTA gaCAcg 10 10 5 RSDTLKE// VSRNLTR
Asn TAATTA gaCAcg 10 10 6 RSDTLQE// TARNLTR
Asn TAATTA gaCAcg 10 10 7 RSDTLAE// ARRNLTR
Asn TAATTA gaCAcg 10 10 8 RSDTLKQ// CKPNLTR
Asn TAATTA gaCAcg 10 10 9 RSDTLVE// CKPNLTR
Asn TAATTA gaCAcg 25 10 1 RSDTLKE// GRSNLTR
Asn TAATTA gaCAcg 25 10 2 RSDTLKD// IRRNLTR
Asn TAATTA gaCAcg 25 10 3 RSDTLKE// RRSNLTR
Asn TAATTA gaCAcg 25 10 4 RSDTLKQ// DRRNLTR
Asn TAATTA gaCAcg 25 10 5 RSDTLKE// SKSNLTR
Asn TAATTA gaCAcg 25 10 6 RSDTLKE// VRRNLTR
Asn TAATTA gaCAcg 25 10 7 RSDTLKE// CRRNLTR
Asn TAATTA gaCAcg 25 10 8 RSDTLKQ// DKRNLTR
HIS TAATTA gaCAcg 5 10 1 RSDTLND// TRRHLTR
HIS TAATTA gaCAcg 5 10 2 RSDTLKE// TRRHLTR
HIS TAATTA gaCAcg 5 10 3 RSDTLAE// TRRHLTR
HIS TAATTA gaCAcg 5 10 4 RSDTLKR// ERGHLTR
HIS TAATTA gaCAcg 5 10 5
HIS TAATTA gaCAcg 5 10 6 RSDTLKE// ARRHLTR
HIS TAATTA gaCAcg 5 10 7
HIS TAATTA gaCAcg 5 10 8 RSDTLKE// ARRHLTR
Asn TAATTA gaCCcg 10 10 1 RSDTLKE// YRSNLTR
Asn TAATTA gaCCcg 10 10 2
Asn TAATTA gaCCcg 10 10 3 RSDTLRE// CRSNLTR
Asn TAATTA gaCCcg 10 10 4
Asn TAATTA gaCCcg 10 10 5 RSDTLKD// IRSNLTR
Asn TAATTA gaCCcg 10 10 6 RSDTLKD// CHRNLTR
Asn TAATTA gaCCcg 10 10 7 RSDTLAE// GRSNLTR
Asn TAATTA gaCCcg 10 10 8 RSDTLLE// CRSNLTR
His TAATTA gaCCcg 10 10 1
His TAATTA gaCCcg 10 10 2 RSDTLAT// DRSHLTR
His TAATTA gaCCcg 10 10 3 RSDTLDP// LYEHLTR
His TAATTA gaCCcg 10 10 4 RSDTLKD// TRKHLTR
His TAATTA gaCCcg 10 10 5 RSDTLKE// LRRHLTR
His TAATTA gaCCcg 10 10 6 RSDTLKA// ERGHLTR
His TAATTA gaCCcg 10 10 7 RSDTLKE// LRRHLTR
His TAATTA gaCCcg 10 10 8
Asn TAATTA gaCGcg 10 10 1 RSDTLKQ// CASNLTR
Asn TAATTA gaCGcg 10 10 2 RSDTLKR// CRGNLTR
Asn TAATTA gaCGcg 10 10 3 RSDTLKR// EASNLTR
Asn TAATTA gaCGcg 10 10 4 RSDTLKR// DRRNLTR
Asn TAATTA gaCGcg 10 10 5 RSDTLKL// GRSNLTR
Asn TAATTA gaCGcg 10 10 6 RSDTLAR// EGGNLTR
Asn TAATTA gaCGcg 10 10 7 RSDTLKR// DRGNLTR
Asn TAATTA gaCGcg 10 10 8 RSDTLVR// ERGNLTR
HIS TAATTA gaCGcg 5 10 1 RSDTLRR// ESGHLTR
HIS TAATTA gaCGcg 5 10 2 RSDTLKR// EGGHLTR
HIS TAATTA gaCGcg 5 10 3 RSDTLRR// ERGHLTR
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HIS TAATTA gaCGcg 5 10 4 RSDTLLR// ERGHLTR
HIS TAATTA gaCGcg 5 10 5 RSDTLKR// EGGHLTR
HIS TAATTA gaCGcg 5 10 6 RSDTLLR// ESGHLTR
HIS TAATTA gaCGcg 5 10 7
HIS TAATTA gaCGcg 5 10 8 RSDTLLR// ERGHLTR
His TAATTA gaCGcg 10 10 1 RSDTLKR// ERGHLTR
His TAATTA gaCGcg 10 10 2 RSDTLRR// ESGHLTR
His TAATTA gaCGcg 10 10 3 RDSTLKR// EQGHTLR
His TAATTA gaCGcg 10 10 4 RSDTLKR// ERGHLTR
His TAATTA gaCGcg 10 10 5 RSDTLKR// EGGHLTR
His TAATTA gaCGcg 10 10 6 RSDTLRR// ERGHLTR
His TAATTA gaCGcg 10 10 7 RSDTLRK// EKFHLTR
His TAATTA gaCGcg 10 10 8 RSDTLRR// EKGHLTR
Asn TAATTA gaCTcg 5 10 1 RSDTLSL// CRANLTR
Asn TAATTA gaCTcg 5 10 2 RSDTLKG// DRSNLTR
Asn TAATTA gaCTcg 5 10 3 RSDTLKL// GGSNLTR
Asn TAATTA gaCTcg 5 10 4 RSDTLAV// DRSNLTR
Asn TAATTA gaCTcg 5 10 5 RSDTLKM// NASNLTR
Asn TAATTA gaCTcg 5 10 6 RSDTLVR// DPCNLTR
Asn TAATTA gaCTcg 5 10 7 RSDTLKE// GRSNLTR
Asn TAATTA gaCTcg 5 10 8 RSDTLRD// CRSNLTR
Asn TAATTA gaCTcg 5 10 9 RSDTLKE// SKSNLTR
Asn TAATTA gaCTcg 10 10 1 RSDTLKL// CGSNLTR
Asn TAATTA gaCTcg 10 10 2 RSDTLRL// CSSNLTR
Asn TAATTA gaCTcg 10 10 3 RSDTLVL// CKSNLTR
Asn TAATTA gaCTcg 10 10 4 RSDTLAG// DRSNLTR
Asn TAATTA gaCTcg 10 10 5 RSDTLKL// CASNLTR
Asn TAATTA gaCTcg 10 10 6 RSDTLKG// DRCNLTR
Asn TAATTA gaCTcg 10 10 7 RSDTLQL// CRSNLTR
Asn TAATTA gaCTcg 10 10 8 RSDTLAL// CRCNLTR
His TAATTA gaCTcg 10 10 1 RSDTLQT// GDLHQTR
His TAATTA gaCTcg 10 10 2 RSDTLLR// HYAHLTR
His TAATTA gaCTcg 10 10 3 RSDTLTR// SPCHLTR
His TAATTA gaCTcg 10 10 4 RSDTLKG// GLLHLTR
His TAATTA gaCTcg 10 10 5 RSDTLRL// CYSNLTR
His TAATTA gaCTcg 10 10 6 RSDTLLA// RPVHLTR
His TAATTA gaCTcg 10 10 7 bad read
His TAATTA gaCTcg 10 10 8 RSDTLRL// CYSNLTR
His TAATTA gaCTcg 10 10 9 RSDTLPE// SGDHLTR
His TAATTA gaCTcg 10 10 10 bad read
His TAATTA gaCTcg 10 10 11 RSDTLGR// VESHLTR
His TAATTA gaCTcg 10 10 12 RSDTLGG// GDHHLTR
His TAATTA gaCTcg 5 10 1 RSDTLGR// G*RHLTR
His TAATTA gaCTcg 5 10 2 RSDTLEV// VSPHLTR
His TAATTA gaCTcg 5 10 3 bad read
Asn TAATTA gaGAcg 10 10 1 RSDTLRE// TRRNLTR
Asn TAATTA gaGAcg 10 10 2 RSDTLAE// AKRNLTR
Asn TAATTA gaGAcg 10 10 3 RSDTLKE// CSRNLTR
Asn TAATTA gaGAcg 10 10 4 RSDTLAN// RKGNLTR
Table A-1
212
1352 lib 
Asn+3F2/
His+3F2
Homeodomain 
Binding 
site
ZFP 
Binding 
site
3-AT 
conc  
(mM)
IPTG 
(uM)
Clone  
#
Recognition helices      
F1(VNS)// F2(NNW)
-1123456//-1123456
Asn TAATTA gaGAcg 10 10 5 RSDTLVE// VHRNLTR
Asn TAATTA gaGAcg 10 10 6 RSDTLKE// VRRNLTR
Asn TAATTA gaGAcg 10 10 7 RSDTLRE// AARNLTR
Asn TAATTA gaGAcg 10 10 8
HIS TAATTA gaGAcg 5 10 1 RSDTLKE// TTRHLTR
HIS TAATTA gaGAcg 5 10 2 RSDTLAD// VRRHLTR
HIS TAATTA gaGAcg 5 10 3 RSDTLKE// VSRHLTR
HIS TAATTA gaGAcg 5 10 4 RSDTLVE// RKRHLTR
HIS TAATTA gaGAcg 5 10 5 RSDTLRE// VRRHLTR
HIS TAATTA gaGAcg 5 10 6 RSDTLKE// VGRHLTR
HIS TAATTA gaGAcg 5 10 7 RSDTLKE// RRRHLTR
HIS TAATTA gaGAcg 5 10 8 RSDTLRD// VRRHLTR
His TAATTA gaGAcg 10 10 1 RSDTLKE// VRRHLTR
His TAATTA gaGAcg 10 10 2 RSDTLKE// TKRHLTR
His TAATTA gaGAcg 10 10 3 RSDTLKE// VRRHLTR
His TAATTA gaGAcg 10 10 4 RSDTLKE// VARHLTR
His TAATTA gaGAcg 10 10 5 RSDTLKE// VRRHLTR
His TAATTA gaGAcg 10 10 6
His TAATTA gaGAcg 10 10 7 RDTLKE// VRRHLTR
His TAATTA gaGAcg 10 10 8
Asn TAATTA gaGCcg 25 10 1 RSDTLKA// KRSNLTR
Asn TAATTA gaGCcg 25 10 2 RSDTLRS// RRFNLTR
Asn TAATTA gaGCcg 25 10 3 RSDTLKA// KRYNLTR
Asn TAATTA gaGCcg 25 10 4
Asn TAATTA gaGCcg 25 10 5 RSDTLRS// RAYNLTR
Asn TAATTA gaGCcg 25 10 6 RSDTLAA// RNSNLTR
Asn TAATTA gaGCcg 25 10 7 RSDTLRS// KKYNLTR
Asn TAATTA gaGCcg 25 10 8 RSDTLRA// RNFNLTR
Asn TAATTA gaGCcg 25-Ura 0 1 RSDTLKE// KGFNLTR
Asn TAATTA gaGCcg 25-Ura 0 2 RSDTLKA// ARYNLTR
Asn TAATTA gaGCcg 25-Ura 0 3 RSDTLKE// RRSNLTR
Asn TAATTA gaGCcg 25-Ura 0 4 RSDTLKE// KRYNLTR
Asn TAATTA gaGCcg 25-Ura 0 5 RSDTLRD// KRFNLTR
Asn TAATTA gaGCcg 25-Ura 0 6 RSDTLRE// KSGNLTR
Asn TAATTA gaGCcg 25-Ura 0 7 RSDTLKE// KACNLTR
Asn TAATTA gaGCcg 25-Ura 0 8 RSDTLKA// QRFNLTR
Asn TAATTA gaGCcg 25-Ura 0 9 RSDTLKE// RSSNLTR
His TAATTA gaGCcg 5 10 1 RSDTLKE// RKGHLTR
His TAATTA gaGCcg 5 10 2 RSDTLKE// RRYHLTR
His TAATTA gaGCcg 5 10 3
His TAATTA gaGCcg 5 10 4 RSDTLRD// RRGHLTR
His TAATTA gaGCcg 5 10 5 RSDTLAD// RRSHLTR
His TAATTA gaGCcg 5 10 6 RSDTLAD// RSSHLTR
His TAATTA gaGCcg 5 10 7
His TAATTA gaGCcg 5 10 8 RSDTLRD// RRQHLTR
His TAATTA gaGCcg 10 10 1
His TAATTA gaGCcg 10 10 2 RSDTLKE// RRSHLTR
His TAATTA gaGCcg 10 10 3 RSDTLKE// RSSHLTR
His TAATTA gaGCcg 10 10 4
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His TAATTA gaGCcg 10 10 5 RSDTLKE// RSSHLTR
His TAATTA gaGCcg 10 10 6 RSDTLKE// RRTHLTR
His TAATTA gaGCcg 10 10 7 RSDTLRD// RRQHLTR
His TAATTA gaGCcg 10 10 8 RSDTLKE// RRSHLTR
Asn TAATTA gaGGcg 25-Ura 0 1 RSDTLRR// VQYNLTR
Asn TAATTA gaGGcg 25-Ura 0 2 RSDTLIR// RAENLTR
Asn TAATTA gaGGcg 25-Ura 0 3 RSDTLKR// CRFNLTR
Asn TAATTA gaGGcg 25-Ura 0 4 RSDTLKR// AQGNLTR
Asn TAATTA gaGGcg 25-Ura 0 5 RSDTLKR// TTGNLTR
Asn TAATTA gaGGcg 25-Ura 0 6 RSDTLAR// GPQNLTR
Asn TAATTA gaGGcg 25-Ura 0 7 RSDTLVR// TRFNLTR
Asn TAATTA gaGGcg 25-Ura 0 8 RSDTLAR// AAYNLTR
Asn TAAAGG gaGGcg 10 10 1 RSDTLER// RTDNLTR
Asn TAAAGG gaGGcg 10 10 2 RSDTLER// RCDNLTR
Asn TAAAGG gaGGcg 10 10 3 RSDTLKR// RIDNLTR
Asn TAAAGG gaGGcg 10 10 4 RSDTLLR// RQDNLTR
Asn TAAAGG gaGGcg 10 10 5 RSDTLAA// FRRNLTR
Asn TAAAGG gaGGcg 10 10 6 RSDTLVR// RQDHLTR
Asn TAAAGG gaGGcg 10 10 7 RSDTLLR// RTDNLTR
Asn TAAAGG gaGGcg 10 10 8 RSDTLER// RHDNLTR
Asn TAATTA gaGGcg 50 10 1 RSDTLER// RRSNLTR
Asn TAATTA gaGGcg 50 10 2 RSDTLGH// *ECNLTR
Asn TAATTA gaGGcg 50 10 3 RSDTLAR// RSCNLTR
Asn TAATTA gaGGcg 50 10 4 RSDTLKL// RRYNLTR
Asn TAATTA gaGGcg 50 10 5 RSDTLKR// RGSNLTR
Asn TAATTA gaGGcg 50 10 6 RSDTLKR// RNYNLTR
Asn TAATTA gaGGcg 50 10 7 RSDTLVR// RRYNLR
Asn TAATTA gaGGcg 50 10 8 RSDTLRR// RRYNLTR
Asn TAATTA gaGGcg 50 10 9 RSDTLVE// KKYNLTR
Asn TAATTA gaGGcg 50 10 10 RSDTLAR// SRFNLTR
Asn TAATTA gaGGcg 50 10 11 RSDTLAR// RRYNLTR
Asn TAATTA gaGGcg 50 10 12 RSDTLAR// RRFNLTR
His TAATTA gaGGcg 10 10 1 RSDTLRR// RSCHLTR
His TAATTA gaGGcg 10 10 2 RSDTLAR// RFDHLTR
His TAATTA gaGGcg 10 10 3 RSDTLER// RQCHLTR
His TAATTA gaGGcg 10 10 4 RSDTLMR// RFDHLTR
His TAATTA gaGGcg 10 10 5
His TAATTA gaGGcg 10 10 6
His TAATTA gaGGcg 10 10 7
His TAATTA gaGGcg 10 10 8 RSDTLQR// RGCHLTR
His TAATTA gaGGcg 25 10 1
His TAATTA gaGGcg 25 10 2 RSDTLVR// RAEHLTR
His TAATTA gaGGcg 25 10 3 RSDTLSR// RREHLTR
His TAATTA gaGGcg 25 10 4 RSDTLAR// RAEHLTR
His TAATTA gaGGcg 25 10 5 RSDTLVR// RLDHLTR
His TAATTA gaGGcg 25 10 6 RSDTLIR// RYDHLTR
His TAATTA gaGGcg 25 10 7
His TAATTA gaGGcg 25 10 8 RSDTLKR// RSCHLTR
Asn TAATTA gaGTcg 5 10 1 RSDTLKE// RSCNLTR
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Asn TAATTA gaGTcg 5 10 2 RSDTLRE// KACNLTR
Asn TAATTA gaGTcg 5 10 3 RSDTLKV// TSSNLTR
Asn TAATTA gaGTcg 5 10 4 RSDTLLA// KGCNLTR
Asn TAATTA gaGTcg 5 10 5 RSDTLRG// KSCNLTR
Asn TAATTA gaGTcg 5 10 6 RSDTLKA// RADNLTR
Asn TAATTA gaGTcg 5 10 7 RSDTLKE// VRRNLTR
Asn TAATTA gaGTcg 5 10 8 RSDTLKL// SGSNLTR
Asn TAATTA gaGTcg 5 10 9
Asn TAATTA gaGTcg 5 10 10 RSDTLVE// VRRNLTR
Asn TAATTA gaGTcg 10 10 1 RSDTLME// KSCNLTR
Asn TAATTA gaGTcg 10 10 2 RSDTLME// KSCNLTR
Asn TAATTA gaGTcg 10 10 3 RSDTLLE// IKRNLTR
Asn TAATTA gaGTcg 10 10 4 RSDTLIE// IKRNLTR
Asn TAATTA gaGTcg 10 10 5
Asn TAATTA gaGTcg 10 10 6 RSDTLVE// KSCNLTR
Asn TAATTA gaGTcg 10 10 7 RSDTLRE// KQCNLTR
Asn TAATTA gaGTcg 10 10 8 RSDTLKE// KGCNLTR
Asn TAATTA gaGTcg 10 10 9 RSDTLIR// ASSNLTR
Asn TAATTA gaGTcg 10 10 10 RSDTLVE// KGCNLTR
Asn TAATTA gaGTcg 10 0 1 RSDTLKE// KRCNLTR
Asn TAATTA gaGTcg 10 0 2 RSDTLRV// RSGNLTR
Asn TAATTA gaGTcg 10 0 3 RSDTLRE// KSCNLTR
Asn TAATTA gaGTcg 10 0 4 RSDTLME// KRCNLTR
Asn TAATTA gaGTcg 10 0 5 RSDTLKE// KSCNLTR
Asn TAATTA gaGTcg 10 0 6 RSDTLME// KRCNLTR
Asn TAATTA gaGTcg 10 0 7 RSDTLKE// KGCNLTR
Asn TAATTA gaGTcg 10 0 8 RSDTLVE// KSCNLTR
Asn TAATTA gaGTcg 10 0 9 RSDTLVE// KRCNLTR
Asn TAATTA gaGTcg 10 0 10 RSDTLRE// KRCNLTR
His TAATTA gaGTcg 5 10 1 RSDTLQA// AHAHLTR
His TAATTA gaGTcg 5 10 2 RSDTLVG// VRQHLTR
His TAATTA gaGTcg 5 10 3 RSDTLPM// RSRHLTR
His TAATTA gaGTcg 5 10 4 RSDTLLV// GAVHLTR
His TAATTA gaGTcg 5 10 5 RSDTLVK// RSDHLTR
His TAATTA gaGTcg 5 10 6
His TAATTA gaGTcg 5 10 7 RSDTLLK// RGDHLTR
His TAATTA gaGTcg 5 10 8
His TAATTA gaGTcg 5 10 9 RSDTLQK// RSDHLTR
His TAATTA gaGTcg 2 0 1 RSDTLLL// RSDHLTR
His TAATTA gaGTcg 2 0 2 RSDTLLL// RRDHLTR
His TAATTA gaGTcg 2 0 3 RSDTLLK// GPGHLTR
His TAATTA gaGTcg 2 0 4 RSDTLVR// GIQHLTR
His TAATTA gaGTcg 2 0 5 RSDTLKE// HLHHLTR
Asn TAATTA gaTAcg 10-Ura 0 1 RSDTLKV// VRGNLTR
Asn TAATTA gaTAcg 10-Ura 0 2 RSDTLKQ// AAGNLTR
Asn TAATTA gaTAcg 10-Ura 0 3 RSDTLLT// VRGNLTR
Asn TAATTA gaTAcg 10-Ura 0 4 RSDTLLV// TRGNLTR
Asn TAATTA gaTAcg 10-Ura 0 5 RSDTLAV// VRGNLTR
Asn TAATTA gaTAcg 10-Ura 0 6 RSDTLAA// IRGNLTR
Table A-1
215
1352 lib 
Asn+3F2/
His+3F2
Homeodomain 
Binding 
site
ZFP 
Binding 
site
3-AT 
conc  
(mM)
IPTG 
(uM)
Clone  
#
Recognition helices      
F1(VNS)// F2(NNW)
-1123456//-1123456
Asn TAATTA gaTAcg 25-URA 0 1 RSDTLKA// VAGNLTR
Asn TAATTA gaTAcg 25-URA 0 2 RSDTLKA// VRGNLTR
Asn TAATTA gaTAcg 25-URA 0 3 RSDTLKD// VRANLTR
Asn TAATTA gaTAcg 25-URA 0 4 RSDTLKV// TVGNLTR
Asn TAATTA gaTAcg 25-URA 0 5 RSDTLKV// APGNLTR
Asn TAATTA gaTAcg 25-URA 0 6 RSDTLKI// AKGNLTR
Asn TAATTA gaTAcg 25-URA 0 7 RSDTLKA// IRANLTR
Asn TAATTA gaTAcg 25-URA 0 8 RSDTLKA// VAGNLTR
His TAATTA gaTAcg 5 10 1
His TAATTA gaTAcg 5 10 2 RSDTLLD// LRRHLTR
His TAATTA gaTAcg 5 10 3
His TAATTA gaTAcg 5 10 4
His TAATTA gaTAcg 5 10 5
His TAATTA gaTAcg 5 10 6 RSDTLRE// LRRHLTR
His TAATTA gaTAcg 5 10 7
His TAATTA gaTAcg 5 10 8 RSDTLKD// LRRHLTR
His TAATTA gaTAcg 10 10 1 RSDTLKD// LKRHLTR
His TAATTA gaTAcg 10 10 2 RSDTLKE// LRRHLTR
His TAATTA gaTAcg 10 10 3 RSDTLKE// LKRHLTR
His TAATTA gaTAcg 10 10 4 RSDTLKE// LKRHLTR
His TAATTA gaTAcg 10 10 5 RSDTLKE// LRRHLTR
His TAATTA gaTAcg 10 10 6 RSDTLKE// LKRHLTR
His TAATTA gaTAcg 10 10 7 RSDTLMV// ARCNLTR
His TAATTA gaTAcg 10 10 8 RSDTLVR// LRCYLTR
His TAATTA gaTAcg 10 10 9 RSDTLRE// LKRHLTR
Asn TAATTA gaTCcg 10 10 1 RSDTLKE// LKRNLTR
Asn TAATTA gaTCcg 10 10 2 RSDTLKD// RRSNLTR
Asn TAATTA gaTCcg 10 10 3 RSDTLKD// RKTNLTR
Asn TAATTA gaTCcg 10 10 4
Asn TAATTA gaTCcg 10 10 5 RSDTLKD// RSSNLTR
Asn TAATTA gaTCcg 10 10 6 RSDTLLM// GGSNLTR
Asn TAATTA gaTCcg 10 10 7 RSDTLKE// LNRNLTR
Asn TAATTA gaTCcg 10 10 8 RSDTLRD// RSTNLTR
His TAATTA gaTCcg 10 10 1 RSDTLKR// ERSHLTR
His TAATTA gaTCcg 10 10 2
His TAATTA gaTCcg 10 10 3 RSDTLKD// LKRHLTR
His TAATTA gaTCcg 10 10 4 RSDTLKE// IKRHLTR
His TAATTA gaTCcg 10 10 5
His TAATTA gaTCcg 10 10 6 RSDTLKV// VKAHLTR
His TAATTA gaTCcg 10 10 7 RSDTLKD// TRGHLTR
His TAATTA gaTCcg 10 10 8 RSDTLKV// ARGHLTR
His TAATTA gaTCcg 5 -Ura 0 1 RSDTLKA// VRNHLTR
His TAATTA gaTCcg 5 -Ura 0 2 RSDTLRE// LKRHLTR
His TAATTA gaTCcg 5 -Ura 0 3 RSDTLKD// IQRHLTR
His TAATTA gaTCcg 5 -Ura 0 4 RDSTLKV// ARGHLTR
His TAATTA gaTCcg 5 -Ura 0 5 RSDTLKE// CRRHLTR
His TAATTA gaTCcg 5 -Ura 0 6 RDSTLKV// VRAHLTR
His TAATTA gaTCcg 5 -Ura 0 7 RSDTLKV// ASGHLTR
His TAATTA gaTCcg 5 -Ura 0 8 RSDTLQD// NKRHLTR
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Asn TAATTA gaTGcg 25-Ura 0 1 RSDTLQR// VGSNLTR
Asn TAATTA gaTGcg 25-Ura 0 2
Asn TAATTA gaTGcg 25-Ura 0 3 RSDTLVR// HAFNLTR
Asn TAATTA gaTGcg 25-Ura 0 4 RSDTLAR// CRGNLTR
Asn TAATTA gaTGcg 25-Ura 0 5 RSDTLGR// VRCNLTR
Asn TAATTA gaTGcg 25-Ura 0 6 RSDTLAR// VRANLTR
Asn TAATTA gaTGcg 25-Ura 0 7 RSDTLVR// CRHNLTR
Asn TAATTA gaTGcg 25-Ura 0 8 RSDTLQR// VGGNLTR
Asn TAATTA gaTGcg 10 10 1 RSDTLMR// IRSNLTR
Asn TAATTA gaTGcg 10 10 2 RSDTLRR// CRFNLTR
Asn TAATTA gaTGcg 10 10 3 RSDTLAT// VRGNLTR
Asn TAATTA gaTGcg 10 10 4 RSDTLER// VKSNLTR
Asn TAATTA gaTGcg 10 10 5 RSDTLGR// VRANLTR
Asn TAATTA gaTGcg 10 10 6
Asn TAATTA gaTGcg 10 10 7
Asn TAATTA gaTGcg 10 10 8 RSDTLRA// TGGNLTR
HIS TAATTA gaTGcg 5 10 1
HIS TAATTA gaTGcg 5 10 2 RSDTLVR// LRFHLTR
HIS TAATTA gaTGcg 5 10 3 RSDTLER// LSFHLTR
HIS TAATTA gaTGcg 5 10 4 RSDTLRR// ISFHLTR
HIS TAATTA gaTGcg 5 10 5 RSDTLAR// FRFHLTR
HIS TAATTA gaTGcg 5 10 6 RSDTLKR// LPFHLTR
HIS TAATTA gaTGcg 5 10 7 RSDTLTR// LRYHLTR
HIS TAATTA gaTGcg 5 10 8 RSDTLKR// LTFHLTR
His TAATTA gaTGcg 10 10 1 RSDTLRR// IRFHLTR
His TAATTA gaTGcg 10 10 2 RSDTLKR// CGFHLTR
His TAATTA gaTGcg 10 10 3 RSDTLRR// LPFHLTR
His TAATTA gaTGcg 10 10 4 RSDTLAR// FRFHLTR
His TAATTA gaTGcg 10 10 5 RSDTLGR// LRFHLTR
His TAATTA gaTGcg 10 10 6 RSDTLVR// LRYHLTR
His TAATTA gaTGcg 10 10 7 RSDTLRR// LSFHLTR
His TAATTA gaTGcg 10 10 8 RSDTLQR// VQFHLTR
Asn TAATTA gaTTcg 10 10 1 RSDTLRV// VRSNLTR
Asn TAATTA gaTTcg 10 10 2 RSDTLKQ// ARSNLTR
Asn TAATTA gaTTcg 10 10 3 RSDTLAI// VSSNLTR
Asn TAATTA gaTTcg 10 10 4 RSDTLKV// VRGNLTR
Asn TAATTA gaTTcg 10 10 5 RSDTLLV// TSSNLTR
Asn TAATTA gaTTcg 10 10 6 RSDTLAV// VRSNLTR
Asn TAATTA gaTTcg 10 10 7 RSDTLRT// TKSNLTR
Asn TAATTA gaTTcg 10 10 8 RSDTLAT// VSSNLTR
His TAATTA gaTTcg 10 10 1 bad read
His TAATTA gaTTcg 10 10 2 RSDTLLE// SGGHLTR
His TAATTA gaTTcg 10 10 3 RSDTLGT// RVLHLTR
His TAATTA gaTTcg 10 10 4 RSDTLAE// SAGHLTR
His TAATTA gaTTcg 10 10 5 RSDTLRR// AAAHLTR
His TAATTA gaTTcg 10 10 6 RSDTLLE// CARHLTR
His TAATTA gaTTcg 10 10 7 RSDTLRT// Mutations
His TAATTA gaTTcg 10 10 8 RSDTLRR// GGGHLTR
His TAATTA gaTTcg 10 10 9 RSDTLKS// VGSNLTR
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1352 lib 
Asn+3F2/
His+3F2
Homeodomain 
Binding 
site
ZFP 
Binding 
site
3-AT 
conc  
(mM)
IPTG 
(uM)
Clone  
#
Recognition helices      
F1(VNS)// F2(NNW)
-1123456//-1123456
His TAATTA gaTTcg 10 10 10 RSDTLLS// FSGHLTR
His TAATTA gaTTcg 10 10 11 RSDTLER// STCHLTR
His TAATTA gaTTcg 10 10 12 mutations
His TAATTA gaTTcg 5 10 1 RSDTLLR// TLSHLTR
His TAATTA gaTTcg 5 10 2 RSDTLLE// GATHLTR
His TAATTA gaTTcg 5 10 3 RSDTLPV// KCGHLTR
His TAATTA gaTTcg 5 10 4 RSDTLGP// HYEHLTR
!"#$%&'(): *+,-&./&"$$&01(2.34$%,&.#-"+5%3&"/-%6&7)8(,%$%9-+.5,&/6.2&-:%&',5;<10(
$+#6"6=&"53&-:%&8+,;<10($+#6"6=. Recognition helix sequences (‐1, 1, 2, 3, 4, 5, 6) for F1 and F2 for selected 2F‐modules are shown for 2F‐modules selected for zinc Dinger binding sites (gaNNcg where NN represents the 2bp‐interface). The amino acid at position 3 of F2 can either be Asn or His depending on the zinc Dinger library used. The selection conditions (3‐AT, IPTG and Uracil concentrations) are given. For selection of 2F‐modules that bind the G‐G interface with the Asn+3F2‐library library, a mutant homeodomain binding site (TAAAGG) was used. 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Table A-2 
List of all 2F-modules in the archive. Recognition helix sequences for F1 and F2 of 
2F-modules characterized in this study are shown. 
Name 
F1:  
-1123456 
F2:  
-1123456 Note 
Target 
site 
2FM-1 RSDTLTQ QRGNLTR Selected GAAACG 
2FM-1 RSDTLTQ QRGNLTR Selected GAAATG 
2FM-1-QRG QRGTLTQ QRGNLTR Rationally Designed GAAACA 
2FM-1-QRG QRGTLTQ QRGNLTR Rationally Designed GAAATA 
2FM-2 RSDTLVE QRGNLTR Selected GAACCG 
2FM-2 RSDTLVE QRGNLTR Selected GAACTG 
2FM-2-QRG QRGTLVE QRGNLTR Rationally Designed GAACCA 
2FM-2-QRG QRGTLVE QRGNLTR Rationally Designed GAACTA 
2FM-3 RSDTLQR QKSNLTR Selected GAAGCG 
2FM-3 RSDTLQR QKSNLTR Selected GAAGTG 
2FM-3-QRG QRGTLQR QKSNLTR Selected GAAGCA 
2FM-3-QRG QRGTLQR QKSNLTR Selected GAAGTA 
2FM-4 RSDTLKG QRCNLTR Rationally Designed GAATCG 
2FM-4 RSDTLKG QRCNLTR Rationally Designed GAATTG 
2FM-4 RSDTLKG QRCNLTR Rationally Designed GAATAG 
2FM-4-QRG QRGTLKG QRCNLTR Rationally Designed GAATCA 
2FM-4-QRG QRGTLKG QRCNLTR Rationally Designed GAATTA 
2FM-4-QRG QRGTLKG QRCNLTR Rationally Designed GAATAA 
2FM-5 RSDTLKQ DKGNLTR Rationally Designed GACACG 
2FM-5 RSDTLKQ DKGNLTR Rationally Designed GACATG 
2FM-5-QRG QRGTLKQ DKGNLTR Rationally Designed GACACA 
2FM-5-QRG QRGTLKQ DKGNLTR Rationally Designed GACATA 
2FM-6 RSDTLMV DRSNLTR Rationally Designed GACCCG 
2FM-6 RSDTLMV DRSNLTR Rationally Designed GACCTG 
2FM-6-QRG QRGTLMV DRSNLTR Rationally Designed GACCCA 
2FM-6-QRG QRGTLMV DRSNLTR Rationally Designed GACCTA 
2FM-7 RSDTLER DRGNLTR Selected GACGCG 
2FM-7 RSDTLER DRGNLTR Selected GACGTG 
2FM-7-QRG QRGTLER DRGNLTR Selected GACGCA 
2FM-7-QRG QRGTLER DRGNLTR Selected GACGTA 
2FM-8 RSDTLKG DRCNLTR Selected GACTTG 
2FM-8 RSDTLKG DRCNLTR Selected GACTCG 
2FM-8-QRG QRGTLKG DRCNLTR Selected GACTTA 
2FM-8-QRG QRGTLKG DRCNLTR Selected GACTCA 
2FM-9 RSDTLVE RKRNLTR Rationally Designed GAGACG 
2FM-9 RSDTLVE RKRNLTR Rationally Designed GAGATG 
2FM-9-QRG QRGTLVE RKRNLTR Rationally Designed GAGACA 
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2FM-9-QRG QRGTLVE RKRNLTR Rationally Designed GAGATA 
2FM-10 RSDTLKE RSSNLTR Selected GAGCCG 
2FM-10 RSDTLKE RSSNLTR Selected GAGCTG 
2FM-10-QRG QRGTLKE RSSNLTR Selected GAGCCA 
2FM-10-QRG QRGTLKE RSSNLTR Selected GAGCTA 
2FM-11 RSDTLIR RAENLTR Selected GAGGCG 
2FM-11 RSDTLIR RAENLTR Selected GAGGTG 
2FM-11-QRG QRGTLIR RAENLTR Selected GAGGCA 
2FM-11-QRG QRGTLIR RAENLTR Selected GAGGTA 
2FM-12 RSDTLKE KGCNLTR Selected GAGTCG 
2FM-12 RSDTLKE KGCNLTR Selected GAGTTG 
2FM-12-QRG QRGTLKE KGCNLTR Selected GAGTCA 
2FM-12-QRG QRGTLKE KGCNLTR Selected GAGTTA 
2FM-13 RSDTLKQ AAGNLTR Selected GATACG 
2FM-13 RSDTLKQ AAGNLTR Selected GATATG 
2FM-13-QRG QRGTLKQ AAGNLTR Selected GATACA 
2FM-13-QRG QRGTLKQ AAGNLTR Selected GATATA 
2FM-14 RSDTLLE LKGHLTR Rationally Designed GATCCG 
2FM-14 RSDTLLE LKGHLTR Rationally Designed GATCTG 
2FM-14-QRG QRGTLLE LKGHLTR Rationally Designed GATCCA 
2FM-14-QRG QRGTLLE LKGHLTR Rationally Designed GATCTA 
2FM-15 RSDTLMR IRSNLTR Selected GATGCG 
2FM-15 RSDTLMR IRSNLTR Selected GATGTG 
2FM-15-QRG QRGTLMR IRSNLTR Selected GATGCA 
2FM-15-QRG QRGTLMR IRSNLTR Selected GATGTA 
2FM-16 RSDTLRT TKSNLTR Selected GATTCG 
2FM-16 RSDTLRT TKSNLTR Selected GATTTG 
2FM-16-QRG QRGTLRT TKSNLTR Selected GATTCA 
2FM-17 RSDTLTQ QRGHLTR Selected GGAACG 
2FM-17 RSDTLTQ QRGHLTR Selected GGAATG 
2FM-17-QRG QRGTLTQ QRGHLTR Selected GGAACA 
2FM-17-QRG QRGTLTQ QRGHLTR Selected GGAATA 
2FM-18 RSDTLRE QRGHLTR Selected GGACCG 
2FM-18 RSDTLRE QRGHLTR Selected GGACTG 
2FM-18-QRG QRGTLRE QRGHLTR Selected GGACCA 
2FM-18-QRG QRGTLRE QRGHLTR Selected GGACTA 
2FM-19 RSDTLVR QSGHLTR Selected GGAGCG 
2FM-19 RSDTLVR QSGHLTR Selected GGAGTG 
2FM-19-QRG QRGTLVR QSGHLTR Selected GGAGCA 
2FM-19-QRG QRGTLVR QSGHLTR Selected GGAGTA 
2FM-20 RSDTLKG QRCHLTR Rationally Designed GGATCG 
2FM-20 RSDTLKG QRCHLTR Rationally Designed GGATTG 
2FM-20 RSDTLKG QRCHLTR Rationally Designed GGATAG 
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2FM-20-QRG QRGTLKG QRCHLTR Rationally Designed GGATCA 
2FM-20-QRG QRGTLKG QRCHLTR Rationally Designed GGATTA 
2FM-20-QRG QRGTLKG QRCHLTR Rationally Designed GGATAA 
2FM-1014 RSDTLKE ARRNLTR Selected GGCATG 
2FM-1014 RSDTLKE ARRNLTR Selected GGCACG 
2FM-1014-QRG QRGTLKE ARRNLTR Selected GGCATA 
2FM-1014-QRG QRGTLKE ARRNLTR Selected GGCACA 
2FM-21 RSDTLMV DRSHLTR Rationally Designed GGCCCG 
2FM-21 RSDTLMV DRSHLTR Rationally Designed GGCCTG 
2FM-21-QRG QRGTLMV DRSHLTR Rationally Designed GGCCCA 
2FM-21-QRG QRGTLMV DRSHLTR Rationally Designed GGCCTA 
2FM-23 RSDTLLR ESGHLTR Selected GGCGCG 
2FM-23 RSDTLLR ESGHLTR Selected GGCGTG 
2FM-23-QRG QRGTLLR ESGHLTR Selected GGCGCA 
2FM-23-QRG QRGTLLR ESGHLTR Selected GGCGTA 
2FM-24 RSDTLKG DRCHLTR Rationally Designed GGCTCG 
2FM-24 RSDTLKG DRCHLTR Rationally Designed GGCTTG 
2FM-24-QRG QRGTLKG DRCHLTR Rationally Designed GGCTCA 
2FM-24-QRG QRGTLKG DRCHLTR Rationally Designed GGCTTA 
2FM-25 RSDTLVE RKRHLTR Selected GGGACG 
2FM-25 RSDTLVE RKRHLTR Selected GGGATG 
2FM-25-QRG QRGTLVE RKRHLTR Selected GGGACA 
2FM-25-QRG QRGTLVE RKRHLTR Selected GGGATA 
2FM-26 RSDTLKE RSSHLTR Selected GGGCCG 
2FM-26 RSDTLKE RSSHLTR Selected GGGCTG 
2FM-26-QRG QRGTLKE RSSHLTR Selected GGGCCA 
2FM-26-QRG QRGTLKE RSSHLTR Selected GGGCTA 
2FM-27 RSDTLAR RAEHLTR Selected GGGGCG 
2FM-27 RSDTLAR RAEHLTR Selected GGGGTG 
2FM-27-QRG QRGTLAR RAEHLTR Selected GGGGCA 
2FM-27-QRG QRGTLAR RAEHLTR Selected GGGGTA 
2FM-28 RSDTLLL RSDHLTR Selected GGGTTG 
2FM-28-QRG QRGTLLL RSDHLTR Selected GGGTTA 
2FM-29 RSDTLKQ AAGHLTR Rationally Designed GGTACG 
2FM-29 RSDTLKQ AAGHLTR Rationally Designed GGTATG 
2FM-29-QRG QRGTLKQ AAGHLTR Rationally Designed GGTACA 
2FM-22 RSDTLLE SGGHLTR Selected GGTCCG 
2FM-22 RSDTLLE SGGHLTR Selected GGTCTG 
2FM-22-QRG QRGTLLE SGGHLTR Selected GGTCCA 
2FM-22-QRG QRGTLLE SGGHLTR Selected GGTCTA 
2FM-31 RSDTLRR IRFHLTR Selected GGTGTG 
2FM-31 RSDTLRR IRFHLTR Selected GGTGCG 
2FM-31-QRG QRGTLRR IRFHLTR Selected GGTGTA 
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2FM-31-QRG QRGTLRR IRFHLTR Selected GGTGCA 
2FM-33 RSDTLTQ QRGDLTR 
Site directed 
mutagenesis GCAACG 
2FM-33-QRG QRGTLTQ QRGDLTR 
Site directed 
mutagenesis GCAACA 
2FM-33 RSDTLTQ QRGDLTR 
Site directed 
mutagenesis GCAATG 
2FM-33-QRG QRGTLTQ QRGDLTR 
Site directed 
mutagenesis GCAATA 
2FM-34 RSDTLTQ QRGELTR 
Site directed 
mutagenesis GTAACG 
2FM-34-QRG QRGTLTQ QRGELTR 
Site directed 
mutagenesis GTAACA 
2FM-34 RSDTLTQ QRGELTR 
Site directed 
mutagenesis GTAATG 
2FM-34-QRG QRGTLTQ QRGELTR 
Site directed 
mutagenesis GTAATA 
2FM-35 RSDTLAE CARDLTR 
Site directed 
mutagenesis GCCACG 
2FM-35-QRG QRGTLAE CARDLTR 
Site directed 
mutagenesis GCCACA 
2FM-36 RSDTLKQ AAGDLTR 
Site directed 
mutagenesis GCTACG 
2FM-36-QRG QRGTLKQ AAGDLTR 
Site directed 
mutagenesis GCTACA 
2FM-36 RSDTLKQ AAGDLTR 
Site directed 
mutagenesis GCTATG 
2FM-36-QRG QRGTLKQ AAGDLTR 
Site directed 
mutagenesis GCTATA 
2FM-37 RSDHLTQ QRGNLTR 
Site directed 
mutagenesis GAAAGG 
2FM-37-QRG QRGHLTQ QRGNLTR 
Site directed 
mutagenesis GAAAGA 
2FM-37 RSDHLTQ QRGNLTR 
Site directed 
mutagenesis GAATGG 
2FM-37-QRG QRGHLTQ QRGNLTR 
Site directed 
mutagenesis GAATGA 
2FM-38 RSDHLKQ AAGNLTR 
Site directed 
mutagenesis GATAGG 
2FM-38-QRG QRGHLKQ AAGNLTR 
Site directed 
mutagenesis GATAGA 
2FM-39 RSDNLKQ AAGNLTR 
Site directed 
mutagenesis GATAAG 
2FM-39-QRG QRGNLKQ AAGNLTR 
Site directed 
mutagenesis GATAAA 
2FM-40 RSDTLVE RKRSLTR 
Site directed 
mutagenesis GTGACG 
2FM-40-QRG QRGTLVE RKRSLTR 
Site directed 
mutagenesis GTGACA 
2FM-40 RSDTLVE RKRSLTR 
Site directed 
mutagenesis GTGATG 
2FM-40-QRG QRGTLVE RKRSLTR 
Site directed 
mutagenesis GTGATA 
2FM-41 RSDNLTQ QRGNLTR Site directed GAAAAG 
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mutagenesis 
2FM-41-QRG QRGNLTQ QRGNLTR 
Site directed 
mutagenesis GAAAAA 
2FM-42 RSDTLKQ DKRSLTR 
Site directed 
mutagenesis GTCACG 
2FM-42-QRG QRGTLKQ DKRSLTR 
Site directed 
mutagenesis GTCACA 
2FM-48 DKGTLTQ QRGNLTR N-terminal Cap GAAACT 
2FM-48 DKGTLTQ QRGNLTR N-terminal Cap GAAATT 
2FM-49 DKRTLTQ QRGNLTR N-terminal Cap GAAACC 
2FM-49 DKRTLTQ QRGNLTR N-terminal Cap GAAATC 
2FM-51 DKGTLVE RKRHLTR N-terminal Cap GGGACT 
2FM-52 DKGTLKE RSSNLTR N-terminal Cap GAGCCT 
2FM-52 DKGTLKE RSSNLTR N-terminal Cap GAGCTT 
2FM-1131 DKGTLVE QRGNLTR N-terminal Cap GAACCT  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Table A-3: Primer sequences for ZFN assembly. 
Primer Name Sequence (5' to 3') 
F0Fn CCCAGTCACGACGTTGTAAAACGGTACCAAGCCCTATAAATGTCCTGAATG 
F0Rn ACACGCGTATGGCTTCTCACCGGTGTGCGTA 
F1Fn TGAGAAGCCATACGCGTGTCCTGTCGAGTCCTGT 
F1Rn GCATTGAAACGGTTTTTGCCCTGTGTGAATC 
F2Fn GCAAAAACCGTTTCAATGCCGCATCTGCATG 
F2Rn ACAGGCGAAGGGCTTTTCTCCTGTGTGGGTG 
F3Fn AGAAAAGCCCTTCGCCTGTGACATCTGCGG 
F3RnLRGS AGCGGATAACAATTTCACACAGGATCCACGGAGGTGGATCTTGGTGTG 
F3RnTGPGAAGS AGCGGATAACAATTTCACACAGGATCCTGCAGCACCAGGGCCAGTGTGGATCTTGGTGTG 
F1(noF0)Fn CCCAGTCACGACGTTGTAAAACGGTACCCGCCCATATGCTTGCCC 
2FM-F0Fn CCCAGTCACGACGTTGTAAAACGGTACCAAACCGTATGCTTGCCCTGTC 
2FM-F1Rn GCATTGAAACGGTTTTTGCCCTGTGTGGGTCCTGATGTG 
2FM-F1Fn  TGAGAAGCCATACGCGTGTCCTGTCGAGTCCTGTGAC 
2FM-F2Rn  ACAGGCGAAGGGCTTTTCTCCTGTGTGGGTCCTGATGTG 
2FM-F2Fn  GCAAAAACCGTTTCAATGCCCTGTCGAGTCCTGCGAC 
2FM-F3RnLRGS  AGCGGATAACAATTTCACACAGGATCCACGGAGGTGGGTCCTGATGTG 
2FM-F3RnTGPGAAGS AGCGGATAACAATTTCACACAGGATCCTGCAGCACCAGGGCCAGTGTGGGTCCTGATGTG 
2FM-F1(noF0)Fn  CCCAGTCACGACGTTGTAAAACGGTACCAAACCGTATGCTTGCCCTG 
2FM-F0-QRG(X)Fn CCGTATGCTTGCCCTGTCGAGTCCTGCGACCGCCGCTTCTCCcagcgcggcNNNCT 
2FM-F1-QRG(X)Fn  TGAGAAGCCATACGCGTGTCCTGTCGAGTCCTGTGACCGCCGCTTCTCCcagcgcggcNNNCT 
2FM-F2-QRG(X)Fn  GCAAAAACCGTTTCAATGCCCTGTCGAGTCCTGCGACCGCCGCTTCTCCcagcgcggcNNNCT 
2FM-F1(noF0)-QRG(X)Fn TTGTAAAACGGTACCAAACCGTATGCTTGCCCTGTCGAGTCCTGCGACCGCCGCTTCTCCcagcgcggcNNNCT 
2FM-NT-in-Fn  CGTTGTAAAACGGTACCAAACCTTATGCTTGCCCTGTC 
2FM-NT-out-Fn  ACGTTGTAAAACGGTACCAAACCT 
2FM-CT-out-Rn  AACAATTTCACACAGGATCCACG 
NOTE: For QRG(X) primers in place of NNN use ACN if X (F1 position 3) is Thr, use AAY if X (F1 position 3) is Asn, use 
CAC if X (F1 position 3) is His. 
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Table A-4:  
Gene 
G
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sa
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us
ed
 
Genotyping 
Forward primer 
for RFLP analysis 
or CelI assay    
 (5' to 3') 
Genotyping Reverse 
primer for RFLP 
analysis or CelI 
assay                       
(5' to 3') 
Forward Primer for 
Illumina Sequencing  
(5' to 3') 
Reverse Primer for Illumina 
Sequencing (5' to 3') R
es
tr
ic
tio
n 
E
nz
ym
e 
si
te
 u
se
d 
fo
r 
Il
lu
m
in
a 
 
sa
m
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e 
pr
ep
ar
at
io
n 
5' Tag for Counting 
InDels 
3' Tag for 
Counting 
InDels 
dab2ip 
RFLP - 
SfcI 
CAGGGTACCAC
TTCTCCAC 
CAGCCTATATGCC
CGCAC 
CGGCATACGAGCTCTTCC
GATCTCCACTTCTCCACC
AGCTGC GCGGTCCAGAGCGGTACCGTCC Hpy188I GTACCGTCCAT     TCGGAC 
hey2 
RFLP - 
XcmI 
CAGCCCCAGCG
TTACAGC 
CTGCTGACCGAA
GCAGGC 
CAAGCAGAAGACGGCAT
ACGAGCTCTTCCGATCTC
TGCTGACCGAAGCAGGC CTGCTGACCGAAGCAGGC Hpy166II AACCAT  GAACTG 
rock1 
RFLP - 
Hpy188I 
GAGATGGTGGA
GTCTTTCTC 
GTATTGTCTGCAG
GGAGTCTC 
CAAGCAGAAGACGGCAT
ACGAGCTCTTCCGATCTG
AGATGGTGGAGTCTTTCT
C GTATTGTCTGCAGGGAGTCTC StyI HF CAAGGCCGA GGCACG 
zgc77041 Cel1 
GGAGCAAATGT
AAGGCAAACC 
ATTGTTACATTTT
CAAAGATGCTG 
GGAGCAAATGTAAGGCA
AACC 
CAAGCAGAAGACGGCATACGAG
CTCTTCCGATCTATTGTTACATT
TTCAAAGATGCTG SnaBI GTACCCAT CTGGAG 
dclk2 
RFLP - 
AvaI 
GACACGGCGTA
CACAAGCC 
GAACCAGCGCTA
TCACTTAAG 
CAAGCAGAAGACGGCAT
ACGAGCTCTTCCGATCTG
ACACGGCGTACACAAGC
C GGCAGCGGCCGGCTCCC NaeI GGCTCCCATTCCGG ACGGGA 
mc4r Cel1 
CAGCCTCCTGGA
GAACATCC 
TCACGGTTGGTCA
GGTTGC 
CAAGAACCTACATTCCCC
TATGAACTTCTTC 
CGGCATACGAGCTCTTCCGATCT
CATAGAGTCAAACACGTTGTC XmnI TCTTCATCTGC GCAGAC 
lrp8 
RFLP - 
MwoI 
GAGGCTGTGAG
TATCTGTGC 
GAAAGTGTGCAG
TATGAGTAAAC 
CACTCACCCAAATACACC
GGTACCTGCC 
CGGCATACGAGCTCTTCCGATCT
CCAAATTTTACTCACAACAATG Acc65I GTACCTGCCCC CTGGGC 
mc3r Cel1 
TTCTTCTCGCCA
GACTTCAC 
CACCAGTAGAAT
GAGGTGGAG 
CCCGGCGGCTCCTGGTGC
TGGGTACCCAGCTC 
CGGCATACGAGCTCTTCCGATCT
GCAGAGGCAGAGCGGATG Acc65I GTACCCAGCTCCAC GCATGA 
apoeb 
RFLP - 
Hpy188III 
CCACCCAGAAA
CTGGGCGC 
GGTAAGTGTGGA
GCTCTTAAGC 
GAAGCTGGAGGAGACAG
CCGGGTACCTAC 
CGGCATACGAGCTCTTCCGATCT
GGTAAGTGTGGAGCTCTTAAGC Acc65I GTACCTACGC GGGCCG 
lepr Cel1 
AGGTGGACCGG
CACACAAC 
CACAATTCTTACA
AACATCAC 
CGGCATACGAGCTCTTCC
GATCTGGCGCACCTGTCA
ATCTGC 
CATTACACCAACAAAAGAGACC
AGGTACCTTCC Acc65I GTACCTTCCAC GAATTG 
irs2 
RFLP - 
Hpy188III 
GTTCACACTCTT
CTAAACTGTG 
CCTTTTGAAACCC
CCTGGTTG 
GTTTTCTCAACGAACAGA
GAAAGGTACCATG 
CGGCATACGAGCTCTTCCGATCT
CCTTTTGAAACCCCCTGGTTG Acc65I GAATGTACCATGCC GAAAAG 
Table A-4: Sequences of the genotyping primers used for lesions detection in zebrafish embryos. For the analysis by 
Illumina sequencing the restriction enzymes used for truncating the PCR product near the ZFN site for adaptor ligation are 
indicated. The unique 5’ and 3’ tags employed for distinguishing and counting sequences containing InDels for each target site 
are listed. 
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Table A-5: Sequences for barcoded adapters 
Barcode 
Strand 1 Sequence (no 
phosphorylation) 
Strand 2 Sequence (no 
phosphorylation) 
TT aaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTttT 
TG caAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtgT 
TC gaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtcT 
TA taAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtaT 
GT acAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgtT 
GG ccAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTggT 
GC gcAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgcT 
GA tcAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgaT 
CT agAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTctT 
CG cgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcgT 
CC ggAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTccT 
CA tgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcaT 
AT atAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTatT 
AG ctAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTagT 
AC gtAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTacT 
AA ttAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTaaT 
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Table A­6: List of 2F­modules selected using the B2H system.  
Clone 
ID 
9bp Binding 
Site F1 F2 F3 
R10-3 GAAGAGGCGG RSDTLAR RRENLIR LSSNLTR 
R10-5 GAAGAGGCGG RSDTLAR RNENLLR QGPNLSR 
R12-1 GAAGGGGCGG RSDTLAR RAEHLTN QHPNLTR 
R12-2 GAAGGGGCGG RSDTLAR RAEHLTN QAPNLGR 
R13-1 GAAGTGGCGG RSDTLAR RRNILQN LSSNLTR 
R15-1 GACGCGGCGG RSDTLAR RTDDLKR DPSNLRR 
R15-4 GACGCGGCGG RSDTLAR RRDDLTR EGGNLMR 
R16-2 GACGGGGCGG RSDTLAR RVDHLHR GGDNLVR 
R17-1 GACGTGGCGG RSDTLAR RRQILRN DPSNLRR 
R17-4 GACGTGGCGG RSDTLAR RPQILIN DPSNLRR 
R18-4 GAGGAGGCGG RSDTLAR RPDNLGR RHDQLTR 
R18-5 GAGGAGGCGG RSDTLAR RPDNLGR RVDNLPR 
R19-1 GAGGCGGCGG RSDTLAR RRESLVR RDDHLGR 
R19-2 GAGGCGGCGG RSDTLAR REDTLTR RHDQLTR 
R20-1 GAGGGGGCGG RSDTLAR RKAHLKN RRDNLLR 
R20-4 GAGGGGGCGG RSDTLAR RRAHLGN RQDNLQR 
R21-1 GAGGTGGCGG RSDTLAR RRQILRN RRDNLLR 
R21-2 GAGGTGGCGG RSDTLAR RRSILAN RGDNLAR 
R22-1 GATGAGGCGG RSDTLAR RPDNLGR VVNNLAR 
R22-4 GATGAGGCGG RSDTLAR RVDNLGR ISHNLAR 
R23-4 GATGCGGCGG RSDTLAR RQDDLTR LSQNLGR 
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R24-3 GATGGGGCGG RSDTLAR RAAHLDN VTNNLKR 
R24-4 GATGGGGCGG RSDTLAR RNTHLDN VTNNLKR 
R25-3 GATGTGGCGG RSDTLAR RRSILAN VVSNLRR 
R27-2 GCAGCGGCGG RSDTLAR RRDDLLR QGGTLRR 
R27-5 GCAGCGGCGG RSDTLAR RADSLPR QGGTLRR 
R28-1 GCAGGGGCGG RSDTLAR RQEHLVR QGGTLRR 
R28-5 GCAGGGGCGG RSDTLAR RREHLAR QGGTLRR 
R29-2 GCAGTGGCGG RSDTLAR RREVLMN QGGTLRR 
R29-5 GCAGTGGCGG RSDTLAR RSEVLAN QGGTLRR 
R30-1 GCCGAGGCGG RSDTLAR RADNLAR EHRGLKR 
R30-2 GCCGAGGCGG RSDTLAR RGDNLVR GRSDLTR 
R30-3 GCCGAGGCGG RSDTLAR RPDNLGR DHSNLSR 
R34-2 GCGGAGGCGG RSDTLAR RRENLKR RTDSLPR 
R34-3 GCGGAGGCGG RSDTLAR RQDNLGR RHQGLHH 
R34-4 GCGGAGGCGG RSDTLAR RQDNLGR RREGLGR 
R44-3 GCGGCGGCGG RSDTLAR RADSLPR RTDSLPR 
R44-4 GCGGCGGCGG RSDTLAR RSDDLRR RTDSLPR 
R46-2 GCGGTGGCGG RSDTLAR RRQILLN RPDGLAR 
R46-3 GCGGTGGCGG RSDTLAR RRNILQN RLDMLAR 
R47-3 GCTGAGGCGG RSDTLAR RQDNLGR VSNTLTR 
R47-4 GCTGAGGCGG RSDTLAR RQDNLGR LGHTLNR 
R48-4 GCTGCGGCGG RSDTLAR RADGLTR LKHDLGR 
R48-5 GCTGCGGCGG RSDTLAR RRDDLTR LGHTLNR 
R49-2 GCTGGGGCGG RSDTLAR RNDHLTN VTNSLTR 
228
R49-3 GCTGGGGCGG RSDTLAR RSAHLQN VKNTLTR 
R50-1 GCTGTGGCGG RSDTLAR RVEVLTN VRNTLTR 
R50-5 GCTGTGGCGG RSDTLAR RTEVLAN VGASLKR 
R51-1 GGAGAGGCGG RSDTLAR RSDNLGK QTTHLSR 
R51-2 GGAGAGGCGG RSDTLAR RPDNLVR QGGHLAR 
R51-3 GGAGAGGCGG RSDTLAR RPDNLGR KKDTLGN 
R52-2 GGAGCGGCGG RSDTLAR RTDMLAR QGGHLKR 
R52-5 GGAGCGGCGG RSDTLAR RRDILLR QGGHLKR 
R54-3 GGAGTGGCGG RSDTLAR RREVLMN QTTHLSR 
R54-5 GGAGTGGCGG RSDTLAR RREVLVN QSQHLVR 
R55-1 GGCGAGGCGG RSDTLAR RQDNLGR KRVSLNL 
R55-5 GGCGAGGCGG RSDTLAR RADNLGR DPSHLPR 
R56-1 GGCGCGGCGG RSDTLAR RRDDLQR ETGHLKR 
R57-1 GGCGGGGCGG RSDTLAR RGEHLTR ESGHLKR 
R58-1 GGCGTGGCGG RSDTLAR RADSLPR ERRGLHR 
R58-5 GGCGTGGCGG RSDTLAR RRDLLHN KNISLNH 
R59-1 GGGGAGGCGG RSDTLAR RTDNLDR RIDKLGG 
R59-3 GGGGAGGCGG RSDTLAR RPDNLGR RVSHLQR 
R60-5 GGGGCGGCGG RSDTLAR RQDDLTR RRXGLGR 
R61-3 GGGGGGGCGG RSDTLAR RREHLTR RNDKLVP 
R62-1 GGGGTGGCGG RSDTLAR RREVLMN RNHGLVR 
R62-2 GGGGTGGCGG RSDTLAR RREVLEN RNHGLVR 
R63-1 GGTGAGGCGG RSDTLAR RLDNLDR HTHRLVS 
R63-5 GGTGAGGCGG RSDTLAR RRENLKR IRHHLKR 
229
R64-4 GGTGCGGCGG RSDTLAR RPDDLRR AGGGLAR 
R64-5 GGTGCGGCGG RSDTLAR REDGLHR HTHRLVS 
R65-2 GGTGGGGCGG RSDTLAR RQEHLVR HTHRLVS 
R66-3 GGTGTGGCGG RSDTLAR RVEVLTN IKHHLGR 
R66-4 GGTGTGGCGG RSDTLAR RRSILAN IRHHLKR 
R69-3 GTAGGGGCGG RSDTLAR RQEHLVR QHSSLSR 
R70-1 GTAGTGGCGG RSDTLAR RKQILNN QGGALQR 
R70-4 GTAGTGGCGG RXDXLAR RAGILTN QRGSLGR 
R71-1 GTCGAGGCGG RSDTLAR RGDNLGR DLSSLPR 
R71-3 GTCGAGGCGG RSDTLAR RRENLKR DQTVLRR 
R72-1 GTCGCGGCGG RSDTLAR RSDDLRR ESGALRR 
R73-1 GTCGGGGCGG RSDTLAR RQEHLVR EGGALKR 
R73-2 GTCGGGGCGG RSDTLAR RQEHLVR DRTPLNR 
R74-2 GTCGTGGCGG RSDTLAR RTDGLVR ERRSLGR 
R74-4 GTCGTGGCGG RSDTLAR RPDNLGR DRTPLQR 
R75-4 GTGGAGGCGG RSDTLAR RDDNLQR RPDALPR 
R75-5 GTGGAGGCGG RSDTLAR RQDNLGR RDANLAT 
R76-2 GTGGCGGCGG RSDTLAR RPDDLRR RPDALPR 
R76-3 GTGGCGGCGG RSDTLAR REDTLTR RGANLNL 
R77-1 GTGGGGGCGG RSDTLAR RVEHLNN RMDALMR 
R77-3 GTGGGGGCGG RSDTLAR RVDHLHR RGDPLHR 
R78-3 GTGGTGGCGG RSDTLAR RTEILRN RHTSLTR 
R78-4 GTGGTGGCGG RSDTLAR RRDTLRR RRTILVN 
R79-1 GTTGAGGCGG RSDTLAR RQDNLGR ARHRLIP 
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R79-2 GTTGAGGCGG RSDTLAR RRENLIR IRTSLKR 
R79-3 GTTGAGGCGG RSDTLAR RADNLGR ARHNLVP 
R80-2 GTTGCGGCGG RSDTLAR RADSLPR IRTSLKR 
R80-3 GTTGCGGCGG RSDTLAR RADTLRK HHNSLTR 
R81-3 GTTGGGGCGG RSDTLAR RAEHLTN INHSLRR 
R81-4 GTTGGGGCGG RSDTLAR RAAHLDN VNSSLGR 
R82-1 GTTGTGGCGG RSDTLAR RRQILSN HHNSLTR 
R82-2 GTTGTGGCGG RSDTLAR RRNILQN HHNSLTR  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Figure A­1 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Figure A­1: Binding site specificities of B2H-selected 2F-modules.  The binding site 
specificities of B2H-selected 2F-modules were determined using the CV-B1H system. 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